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CHAPTER 1
Introduction
1.1 Aributablemortality of healthcare-associated
infections
A Healthcare-associated infection (HAI) is defined as an infection which was not
incubating at the time of admission to the hospital, usually occurring 48 hours or
more aer admission (American thoracic society and Infectious diseases society of
america, 2005; Valles and Ferrer, 2009). HAI is common in hospitals worldwide. The
European point-prevalence survey of HAI and antimicrobial use 2011-2012 (ECDC,
2013) found a prevalence for Belgium of 7.1% infected patients, with intensive
care the unit type that is most aected (20.3% prevalence). HAI has long been
recognised as an adverse event in clinical care, meaning that it has the potential of
worsening a patient’s health status once it occurs and of being preventable (Valles
and Ferrer, 2009; Chastre, 2005). It is understood that by preventing infection in
a patient in acute care, the risk that this patient dies or needs extra care, can be
reduced. Both these statements, the feasibility of measures for the prevention of
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infection and the eects of infection on mortality and morbidity, are supported by
a vast literature in hospital epidemiology and clinical care.
In what follows we elaborate in particular on the aributable eect estimation
of HAI. Knowing the exact eects of infection is considered important, since it
guides clinicians in prioritising the care of patients with infection, it guides patients
and their relatives on the excess risks of mortality and morbidity, and it guides
hospital sta and external partners on the expected outcomes when investing in
or adopting novel strategies for the prevention of infection (Muscedere, 2009).
Despite the assumed adverse eects of infection on a patient’s health, studies on
aributable mortality eect estimation of infection give controversial results, with
results that describe this eect as being neutral to extremely risk increasing (Carlet,
2001; Muscedere et al., 2010; Timsit et al., 2011; Klompas, 2009; Nguile-Makao et al.,
2010; Melsen et al., 2009; Siempos et al., 2009; Renaud and Brun-Buisson, 2001;
Rello et al., 2000; Digiovine et al., 1999; Rello, 1999). Various explanations can be
given for this. First, no unified case definitions exist for HAI, meaning that it is
diicult to pinpoint the literature on this subject if it uses dierent methods to asses
HAI. Second, data on this subject is derived from dierent study types, ranging
from prospective surveillance studies towards retrospective case-cohort design or
data derived from administrative databases. Third, dierent populations are oen
studied, from single-center intensive care units within tertiary hospitals with a
specific patient population to national or even multinational multicentric studies
having a substantial heterogeneity of units and medical practice, and therefore
of the incidence of HAI, mortality and prognostic factors. Fourth, only a minority
of studies provide details on the appropriateness of the treatment for infection,
while it is agreed that presence or absence of this is pivotal for patient outcome.
Fih, it is well acknowledged that the eect of HAI on mortality or morbidity
needs to be carefully adjusted in order to separate the eect of HAI from those
of underlying prognostic factors prior to infection, both intrinsic (related to the
patient’s profile) and extrinsic (related to the treatments the patients receives)
factors. Indeed, groups of patients with and without infection will to a certain
extent be unbalanced in terms of prognostic factors for mortality and infection,
which leads to confounding of the infection-mortality association. Because of
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this, adjustment for such prognostic factors in any estimation procedure will be
necessary. Additional adjustment may be needed when only patient follow-up
data within the hospital or ward is available for analysis, as is usually the case.
When studying mortality, this means that a group of subjects has an unobserved
outcome event and correspondingly a censored survival time. This censoring occurs
when a patient dropped out from follow-up, or in this case is being discharged
alive from the hospital or ward. When the reasons for censoring are linked to
the outcome event itself, as will be the case here because a patient will mostly be
discharged from the hospital for health reasons, then further adjustment is needed
for this so-called selective drop-out. In the literature, these adjustments are not
always performed, and even so, a wide variety of models and adjustment methods
are used, not all of which are appropriate.
This thesis looks more deeply at the statistical estimation of the aributable
mortality of infection. We will start with explaining how we collected the data
that we used for our analysis. These are derived from the National surveillance
of infections acquired in intensive care units (NSIH-ICU) (Section 1.2, Chapter 2),
a longstanding national surveillance study for monitoring the incidence of HAI,
which has lead to a rich database of participating hospitals, patients, collected
outcomes, and risk factors. Over the years, the NSIH-ICU data have become
an appropriate basis for estimation of aributable eects of infection. This is
due to the many risk factors that are collected during surveillance, which form
a description of a patient’s health status or therapeutic activity, and therefore
can be considered as prognostic variables for mortality. Such variables are ideal
candidates when wanting to adjust the estimated crude eect of HAI on mortality
for underlying patient health, and as such come to an estimated eect that is as
much as possible aributable to the onset of HAI (Samore et al., 2007; Soufir et al.,
1999; Heyland et al., 1999; Fagon et al., 1996).
In Sections 1.3 and 1.4 of this Introduction, we explain why we have chosen two
types of estimators as the basis for estimating the aributable eect of HAI on
mortality. These are Inverse probability of exposure and censoring weighted (IPECW)
estimation under a Marginal structural proportional hazards model (MSPHM), and
Inverse probability of censoring weighted (IPCW) G-estimation under a Structural
3
Chapter 1. Introduction1
nested accelerated failure time model (SNFTM). These are estimators of causal eects,
meaning that they deliver unbiased eects in larger samples, or that the estimated
eect does not deviate systematically from the true eect. We will demonstrate
that this is a challenge given the observational nature of the study, the time-
dependent exposure to HAI, the presence of time-varying prognostic factors that
can act as cause and eect of HAI and as such lead to time-varying confounding
of the infection-mortality relation, and the selective drop-out of patients under
surveillance. Given the specific features of our data, the studied exposure and
outcome, we will then describe relative risks for describing aributable eects with
causal interpretation, and the underlying assumptions of our analysis that allow us
to identify these. We will then demonstrate why, in this context, standard regres-
sion models usually fail in delivering such eects, as opposed to aforementioned
estimators.
The IPECW estimator under a MSPHM is then applied and further developed
in Chapters 3 and 4 respectively, while the IPCW G-estimator under a SNFTM is
further developed and applied in Chapter 5. Finally, Chapter 6 closes this thesis by
summarising the found results, and presenting further comments and ideas for
the future.
1.2 National surveillance of infections acquired in
intensive care units
The National surveillance of infections acquired in intensive care units (NSIH-ICU),
organised by the Scientific institute of public health (IPH), is an observational study
on the incidence of Healthcare-associated infection (HAI) in the Intensive care
unit (ICU). Its objectives are to standardise data collection on infection incidence
within the ICU across acute care hospitals in Belgium, and to collect national
reference data on the incidence of ICU-acquired infection. Both these aspects,
standardisation of methods and collection of reference data, then allow the mon-
itoring of trends on a hospital and a multicentric (regional, national, European)
level and the comparison of infection rates between hospitals. The NSIH-ICU study
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uses the concept of clinical surveillance, applies it to ICU-acquired infections and
extends it towards a national level. Surveillance is here defined as the collection
of data on particular clinical events and analysing and interpreting its results in
light of historic data (trend analysis) or data of other hospitals (benchmarking
with reference data). When done continuously and systematically, surveillance
has proven to be an essential part in a strategy for the prevention of infection,
specifically when it targets HAI as an adverse clinical event, when it measures
its incidence, and when its results are interpreted with the concerned hospital
sta (Haley et al., 1985; Gastmeier et al., 2000b).
Surveillance of HAI within intensive care is one of the principal types of surveil-
lance for HAI. This is due to the high prevalence of infections among intensive care
patients, which results in measures of infection incidence that are both precise and
reducible. The focus on the intensive care environment makes this surveillance also
relatively more feasible from a practical point of view as compared to other types
of surveillance that cover the entire hospital. Such practical considerations are
important, for example when unit sta needs to be trained for epidemiological case
definitions, or when data collection needs to be organised. A high involvement of
unit sta also guarantees a prospective data collection, which is considered advan-
tageous in terms of completeness and quality of data as compared to retrospective
studies. Such prospective data collection will be beneficial in implementing a
culture of increased awareness for the studied event, and can therefore be instru-
mental in the prevention of such events and in limiting its aributable mortality
and morbidity (Blot, 2008).
Because the NSIH-ICU surveillance is multicentric, it provides to a certain extent
representativeness with the Belgian ICU population for the studied time period.
This refers particularly to the inclusion of ICU units from primary and secondary
hospitals, which are oen lacking in literature reports on aributable mortality of
infection that are mostly done by groups from tertiary (teaching and academic) cen-
tres. The amount of data collected also allows deeper investigation of aributable
eects within particular subgroups of patients, based for example on categories of
severity scores. Furthermore, due to eorts during the last two decades at a Euro-
pean level in standardising the methodology of national surveillance of infections
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in the ICU, the results of the Belgian surveillance can be compared with those of
other networks in Europe and contribute to reference data on infection incidence
across Europe (Oical journal of the European communities, 1998, 2009).
Because HAI surveillance occurs within a context of quality improvement of
clinical care, the outcomes of such surveillance need to support clinical decisions.
Therefore, data collection on infections, their risk factors and outcomes need to
have a suicient level of clinical detail. This is made explicit by the surveillance
protocol, which is the principal tool for standardisation of data collection over all
participating hospitals, and is elaborated in close collaboration with clinicians from
hospitals performing infection surveillance. Next to stating the objective of the
surveillance, this protocol gives all specifications of the data that is to be collected,
including definitions of the types of HAI under surveillance, their risk factors and
outcomes.
Case definitions of infections are based on exhaustive lists of clinical signs,
symptoms and radiological and microbiological evidence. The collection of data on
the occurrence of HAI is called case-based, meaning that each individual episode
of HAI that occurs within the followed population needs to be documented. This
includes the day of infection onset, which allows preciser adjustment of infection
incidence, for example on aggregated patient- or device days only occurring before
the onset of an infection episode. Data collection on specific characteristics of
infections aims to distinguish particular infection subtypes that are the focus of
prevention strategies (such as invasive device-associated infections), and also to
distinguish the diagnostic strategies within hospitals for particular infections (for
example when due to pneumonia) (Suetens et al., 2002).
The collection of risk factors for infection supports the objective of standardisa-
tion of infection rates for factors related to each hospital’s or unit’s specific patient
population. It therefore objectifies a hospital’s evolution of its HAI incidence over
time, as well as the comparison of its infection incidence with other hospitals (Sax
and Piet, 2002). These risk factors form a description of the patient’s health
status at admission to the ICU (intrinsic factors), or of the therapeutic activity
done during a patient’s stay at unit (extrinsic factors). Risk factor data collection
is done on all patients included in the surveillance, therefore making surveillance
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also patient-based. Furthermore, because the daily infection risk increases with the
number of days that a patient remains in the unit, risk factors for infection are
also collected on a daily basis.
Other outcomes (next to infections) that are collected are the vital status at
discharge from the unit, including the date of discharge which allows calculating
the number of patient days for each patient. Knowing these outcomes is important,
because they can be used to measure the impact of infection incidence on either
mortality, length of stay, or device utilisation. This is done either for a specific
period, or by relating the trend in infection incidence to the trend of other measured
outcomes.
The surveillance protocol is further complemented by registration soware
allowing entry and validation of surveillance data locally by the hospital (Freeman
et al., 2013), and by feedback reports that calculate relevant indicators on infection
incidence, their risk factors and outcomes (Gaynes et al., 2001). The registration
soware allows in the first place to do manual entry of locally collected surveillance
data. A separate module supports the import of existing electronic data. In practice,
this is a cumbersome task as many computerised systems in hospitals were initially
implemented for administrative purposes. Even when implemented for clinical
reasons, these do not automatically serve the objective of epidemiological follow-
up, and necessitate expert data querying skills by the hospital (Colpaert et al., 2010).
Also, surveillance data in electronic format will need to be collected from many
sources, such as databases on admissions, laboratory results or clinical therapies,
which renders an integrated automatic re-use even more diicult.
Reporting of surveillance data collected in a multicentric context is a complex
task because it needs to be done for each participating hospital or their individual
units, and for a particular surveillance year or quarter. In a first stage, reporting is
done by the hospital on the local hospital database using the registration soware,
which allows for a hospital or unit to validate its data before it is decided to send
these to the national coordinating center. In a second stage, reporting is done on
the national reference data, which enables comparison for each indicator with the
relevant percentiles of the national distribution of these indicators, and enables
the hospital to position their obtained results within the national distribution.
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Results on infection incidence of individual hospitals are considered to be too
sensitive to be made publicly available. This is because infections are considered
as adverse events; a high incidence can be interpreted as bad performance on the
hospital’s or unit part. However, a hospital is not in complete control of the HAIs
that it observes during surveillance, its infection rates are determined by many
other factors that are beyond the control of the hospital and its sta. Still, due to
this sensitivity, a hospital’s specific results together with their comparison with
national reference data are only reported to the hospital that contributed the
surveillance data. The IPH formally acts here as a Trusted third party (TTP), taking
up the role of intermediate between the hospital and the federal government, by
feeding back the hospital-specific results only to the hospital itself (as described
above), and by reporting results to the Federal or other levels only in aggregated
form, not allowing identification of results of individual hospitals. This definition
and role of a TTP ensures that valid multicentric data on adverse events can
be collected, guaranteeing hospitals confidentiality and preventing their results
from being used against them. In other words, it guarantees a non-punitive or
-blaming environment (Oical journal of the European communities, 2009; Martin
et al., 2013).
1.3 Causal Inference
1.3.1 Notation
Our study follows a cohort of n subjects in time, with measurements at discrete
time points t = 1, ..., Tm (with Tm the total follow-up time) of a time-dependent
exposure and risk factors, an outcome event, and a drop-out event. In what
follows, we will suppress the identifier for subject i if possible. At each time-point,
the following random variables are defined: the exposure A, the outcome Y , a
vector L of measured prognostic factors aecting both A and Y . Variable U is
a vector of unmeasured prognostic factors. The distinction between U and L
is essential, as we assume that it is impossible in a collection of observational
data to measure every common predictor of exposure and outcome. Variable
8
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C indicates whether the subject is lost to follow-up at a particular time-point,
which will lead to Y being unobserved at that time. Variables A, Y and C are
dichotomous, taking values 0 (not present) or 1 (present). Variables U and L can be
dichotomous, categorical or continuous (or multiples of these combined in a vector).
At a particular t, temporal ordering is (U,L,A,C, Y ). The full data is the vector
of variables V = (U,L,A,C, Y ), while the observed data - which is available for
analysis - will be the vector X = {L,A,C, (1−C)Y }. For any variable Z , a lower
case symbol z will indicate one of its possible realisations; the isolated use of such
a lower case in a counterfactual outcome (see further) or conditioning statement
will indicate “Z = z”, ie. Yz ≡ YZ=z and E(Y |z) ≡ E(Y |Z = z).
All variables defined above are essentially time-varying, meaning that a variable
Z can take a value at a particular time point t that is dierent from its value at
the previous time point t− 1, Zt will therefore indicate Z measured at t. Variables
A, C and Y are defined to have absorbing states at value 1, meaning that once
this value is obtained it will remain so until the rest of the follow-up time. Denote
the history of a variable up to time-point t as Zt = (Z1, .., Zt), with 0 = (01, .., 0t).
Also, let Z0=0. Let the survival time T be the discrete time from study start at
t = 0 until the time t at which the event of interest Y occurs.
Applying the above notation to our study of the eect of infection on mortality
within the ICU, exposure to infection will be denoted by A, death in the ICU by Y ,
being discharged alive from the ICU (or lost to follow-up) by C , and the measured
prognostic factors by L.
1.3.2 A discrete-time proportional hazards model
We can estimate the eect of exposure A on outcome Y by calculating λY (t|at),
which is the conditional hazard of the outcome event for each group of subjects
with observed exposure history At = at. When relying on (semi-)parametric
models, this is usually done using a time-dependent Cox proportional hazards
model (Hosmer et al., 2008). Also, because our study design is based on discrete
time-points at which information on exposure and outcome is collected, we will use
the discrete-time representation of the conditional hazard: P (Yt = 1|Yt−1 = 0, at),
9
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which is the risk of the outcome event Y at time t conditional on Y not having
occurred until t− 1, and on exposure history At = at at t. Using the way the data
is structured, with one observation for each time a subject is under follow-up, it is
straightforward to calculate the discrete-time hazard under the logistic regression
model
P (Yt = 1|Yt−1 = 0, at; βst) = expit(βst0 + βst1 at) (1.1)
with βst an unknown parameter vector (“st” abbreviation for standard) and expit(u) =
exp(u)/{1+exp(u)}. For the sake of exercise, we used the simplest model possible,
thereby ignoring possible time-specific main eects. If we take at = at (therefore
assuming one-dimensional βst1 ), and assume a rare outcome, or expit(u) ≡ exp(u),
model (1.1) can now be used to define the following contrast
exp βst1 =
P{Yt = 1|Y t−1 = 0, at = 1; βst}
P{Yt = 1|Y t−1 = 0, at = 0; βst}
(1.2)
or the ratio of discrete-time hazards at t for subject-times under observed exposure
at = 1 versus observed exposure at = 0. Hazard ratio (HR) (1.2) is a subgroup
contrast ; it contrasts a measure of the outcome across subgroups according to
exposure status at t and to being alive at t−1. Causal interpretation of this contrast
is problematic, due to it being defined within subgroups of subjects that are not
exchangeable in terms of prognostic factors U and L. In further sections, we will
elaborate on how we can arrive at contrasts that do have causal interpretation.
1.3.3 Exposure regimes, potential outcomes and causal con-
trasts
Let a ≡ aTm = (a0, a1, ..., aTm), be the exposure regime set through study end Tm,
and Yt,a, the potential or counterfactual outcome of a subject under exposure regime
a (Rubin, 1978; Robins, 1986; Herna`n, 2004). Yt,a is called a potential outcome,
because for each subject it is only potentially observed, or observed counter-to-fact.
Using a simplified study design with study end at Tm = 2, no drop-out before study
end, and taking into account the absorbing state of At = 1 at any t, each subject
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will have three potential outcomes at Tm = 2, {Yt,(0,0), Yt,(1,1), Yt,(0,1)}. Of these,
only the potential outcome that corresponds to the observed exposure regime will
be observed.
Potential outcomes are used to define a causal or population contrast, which
is clearly distinguished from the earlier defined subgroup contrast. Assume that
we are able to observe for each subject the potential outcomes under all possible
exposure regimes. For now, let us ignore how we achieved this, in further sections
we will explain the assumptions and techniques behind the identification of the
mean of potential outcomes. In the original dataset, each single observation provides
for one subject the result of his or her outcome Yt for exposure At = at at t. When
all potential outcomes are observed, each observation will be augmented according
to the number of possible exposure regimes; in our example, each observation
will be augmented with two supplementary outcomes, accounting for the two
counterfactual outcomes that are unobserved. Using this augmented dataset to fit
a logistic regression for the risk of the outcome as a function of exposure regime a,
this will yield:
P (Yt,a = 1|Yt−1,a = 0; βc) = expit(βc0 + βc1at)
for all a, t ≤ 2 (1.3)
and corresponding contrast
exp βc1 =
P{Yt,(a1,1) = 1|Y t−1,(a1,1) = 0; βc}
P{Yt,(0,0) = 1|Y t−1,(0,0) = 0; βc}
for t ≤ 2 (1.4)
with βc an unknown parameter vector (“c” abbreviation for causal), of which exp βc1
is the counterfactual hazard ratio when exposure regime is set to (a1, 1) versus
when exposure regime is set to (0, 0) at t ≤ 2. Contrast (1.4) uses averages of
counterfactual outcomes, and does not suer from being defined within dierent
(unexchangeable) subgroups of observed exposure history, as was the case with
contrast (1.2). We would therefore be tempted to interpret this as a causal contrast.
This is however problematic, due to the numerator and denominator of (1.4) still
conditioning on dierent subgroups, being Y t−1,(a1,1) and Y t−1,(0,0) respectively,
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that are not exchangeable in terms of prognostic factors. To resolve this, we can
use the predicted hazards of model (1.3) for the calculation of P (Yt,a = 0), or the
counterfactual risk of survival under exposure regime a at t, as follows
P (Yt,a = 0; β
c) =
t∏
s=1
{1− P (Ys,a = 1|Ys−1,a = 0; βc)} (1.5)
and then construct
P{Yt,(a1,1) = 0; βc}
P{Yt,(0,0) = 0; βc} for t ≤ 2 (1.6)
or the counterfactual survival risk ratio when exposure regime is set to (a1, 1) versus
when exposure regime is set to (0, 0) at t ≤ 2. Contrast (1.6) does not suer from the
problems due to conditioning on a counterfactual under dierent exposure regimes,
which makes it a population or causal contrast, or a contrast that is unconfounded
by prognostic factors. We define it as the total causal eect of exposure at any time
on outcome.
Let us study other causal contrasts of interest, and consider following model:
P (Yt,a = 1|Yt−1,a = 0, βc,1) = expit{βc,10 + βc,11 a1
+βc,12 a2(1− a1)}
for all a, t ≤ 2 (1.7)
with βc,1 an unknown parameter vector, of which exp βc,11 is the hazard ratio when
exposure regime is set to (1, 1) versus when exposure regime is set to (0, 0), and
exp βc,12 is the hazard ratio for subjects under exposure regime (0, 1) versus exposure
regime (0, 0). Using formula (1.5) to convert hazards in survival risk, we can
decompose causal contrast (1.6) into contrasts that will give us insight into the
time-varying nature of the causal eect of exposure on outcome, and as such be
able to estimate lag-eects of exposure. This is because βc,11 and β
c,1
2 parametrise
the eect of exposure starting at time-points t = 1 and t = 2 respectively. Aer
conversion to counterfactual survival risk and when compared to exposure regime
a = (0, 0), these parameters will measure the total or overall eect of exposure at
12
11.3. Causal Inference
t = 1 and t = 2 on outcome.
Furthermore, contrast exp(βc,11 −βc,12 ) is the hazard ratio when exposure regime
is set to (1, 1) versus when exposure regime is set to (0, 1). The corresponding
counterfactual survival risk ratio measures the controlled direct eect (Robins and
Greenland, 1992; Vansteelandt, 2012) of exposure at t = 1 on outcome at t = 2,
so-called because the only dierence between these two exposure regimes is the
seing of exposure at t = 1 to 0 or 1, with exposure at t = 2 being fixed to
“exposed”. From the above arguments, we call (1.7) a model for the joint causal
eect of exposure.
1.3.4 Identifying conditions
As explained above, potential outcomes are an abstract concept, ie. for each subject
only one potential outcome for each subject-day will be observed by definition,
with the distribution of potential outcomes under remaining exposure regimes
needing to be identified. The identification of the average of a potential outcome
[such as the numerator or denominator of contrast (1.4)] is possible under a set of
identifying assumptions for causal inference (Rosenbaum and Rubin, 1983), stated
as follows and explained one by one hereaer:
Consistency of exposure regime : Yt,a = Y if A = a
for all a, t (1.8)
Sequential randomisation of exposure : Yt,a q As|ys−1 = 0, as−1, ls
for all t, s ≤ t, as−1, ls (1.9)
Positivity of exposure risk : P (At = at|yt−1 = 0, at−1, lt) > 0
for all at, t (1.10)
Consistency assumption (1.8) states that a subject’s potential outcome under
her actually observed exposure regime is precisely her observed outcome. Under
this assumption, the mechanisms under which the exposure regime a was set, may
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have no other hypothesised influence on the outcome Y than by seing the actual
exposure. It therefore calls for the definition of realistic exposure regimes, and their
corresponding potential outcomes, when relying on these for eect estimation.
More specifically, one needs to be able to explain how a particular exposure regime
could hypothetically be assigned to a subject that was in reality exposed to a
dierent regime. Also, such exposure regime should be in correspondence with
the study that generated the data (Herna`n and Taubman, 2008). Applied to our
study, potential outcome risk for mortality under presence (or absence) of exposure
to infection needs to be unambiguously defined. By defining the eect that would
be seen in patients if infection would be prevented (Fagon et al., 1993, 1996; Bonten
et al., 2004; Rello and Valles, 1998), some authors already have phrased the research
question in causal terms, however without resorting to estimators that directly
involve potential outcomes. In Section 1.2, we explained that the surveillance
study that gave rise to our data is actually part of a strategy for the prevention
of infections; hypothesising about the counterfactual outcome mortality when
infections are prevented is therefore a valid exercise, as such an outcome is both
realistic as well as imaginable in the data we use for this study.
The consistency assumption for causal inference has received aention in re-
sponse to a few studies that look at exposures that could not be immediately
considered as realistic interventions, nor were the potential outcomes under this
exposure immediately realistic for the studied population (Cole and Frangakis,
2009; Vanderweele, 2009; Haight et al., 2005). For example, in a study of the causal
eect of body mass index (BMI) or body composition on mortality (Herna`n and
Taubman, 2008), it is unclear how a studied population could be assigned a par-
ticular BMI, because experiencing a certain BMI at a certain moment is assumed
to depend on a complex series of biological pathways. Also, even when these
pathways are known in such a way that the investigator knows how to arrive
at a particular BMI at a particular time, it is not unrealistic that some pathways
that lead to exposure would also be related to outcome in other ways than by
influencing exposure. As a result, two pathways that lead to the same exposure
level might still lead to dierent outcomes, resulting in ill-defined potential out-
comes. Applied to our study, imagine for example an exposure regime “absence
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of infection” hypothetically generated by a profylactic drug that not only kills o
a pathogen but also independently worsens a patient’s prognosis as a side eect.
The potential outcome generated under such regime would be ill-defined because
the pathways that generate such a regime influence the outcome by other ways
independently of the regime itself.
The Sequential randomisation assumption (SRA) (1.9) states that, conditional on
survival, exposure and confounder history (Y t−1, At−1, Lt), the potential outcome
Ya is independent of exposure A at t. It says that exposure at t is randomised
within levels of exposure and measured confounder history at t, in other words
that exposure is sequentially randomised. This means that, although the overall
groups formed by exposure may be non-comparable in terms of L, they will be-
come comparable sequentially within the levels formed by (Y t−1, At−1, Lt). We
assume that sequential randomisation holds within levels of measured prognostic
factors At−1 and Lt, which is more strict than when this would also include the
unmeasured U t, and therefore this assumption is also known as the assumption
of No unmeasured confounders (Rosenbaum and Rubin, 1983). Informally, it says
that history of exposure and measured confounders is suicient in adjusting the
exposure-outcome association at t.
The assumption of Positivity of the risk of exposure (1.10) states that within
each stratum defined by the measured confounder history Lt, there is variation
in the exposure. In other words, there may be no levels of confounders where
no subjects in the population are (un)exposed, or generally where exposure is
deterministically set. Because of this, this assumption is also referred to as the
assumption of Experimental treatment assignment (van der Laan and Robins, 2003).
As an example, we consider a study with a single time point Tm = 1, and verify
how we can use aforementioned assumptions to identify the average of a potential
outcome E(Ya). With a single time-point, these assumptions will be: Consistency
of exposure: Ya = Y if A = a for all a; Conditional randomisation of exposure:
Ya q A|l for all l; Positivity of exposure risk: P (A = a|l) > 0 for all a.
E(Ya) = E {E(Ya|L)}
= E {E(Ya|a, L)}
15
Chapter 1. Introduction1
= E {E(Y |a, L)} (1.11)
the first equality is due to conditional expectation (Casella and Berger, 2001), the
second to conditional randomisation, the third to consistency of exposure, and
positivity of exposure risk is needed to identify E(Y |A = a, L). Equation (1.11)
shows how to identify the potential outcome from the observed data by means
of standardisation: calculating the outcome’s mean for particular values of the
exposure regime conditional on prognostic variables, and averaging this towards
the risk of the marginal realisations of the prognostic variables, this last step being
called standardisation. Further on, we will use standardisation in the seing of
time-varying exposure regimes.
1.3.5 Censoring of survival time
As introduced above, observation of the outcome Yt depends on whether the subject
did not drop-out at or before t, which is encoded in Ct (with values 1 in case of
drop-out and Yt missing, 0 if not). The same applies to observation of exposure
and prognostic variables At and Lt, which will be only observed when Ct−1 = 0.
Due to this, we need to append ct−1 = 0 to the conditioning events of SRA (1.12)
and Positivity (1.10).
Variable C is called the Censoring event because it encodes information on
censoring of the survival time. Because censoring might lead to a selective subset
of subjects relative to the studied source population (see further), our aim is to
identify the distribution of the outcome for those subjects that drop-out, in analogy
to the identification of potential outcomes defined in terms of exposure regimes.
In order to identify Y under missingness, we adapt assumptions (1.8-1.10) for
identifying potential outcomes as follows (Rubin, 1976; Robins et al., 1994):
Ignorable censoring assumption (ICA): we assume that, at any time-point, cen-
soring is independent of the counterfactual outcome, conditional on neither the
outcome nor censoring having occurred, and on the history of exposure and of risk
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factors for censoring and outcome up to that time:
Yt,a q Ct|yt−1 = ct−1 = 0, lt, at for all at, lt, t (1.12)
It follows that past exposure and confounder history until t suices to predict
censoring at t, without needing any other information at or aer t. This means that
conditional on confounder history up to time t, censoring holds no information
about future survival.
Positivity of risk of remaining uncensored : we assume that the risk of staying
uncensored exceeds 0 within levels of exposure and confounder history, or
P (Ct = 0|yt−1 = ct−1 = 0, at, lt) > 0
with probability 1 (1.13)
We repeat earlier procedure of standardisation (1.11) to identify Ya in a study
with Tm = 1. The above assumptions will then be: Ignorability of censoring:
Ya q C|l, a for all l, a; Positivity of risk of remaining uncensored : P (C = 0|a, l) >
0 with probability 1.
E(Ya) = E {E(Ya|L)}
= E {E(Ya|a, L)}
= E {E(Ya|a, L, c = 0)}
= E {E(Y |a, L, c = 0)} (1.14)
with the first equality due to conditional expectation, the second due to SRA, the
third to ICA, and the fourth to consistency of exposure regime. The average in the
last line of (1.14) assumes positivity of the risks of exposure and censoring.
1.3.6 Causal directed acyclic graphs
We will now explain why, in the presence of time-varying and intermediate con-
founders, standard techniques for the adjustment of confounders may fail to esti-
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U0 L1 A1 C1
L2 A2 C2 Y2
Figure 1.1: Causal directed acyclic graph for the eect of A1 and A2 on Y2.
mate unbiasedly the causal contrasts as defined above. To do so, causal diagrams
are a powerful tool to visualise variables, their relationships and the assumptions
that encode these, and to reveal possible biases occurring in the estimation of
causal eects (Pearl, 1995; Herna`n et al., 2004, 2002; Vanderweele and Robins, 2007).
Figure 1.1 is a causal diagram that shows the random variables defined in Section
1.3.1 by means of nodes, in the temporal order of occurrence (top le occurs earliest,
boom right last) and their possible causal relations by means of directed edges.
The diagram depicts variables and their relationships for 2 time-points t = 1 and
t = 2, except forU which will be only defined as baseline variable at t = 0, however
the results that follow remain valid under a time-dependent U .
Essential to our diagram is that any defined relation between variables depicted
in the diagram is directed, meaning that each edge has only one arrow, and that
the diagram is acyclic, meaning that one can never start from one variable and end
up at the same variable by following the direction of the arrows. The diagram in
Figure 1.1 follows these constraints, and is therefore also called a Directed acyclic
graph (DAG). Two supplementary constraints are needed in order for such DAG to
be called causal, 1) the absence of a directed edge between two variables in the
DAG represents the assumption of absence of a direct causal eect between these
variables (which does not mean lack of association, see further), and 2) the DAG
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must incorporate all common causes of any 2 variables in the diagram.
The relationships in Figure 1.1 are explained as follows. Following the last
requirement of the previous paragraph, variables U0, L1 and L2 need to be part of
the diagram because they are common causes of A1, A2 and Y2 (previously these
were called “prognostic factors”). Figure 1.1 postulates that U0 cannot act as a
direct cause of A1 and A2, but only as an indirect cause through intermediates L1
and L2 respectively. This is therefore an assumption formulated through our causal
DAG, which was previously already stated through SRA (1.9). The arrows from L1
into L2 and from A1 into A2 encode our understanding that factors of previous
time-points causally aect the risk of these factors at the current time-point. The
arrow from A1 into L2 points out that measured prognostic factors at t = 2 might
be aected by exposure at t = 1. Note that L2 has the property to act both as a
common cause and as an intermediate variable of the exposure-outcome relations
A2 − Y2 and A1 − Y2 respectively, the former meaning that it directly causes both
A2 and Y2 and the laer that it is an intermediate variable in the causal path
that leads from A1 to Y2. Finally, Ct at each time-point is only directly caused by
earlier exposure and measured prognostic variables. Also here, U0 is assumed to
only cause Ct through Lt and At. This follows from ICA (1.12), guaranteeing that
all paths that link Ct with Yt pass through Lt or At. Furthermore, Ct and Yt are
assumed not to be causally related. Importantly, the Ct variable being surrounded
by a square box indicates that it is conditioned on, ie. that our analysis is stratified
on this variable. This is indicative of the fact that once a subject is lost to follow-up,
no further information will be available, or that the analysis is restricted to subjects
with Ct = 0.
The causal eects of interest of Diagram 1.1 are shown in Figure 1.2 as isolated
directed edges going from A1 and A2 into Y2 . Subfigure 1.2a shows the overall
eect of A1 on Y2, these are all directed edges from A1 into Y2. Subfigure 1.2b
shows the overall eect of A2 on Y2, this is the single directed edge from A2 into Y2.
Subfigure 1.2c shows the direct eect of A1 on Y2, this is the overall eect shown in
Subfigure 1.2a minus directed edges from A1 into Y2 that pass through A2. The
dierent causal paths between A1 and Y2 and between A2 and Y2 signify that
exposure might have a time-varying and cumulative eect, ie. that the eect of
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A1
L2 A2 Y2
(a) Overall eect of A1.
A1
L2 A2 Y2
(b) Overall eect of A2.
A1
L2 A2 Y2
(c) Controlled direct eect of
A1.
Figure 1.2: Causal paths between exposure A1 and A2, and outcome Y2.
exposure at t = 1 on outcome could be dierent from and add to the eect at
t = 2.
A causal DAG is linked to the full data distribution as follows. Leing f(V ) =
f(V1, ..., Vm) be the joint density of all variables in the diagram withm the number
of variables, Pearl (2009) describes a causal DAG as having an underlying non-
parametric structural equation model. In this model, each observed variable Vj
is represented as the output of a nonparametric functional having as input its
observed and unobserved parent variables. The laer are not explicitly accounted
for but enter as error terms which are assumed to be jointly independent across
functionals. Parent variables of Vj are those variables in the diagram having a
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direct causal eect on Vj . In turn, Vk will be called a descendant of Vj if a causal
path exists between Vj and Vk such that Vk can be reached by starting from Vj
and following the direction of the arrows. Note that
f(V1, ..., VM) =
M∏
j=1
f(Vj|V1, .., Vj−1) (1.15)
which is denoted the Chain rule. Linking this to a causal DAG, we eliminate
from the right part of above equation those variables that are independent of Vj
conditional on its parents, such that
P (Vj|V1, ..., Vj−1) = P (Vj|PAj) (1.16)
in which PAj are the parent variables of Vj as postulated by the DAG. Equation
(1.16) substituted in Chain rule (1.15) is called the Causal Markov Assumption. Using
the study with Tm = 2 under the causal DAG of Figure 1.1 - without censoring
variable Ct - the joint data distribution becomes
f(V ) = f(Y2|A2, L2, A1, L1, U0)f(A2|L2, A1, L1)f(L2|A1, L1, U0)
×f(A1|L1)f(L1|U0)f(U0) (1.17)
The above description of f(V ) based on the variables and relations depicted in
causal DAG of Figure 1.1 is needed to construct the distribution of counterfactual
outcomes. We will use this distribution to identify our causal contrasts of interest.
The counterfactual variables generated under an intervention “set exposure regime
(A1, A2) to level (a1, a2)” can be visualised in the causal DAG by replacing exposure
variables (A1, A2) by (a1, a2), and their descendant variables Vk by Vk,(a1,a2), or
the counterfactual variables under exposure regime (a1, a2). This intervention
will also remove all ingoing edges into (A1, A2) from the diagram. Consider then
f{V 2,(a1,a2)} or the counterfactual joint data distribution under exposure regime
(A1, A2) = (a1, a2):
f{V 2,(a1,a2)} = f{Y2,(a1,a2)|a2, L2,(a1,a2), a1, L1, U0}f{L2,(a1,a2)|a1, L1, U0}
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×f(L1|U0)f(U0)
= f(Y2|a2, L2, a1, L1, U0)f(L2|a1, L1, U0)f(L1|U0)f(U0) (1.18)
the first equality of which is based on seing the conditional distribution functions
f(A2|L2, A1, L1, U0) and f(A1|L1, U0) to 1 once exposure regime (A1, A2) is set
or fixed to a particular exposure regime (a1, a2). Seing counterfactuals through
intervening on an exposure regime under causal Markov assumption (1.16) is called
Truncated factorisation. The last equality of (1.18) is due to consistency of exposure
regime, and is a next step in the identification of causal eects. We will continue
this in Section 1.4, but will first demonstrate how to use causal DAGs to detect
confounding of the exposure-outcome relationship as well as selection bias.
1.3.7 Bias classification
One can now use the causal DAG of Figure 1.1 to verify whether the association
between A and Y is confounded. This happens by inspecting the paths between
A2 (A1) and Y2 that do not allow starting in A2 (A1) and ending in Y2 by following
the direction of the arrows along the considered path. These are called non-causal
paths because any association between A2 (A1) and Y2 by means of such pathway
in the diagram will not reflect causation, and may hence signal confounding of
the exposure-outcome relationship. Not all non-causal paths will however induce
non-causal association (Robins and Morgenstern, 1987; Vanderweele and Shpitser,
2013). To determine whether a non-causal path in the diagram may actually induce
association between exposure and outcome, in which case we call it an “open
path” (as opposed to a “blocked path”), we will rely on 3 rules derived from causal
DAG theory (Pearl, 1995). In these rules, a variable is a collider in a path if two
arrowheads in the path point into (or collide at) this variable. Also, we consider the
analysis to condition on a variable when the analysis stratifies on the values of this
variable; this is depicted on the causal diagram by a square around the conditioned
variable.
1 Any path containing a non-collider that has been conditioned on is blocked.
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2 A path containing no conditioned variables is blocked if it contains a collider.
3 Conditioning on a colliding variable or on one of its descendants will open the
path’s section passing through that variable.
Using the causal DAG of Figure 1.1, we will discuss non-causal paths that link
A2 (A1) with Y2, look for each if it actually creates non-causal association, and see
how it can be resolved in an analysis. Without any adjustment for the eect of
exposure on outcome by prognostic variables U0 and/or L at t = 1 or t = 2, this is
seen as a crude analysis of the eect of joint exposure (A1, A2) on the mean of Y2.
The diagrams depicted in Figures 1.3 and 1.4 have been created by investigating
and classifying all possible non-causal paths between A1 and Y2 and between A2
and Y2 respectively that are not blocked according to rules 1-3, we will call these
open non-causal paths. Neither diagram depicted in Figures 1.3 and 1.4 can be
considered causal or linked to the data of our study since only part of variables
and their causal relations are shown each time.
For example, the diagram of Subfigure 1.3a identifies the following 4 paths
between A1 and Y2:
A1 ← L1 → Y2 (1.19)
A1 ← L1 ← U0 → Y2 (1.20)
A1 → C1 ← L1 → Y2 (1.21)
A1 → C1 ← L1 ← U0 → Y2 (1.22)
All these paths are non-causal because, by following the direction of the arrows in
these paths, A1 can never lead to Y2. Following rules 1 and 2, paths (1.19) and (1.20)
are open because they do not contain colliders or conditioned variables. These
paths will therefore lead to confounding of the A1 − Y2 relationship.
For example, leing L1 indicate exposure to mechanical ventilation, the fact
that L1 is a causal risk factor for both A1 (being exposed to mechanical ventilation
increases the risk for acquiring infection, following the aforementioned example)
and Y2 (being exposed to mechanical ventilation is an eect of a worse prognosis,
and thus increases the risk of dying) will create a positive association between A1
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U0 L1 A1 C1
Y2
(a)
U0 L1 A1
L2 A2 C2 Y2
(b)
U0 L1 A1
L2 C2 Y2
(c)
U0 L1 A1 C1
L2 C2 Y2
(d)
U0 L1 A1
L2 A2 Y2
(e)
U0 L1 A1 C1
L2 A2 Y2
(f)
U0 L1 A1
L2 A2 C2 Y2
(g)
U0 L1 A1
A2 Y2
(h)
U0 L1 A1
L2 A2 Y2
(i)
Figure 1.3: Non-causal open paths between A1 and Y2, in an unadjusted analysis of the
joint eect of (A1, A2) on Y2.
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and Y2 through L2, even in the absence of a causal eect of A1 on Y2.
For paths (1.21) and (1.22) passing through variable C1, recall that our data is
restricted to subjects under follow-up, meaning that the analysis is conditional
on C1 = 0. Variable C1 acts as a collider in these paths, and is conditioned on,
implying that according to rule 3, the section in paths (1.21) and (1.22) fromA1 until
L1 will be open. Because the remaining sections of these paths until Y2 are equal to
open paths (1.19) and (1.20), we conclude that paths (1.21) and (1.22) are also open
paths. The phenomenon when conditioning on a common eect of two variables
leads to a spurious or non-causal association between these variables is called
collider-stratification bias. In this case it is also referred to as informative censoring
or selection bias because censoring is associated with both the outcome (through
L2 and U0) as with exposure, and through conditioning on C1 a sample is created
that is selective with respect to these prognostic factors (ie. not representative
of the source population) (Herna`n et al., 2004; Daniel et al., 2012). Such selection
bias may occur independently from the bias through confounding of the A− Y
relation via non-causal paths (1.19) and (1.20).
Such bias can be intuitively understood by the following example. Suppose that
U0 = 1 leads to L2 = 1 and Y2 = 1, that L2 = 1 leads to A2 = 1, Y2 = 1, C2 = 0,
and that A2 = 1 leads to C2 = 0. Assume also the null hypothesis of no eect
of exposure on outcome. Then even so, by selecting subjects under follow-up (i.e.
having C2 = 0), we will get the impression that exposure is negatively associated
with outcome because those unexposed (A2 = 0) will likely have L2 = 1 and thus
have a worse prognoses (U0 = 1 and Y2 = 1), since the cause why they remain
under follow-up is not due to the absence of exposure. Similarly, those subjects
that are in a beer condition (U0 = 0 and L2 = 0) will likely be exposed (A2 = 1),
since the cause why they remain under follow-up is not the fact that L2 = 1. Thus,
in the group of C2 = 0, there is a negative association betweenA2 and U0. Because
U0 is associated with Y2, this means a negative association between A2 and Y2 is
expected aer conditioning on C2 = 0.
Non-causal paths of Subfigures 1.3e, 1.3f and 1.3g all show A2 as a conditioned
descending variable of L2. Such conditioning on A2 occurs because an analysis
for the unadjusted joint eect will measure the eect of both variables A1 and
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U0 L1
L2 A2 C2 Y2
(a)
U0
L2 A2 C2 Y2
(b)
U0 L1
L2 A2 C2 Y2
(c)
Figure 1.4: Non-causal open paths between A2 and Y2, in an unadjusted analysis of the
joint eect of (A1, A2) on Y2.
A2 simultaneously, therefore the eect of A1 on the risk of Y2 will be conditioned
on the values of A2. According to rule 3, these paths will all be opened by this
and hence create non-causal associations between A1 and Y2 (Robins and Herna`n,
2009). Finally, in non-causal paths of Subfigures 1.3b and 1.3h-1.3i, A2 acts as a
collider that is conditioned on, which open these non-causal paths by rule 3.
Figure 1.4 isolates non-causal open paths between variables A2 and Y2 in an
unadjusted analysis of the joint eect of (A1, A2) on Y2. The three types of open
non-causal paths of Subfigures 1.4a-1.4c are all due to variables U0, L1 and L2
acting as confounders of the causal eect of A2 on Y2. Also, this eect will suer
from the same conditioning on the C2 variable and inherent selection bias as with
C1.
1.3.8 Time-dependent confounding
It is common practice in statistical analysis to eliminate confounding of the
exposure-outcome relationship (like the one described above) by conditioning
on the common cause (e.g. U0 or Lt) of exposure and outcome. This means that
the association between exposure and outcome will be calculated within strata of
the common cause. Because all subjects within a stratum are similar in terms of
this common cause, this will eliminate the association between the common cause
and its eects within each stratum. This is what is meant by rule 1 of causal dia-
gram theory, when blocking a non-causal path between two variables (eliminating
spurious association) by conditioning on a non-collider. The same arguments apply
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when correcting for selection bias by informative censoring: spurious associations
between censoring and outcome can be avoided by stratifying or conditioning on
common causes of the censoring and outcome variable.
The idea is therefore to find variables that can be used to block the open non-
causal paths in Figures 1.3 and 1.4 between A1 and Y2 and between A2 and Y2
respectively, but without opening blocked paths. In order to block non-causal paths
of our causal DAG, conditioning on U0 is impossible as it is unmeasured and not
available for use in the analysis, which leaves us to work with variables L1 and L2.
Figures 1.5 and 1.6 shows non-causal open paths of Figures 1.3 and 1.4 respectively,
but with L1 and L2 variables conditioned on, visible by a square around these
variables. Conditioning on L1 will block open non-causal paths between A1 and Y2
of Subfigures 1.3a-1.3d, while conditioning on L2 will also block remaining open
paths between A1 and Y2 of Subfigure 1.3b. Conditioning on L1 and/or L2 will also
block paths of Subfigures 1.3h-1.3i that were originally opened because A2 was
conditioned on. Also, conditioning on L1 and/or L2 will block open non-causal
paths between A2 and Y2 of Subfigures 1.4a-1.4c.
We succeeded in blocking above non-causal paths even though U0 is unmea-
sured. This is due to SRA (1.9), under which each causal eect of U0 on A1 or A2
must pass through variables L1 or L2. Without this assumption, U0 would have
direct causal eects on A1 or A2, and no measured variables would be available
for adjustment. The same argument applies for ICA (1.12), or that U0 only aects
censoring variables C1 and C2 through measured confounders L1, L2.
Focus now on non-causal paths betweenA1 and Y2 in whichL2 acts as a collider,
more specifically paths in Subfigures 1.3e-1.3g. Originally, these paths were all
opened due to L2 acting as collider with the descendant A2 in these paths being
conditioned on. Conditioning on L1 and L2 will block all paths except for the
one passing through the U0 → L2 section in Subfigure 1.3e. This is because the
direct eect of U0 on L2 oers no possibility to block this path by means of a
measured common cause. In summary, we used causal diagram rule 1 to block
open non-causal paths between A1 and Y2, and between A2 and Y2, and rules 2
and 3 to demonstrate that particular blocked non-causal paths will be opened by
conditioning on L2. In this case, collider-stratification or selection bias is created
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U0 L1 A1 C1
Y2
BLOCKED paths
(a)
U0 L1 A1
L2 A2 C2 Y2
BLOCKED paths
(b)
U0 L1 A1
L2 C2 Y2
BLOCKED paths
(c)
U0 L1 A1 C1
L2 C2 Y2
BLOCKED paths
(d)
U0 L1 A1
L2 A2 Y2
OPEN paths
(e)
U0 L1 A1 C1
L2 A2 Y2
BLOCKED paths
(f)
U0 L1 A1
L2 A2 C2 Y2
BLOCKED paths
(g)
U0 L1 A1
A2 Y2
BLOCKED paths
(h)
U0 L1 A1
L2 A2 Y2
BLOCKED path
(i)
Figure 1.5: Non-causal paths between exposure A1 and outcome Y2, in an adjusted
analysis of the joint eect of (A1, A2) on Y2, when stratifying for prognostic variables
L1 and L2.
28
11.3. Causal Inference
U0 L1
L2 A2 C2 Y2
BLOCKED paths
(a)
U0
L2 A2 C2 Y2
BLOCKED paths
(b)
U0 L1
L2 A2 C2 Y2
BLOCKED paths
(c)
Figure 1.6: Non-causal paths between exposure A2 and outcome Y2, in an adjusted
analysis of the joint eect of (A1, A2) on Y2, when stratifying for prognostic variables
L1 and L2.
by conditioning on L2 which acts as a collider in non-causal path U0 → L2 ← A1.
Here, it will lead to time-dependent confounding of the exposure-outcome relation,
so-called because it is induced by conditioning on the time-dependent confounder
L2. In the presence of such confounding, stratification-based regression methods
for Y2 that adjust for confounders acting both as cause and eect of exposure may
yield biased eect estimates (Herna`n et al., 2004; Robins and Herna`n, 2009; Daniel
et al., 2013). We will elaborate on this in the next section. Avoiding adjusting for
L2 by only conditioning on confounders L1 (occurring before the onset of A1) does
not remedy this problem because then particular non-causal paths between A2
and Y2 that pass through L2 will remain open. All stratification-based methods
that analyse the eect of exposure to infection on ICU-mortality will suer from
this problem of adjustment for time-dependent confounding: while adjustment
is necessary to remove time-dependent confounding, ordinary stratification will
induce selection bias.
Also, besides leading to time-dependent confounding, conditioning on the L2
variable will be problematic when estimating the overall causal eect of A1 on
Y2. As seen in the diagram of Subfigure 1.2a, part of this eect is mediated by L2,
therefore conditioning on L2 will block part of the causal paths between A1 and
Y2.
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1.3.9 Stratified models for the joint eect of exposure
While a causal DAG encodes an underlying nonparametric model for counterfactu-
als, in practice we will not be able to model the mean of Yt nonparametrically using
a dataset with moderate sample size and many time-points, exposure regimes a
and multi-dimensional time-dependent confounders Lt. Therefore, we return to
the example of section 1.3.3 where we relied on a parametric regression model
for the discrete-time hazard of counterfactual outcome Yt,a at t ≤ 2. The DAG’s
causal eects represented in Subfigures 1.2a, 1.2b and 1.2c will correspond with
aforementioned contrasts exp(βc,11 ), exp(β
c,1
2 ) and exp(β
c,1
1 −βc,12 ) respectively that
were derived from model (1.7). Because this example relies on the unrealistic situa-
tion where we could model an original dataset containing counterfactual outcomes
for all exposure regimes, we will now verify if we can obtain causal contrasts by
modelling observed data. In doing so, we will ignore the problems linked to the
causal interpretation of the hazard ratio that we explained in Section 1.3.3, as these
can be resolved by conversion towards the survival risk ratio using (1.5).
First, consider the pooled logistic regression model derived from earlier model
(1.1):
P (Yt = 1|Yt−1 = 0, (a1, a2); βcr) = expit{βcr0 + βcr1 a1 + βcr2 a2(1− a1)}
at t ≤ 2 (1.23)
with unknown parameter βcr, so-called because it estimates a crude eect, due
to no adjustment being made for confounders of the exposure-outcome relation.
Therefore, it will generally fail in delivering causal estimates of the eect of exposure
on outcome. To see this, consider the contrast estimated by βcr1 :
exp βcr1 =
P{Yt = 1|Y t−1, (a1, a2) = (1, 1); βcr}
P{Yt = 1|Y t−1, (a1, a2) = (0, 0); βcr}
=
P{Yt,(1,1) = 1|Y t−1,(1,1), (a1, a2) = (1, 1); βcr}
P{Yt,(0,0) = 1|Y t−1,(0,0), (a1, a2) = (0, 0); βcr}
at t ≤ 2 (1.24)
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or the relative risk for the outcome of subjects under exposure regime (a1, a2) =
(1, 1) versus (0, 0) at t ≤ 2. In order to interpret this as a causal contrast, we use
Consistency assumption (1.8) in the second line of (1.24) to present the numerator
and denominator as means of a counterfactual outcome. Next, we need to turn
the conditional mean for each counterfactual into a population mean, however
we will fail in doing so because SRA (1.9) only defines independence between
Yt,a and At conditional on confounder history Lt, which is a variable lacking from
regression model (1.23). Therefore, contrast (1.24) uses means of counterfactuals
that are defined within dierent subgroups [a = (1, 1) versus a = (0, 0)] that are
not exchangeable in terms of prognostic factors U and L. This contrast will thus
be biased due to confounding by U and/or L. A same reasoning applies for the
contrast that compares exposure regime (a1, a2) = (0, 1) with (0, 0) at t = 2.
Now consider models for the stratified eect of exposure. A causal diagram
adapted towards a conditioned Lt variable represents such a stratified analysis,
ie. by calculating the joint eect of exposure at t − 1 and t on outcome at t
by using observations for which Ct = 0 and stratified for Lt. Table 1.1 shows
the identification of causal contrasts under SRA (1.9) using a stratified pooled
logistic regression model for the discrete-time hazard of Yt: P (Yt = 1|Yt−1 =
0, V ; βs) = expit{βs′V } at t ≤ 2. This uses the unknown parameter vector βs (“s”
for stratified), with the following model parametrisations for βs
′
V :
βs0 + β
s
1a1 + β
s
2a2(1− a1) + βs3L1 + βs4L2 (1.25)
βs0 + β
s
1a1 + β
s
2a2(1− a1) + βs3L1 (1.26)
βs0 + β
s
1a1 + β
s
2a2(1− a1) + βs3L1 + βs4L2(1− a1) (1.27)
Model (1.25) stratifies the eect of joint exposure for L1 and L2, model (1.26)
stratifies for L1 only, and model (1.27) stratifies for L1 and L2 under (a1, a2) =
{(0, 0), (0, 1)} and for L1 under (a1, a2) = (1, 1). Note that we use a monotonous
exposure where only the onset of exposure is set randomly conditionally on expo-
sure and covariate history, and deterministically (to 1) once onset occurred. Under
such monotonous exposure, the use of SRA will be limited to only one time-point
when identifying the conditional average of the counterfactual outcome under
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exposure regimes (1, 1). This is shown as follows for stratified model (1.25):
P{Yt = 1|Yt−1 = 0, (a1, a2) = (1, 1), L2}
= P{Yt = 1|Yt−1 = 0, a1 = 1, a2 = 1, L1, L2}
= P{Yt = 1|Yt−1 = 0, a1 = 1, L1, L2}
= P{Yt,(1,1) = 1|Yt−1,(1,1) = 0, a1 = 1, L1, L2,(1,1)}
= P{Yt,(1,1) = 1|Yt−1,(1,1) = 0, L1, L2,(1,1)} (1.28)
with the second equality due to monotonous exposure, the third to consistency
of exposure regime, and the fourth to SRA at t = 1. Similarly, we can derive the
conditional average of the counterfactual outcome under exposure regime (0, 0)
as follows
P{Yt = 1|Yt−1 = 0, (a1, a2) = (0, 0), L2}
= P{Yt = 1|Yt−1 = 0, a1 = 0, a2 = 0, L1, L2}
= P{Yt = 1|Yt−1 = 0, a2 = 0, L1, L2}
= P{Yt,(0,0) = 1|Yt−1,(0,0) = 0, a2 = 0, L1, L2,(0,0)}
= P{Yt,(0,0) = 1|Yt−1,(0,0) = 0, L1, L2,(0,0)} (1.29)
with the second equality due to monotonous exposure, the third to consistency of
exposure regime, and the fourth to SRA at t = 2.
Table 1.1 shows that none of the stratified models succeed in delivering joint
causal contrasts. This is due to all regression models failing to identify a valid
causal contrast between exposure regimes (a1, a2) = (1, 1) and (0, 0) at t = 2.
Interestingly, the models and types of exposure that are able to identify averages of
counterfactual outcomes in both numerator and denominator, still fail in identifying
a causal contrast because the counterfactual means are defined within dierent
subgroups. For example, model (1.25) in the 1st line of Table 1.1 compares a
counterfactual mean defined within subgroup L2,(1,a2) with a counterfactual mean
defined within subgroup L2,(0,a2). Counterfactual variable Lt,a is here defined as Lt
under exposure regime set to a. Because stratification for L2 in a regression model
based on (1.25) will force the subgroups defined by L2,a to be equal, this will lead
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to the time-dependent confounding described in the previous section. Model (1.27)
only partially corrects for this, in that the denominator’s counterfactual mean is
still defined within subgroup L2,(0,a2), which is dierent from the numerator.
In contrast to this, some models do succeed in identifying the causal contrast
between exposure regimes (a1, a2) = (0, 1) and (0, 0). As shown in the second
part of Table 1.1, this is the case for models (1.25) and (1.27), where contrasts have
a causal interpretation not only because of successful identification of averages of
counterfactual outcomes in both numerator and denominator, but also because
these are defined within the same subgroup. Note however that contrasts are
defined as conditional contrasts, and that for this reason, they may not be equal
to the earlier defined marginal contrast, for example see parameter exp βc2 in model
(1.7) for the eect of exposure regime (a1, a2) = (0, 1) versus (0, 0).
It might be insightful to verify whether we can use stratified regression models
to estimate the aggregated overall causal eect of exposure, like we did earlier using
model (1.3). In such a stratified model, the coeicients βs1 and β
s
2 will be aggregated
into one coeicient, using a parametrisation such as
βsa0 + β
sa
1 a2 + β
sa
2 L1 + β
sa
2 L2(1− a1) (1.30)
in which coeicient βsa1 will now encode the eect of either exposure regime
(a1, a2) = (0, 1) or (1, 1) versus exposure regime (0, 0), and which will be adjusted
for L1 and/or L2 depending on exposure status at the first time-point. Because βsa1
now summarises the earlier two exposure eects into one, for which we showed
that one (the βs1 coeicient in models 1.25-1.27) cannot lead to a causal contrast, we
conclude that the parameter βsa1 will not identify a causal contrast either. Therefore,
stratified regression models will also be unable to provide estimates of aggregated
causal eects.
If we consider a point-treatment study with Tm = 1, we can use the results of
the previous paragraphs to identify a valid causal contrast between exposure a = 1
and 0. To do so, we need to ignore all variables at t = 2, aer which models (1.25-
1.27) will be equal, and exp βs1 can be shown to estimate a valid causal contrast
P (Y1,a1=1|L1)/P (Y1,a1=0|L1). This shows that, under conditional randomisation in
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a point-treatment study, stratification will be suicient in identifying a conditional
contrast for the causal eect of exposure. However, in a longitudinal study where
the objective is to estimate the eect of time-varying exposures in the presence
of time-dependent prognostic factors acting as both cause and eect of exposure,
stratification will fail in identifying the causal contrast between exposure regimes
(a1, a2) = (1, 1) and (0, 0). Therefore, it will also fail to identify the causal con-
trasts between exposure regimes (a1, 1) and (0, 0) (the aggregated overall eect of
exposure) and between exposure regimes (1, 1) and (0, 1) (earlier described as the
controlled direct eect of exposure at t = 1 on outcome at t = 2). We conclude
that, despite the simplicity that lies in the use of stratified regression models
to eliminate confounding, stratification under such models will only be able to
estimate parameters that measure associations between time-varying exposures
and outcomes, instead of causal eects.
1.4 Estimators of joint causal eects
1.4.1 G-computation
Our objective is to identify the average of Y2,a, thereby avoiding the pitfalls de-
scribed in the previous section. We will try to find ways in which this average
can be identified from earlier derived counterfactual density f(V 2,a) (1.18). The
density f(Y2,a) for the counterfactual Y2,a is obtained by summing (1.18) over all
realisations of variables in set V 2 \ (A2, A1, Y2) as in∑
U0,L1,L2
f
{
(U0, L1, a1, L2, a2, Y2)(a1,a2)
}
= f
{
(Y2, a2, a1)(a1,a2)
}
= f(Y2,(a1,a2)) (1.31)
in which we assume categorical (U0, L1, L2) for simplicity, and similarly for the
right-hand side of the last line of (1.18)
f{Y2,(a1,a2)} =
∑
U0,L1,L2
f(Y2|a2, a1, L1, L2, U0)f(L2|a1, L1, U0)
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×f(L1, U0) (1.32)
which is the standardisation procedure of equation (1.11) but applied to causal
DAG of Figure 1.1. Because (1.32) relies on parent variables of Y2, which includes
the unmeasured U0, this will be of no practical use for identification of the mean
of Y2,(a1,a2). Making use of the assumptions encoded by the causal DAG of Figure
(1.1) (Daniel et al., 2013), we obtain
f{Y2,(a1,a2)} =
∑
U0,L1,L2
f(Y2|a2, a1, L2, L1, U0)f(L2|a1, L1, U0)f(L1, U0)
=
∑
U0,L1,L2
f(Y2|a2, a1, L2, L1, U0)f(L2|a1, L1, U0)f(L1, U0)
×f(A2 = a2|L2, a1, L1, U0)f(A1 = a1|L1, U0)
f(A2 = a2|L2, a1, L1, U0)f(A1 = a1|L1, U0)
=
∑
U0,L1,L2
f(Y2|a2, a1, L2, L1, U0)
× f(a2, L2, a1, L1, U0)
f(A2 = a2|L2, a1, L1, U0)f(A1 = a1|L1, U0)
=
∑
U0,L1,L2
f(Y2|a2, a1, L2, L1, U0)
×f(U0|a2, L2, a1, L1)f(L2|a1, L1)
× f(A2 = a2|L2, a1, L1)f(A1 = a1|L1)
f(A2 = a2|a1, L2, L1, U0)f(A1 = a1|L1, U0)f(L1)
=
∑
L1,L2
{∑
U0
f(Y2|a2, a1, L2, L1, U0)f(U0|a2, L2, a1, L1)
}
×f(L2|a1, L1)f(L1)
=
∑
L1,L2
f(Y2|a2, a1, L2, L1)f(L2|a1, L1)f(L1)
if (A1, A2) = (a1, a2) (1.33)
In the above derivation, more specifically in the fourth equality, we use SRA (1.9),
by which
f(A2 = a2|a1, L2, L1, U0) = f(A2 = a2|a1, L2, L1)
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f(A1 = a1|L1, U0) = f(A1 = a1|L1) (1.34)
Equation (1.33) is a time-dependent generalisation of standardisation procedure
(1.11) to identify potential outcomes under time-dependent exposure regimes, and
is called the G-computation formula (Robins, 1986; Robins and Herna`n, 2009; Daniel
et al., 2013). G-computation has been shown to be a valid technique to identify
joint causal eects in nonparametric seings. However, with high-dimensional L
and moderate sample sizes, insuicient data will be available to allow separate es-
timation of the distributions for f(Yt|Y t−1, a, Lt) and f(Lt|at−1, Lt−1). Therefore,
parametric modelling will be needed to estimate these quantities, with possible
misspecification bounded to occur in the presence of high-dimensional L. Fur-
thermore, Robins (1997) has shown that it is generally not feasible to postulate
nonlinear models for Yt and Lt that allow for both specification of the null hypoth-
esis of no joint exposure eect and for intermediate confounding by Lt, leading to
false rejection of the causal null hypothesis when it is true. This is known as the
null paradox of the estimated G-formula.
For example, consider logistic regression modelsP{Yt = 1|Yt−1 = 0, (a1, a2), L2; βs}
based on model parametrisation (1.25) for the discrete-time hazard of Yt and
P (L2 = 1|a1;α) = expit(α0 + α1a1) for the conditional mean of a binary L2.
Using both models in G-computation formula (1.33) will give a model for the
discrete-time counterfactual hazard as follows
P{Yt,(a1,a2) = 1|Yt−1,(a1,a2) = 0, L1; βs}
= exp{βs0 + βs1a1 + βs2a2(1− a1) + βs3L1 + βs4}expit(α0 + α1a1)
+ exp{βs0 + βs1a1 + βs2a2(1− a1) + βs3L1}{1− expit(α0 + α1a1)}
=
[
exp{βs0 + βs1a1 + βs2a2(1− a1) + βs3L1 + βs4 + α0 + α1a1}
+ exp{βs0 + βs1a1 + βs2a2(1− a1) + βs3L1}
]
× 1
1 + exp(α0 + α1a1)
(1.35)
in which the direct eect of A1 will be estimated by following contrast of counter-
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factual hazards for exposure regime (a1, a2) = (1, 1) versus (0, 1):
exp(βs0 + β
s
1 + β
s
3 + β
s
4 + α0 + α1) + exp(β
s
0 + β
s
1 + β
s
3)
exp(βs0 + β
s
2 + β
s
3 + β
s
4 + α0) + exp(β
s
0 + β
s
2 + β
s
3)
× 1 + exp(α0)
1 + exp(α0 + α1)
=
exp(βs1)
exp(βs2)
× 1 + exp(β
s
4 + α0 + α1)
1 + exp(βs4 + α0)
× 1 + exp(α0)
1 + exp(α0 + α1)
(1.36)
It proves to be very diicult to find parameter realisations in which the null hy-
pothesis of no direct eect of A1 will hold, unless either βs1 − βs2 = α1 = 0 or
βs1−βs2 = βs4 = 0. However, α1 = 0 would imply thatA1 has no causal eect onL2,
meaning absence of time-dependent confounding, while βs4 = 0 would imply that
A2 and Y2 are not confounded by L2. Both these conditions are false under causal
DAG of Figure 1.1. For reference, a null eect under a normally distributed L2
variable that is modelled linearly with constant variance across exposure regimes
would imply that βs1 − βs2 + βs4α1 = 0, which is feasible under scenarios other than
seing βs4 = 0 or α1 = 0, see Young and Tchetgen (2014) for details. Given these
remarks, we will seek other methods for joint estimation of the causal eect of
(A1, A2) on Yt
1.4.2 Marginal structural proportional hazard models
Robins (1992, 2000) and colleagues propose Marginal structural proportional hazards
models (MSPHMs) and Structural nested accelerated failure time models (SNFTMs) to
estimate the aributable eect of a time-dependent exposure on a failure outcome
in the presence of time-dependent confounders and informative censoring. We
will introduce and illustrate MSPHMs here, and SNFTMs in the following section.
A MSPHM is a model for the marginal eect of exposure regime a on λYa , the
hazard of the counterfactual outcome Y under this exposure (Robins, 2000; Herna`n
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et al., 2001), and have the form (discrete-time version)
(1.37)
P (Yt,a = 1|Yt−1,a = 0, L0; β0) = expit{γmsm(at, L0; β0)}
for all at (1.38)
with γmsm a known function and β0 the (unknown) true parameter vector of interest
that gives the causal eect of exposure on survival on the hazard scale. The term
“marginal” implies that the hazard is calculated over the levels of Lt, the measured
time-dependent confounder history until t. Because model (1.37) allows to con-
trast the counterfactual hazard under exposure regime a with that same subject’s
counterfactual hazard under absence of exposure, parameter β0 of the exposure
eect a has a causal interpretation. For example, when γmsm{(a1, a2), L0; β0} =
β00 +β
0
1a1+β
0
2a2(1−a1), then model (1.37) will be equal to earlier discussed model
(1.7) that parametrised causal contrasts.
Informally, the MSPHM is constructed as follows. Because the potential out-
comes Yt,a of each subject are partly unobserved - instead only outcomes Yt for
the actual received exposures a are observed - the MSPHM cannot be constructed
by only using the observed data. It is however possible to generate the distribution
of the missing Yt,a, and this by upweighting each observation with actual a by the
inverse probability of experiencing this specific a. Hereby, it treats unobserved
potential outcomes Yt,a as missing observations from the distribution of potential
outcomes, and will rely on upweighting according to the probability or propensity
of having the observed data (ie. having actual exposure history a) to create a
population in which everybody experienced a. If upweighting is repeated for all
possible a, we will thus create a pseudo-population of potential outcomes Yt under
all possible exposure regimes a.
Upweighting by the inverse probability of experiencing exposure history a =
(a1, a2) enables identifying the distribution of potential outcomes under the causal
DAG of Figure (1.1) - without C - as follows. We start with the average of the
outcome Y2 that is weighted for the inverse probability of exposure for subjects
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with I(a1, a2) = 1, or those having a = (a1, a2):
E
{
I(A1 = a1, A2 = a2)
f(A2 = a2|L2, A1, L1)f(A1 = a1|L1)Y2
}
= E
{
I(A1 = a1, A2 = a2)
f(A2 = a2|L2, A1, L1)f(A1 = a1|L1)Y2,(a1,a2)
}
= E
[
E
{
I(A2 = a2)I(A1 = a1)
f(A2 = a2|L2, A1, L1)f(A1 = a1|L1)Y2,(a1,a2)
∣∣∣∣A1, L2}]
= E
[
P (A2 = a2|L2, A1, L1)I(A1 = a1)
f(A2 = a2|L2, A1, L1)f(A1 = a1|L1)E{Y2,(a1,a2)|A1, L2}
]
= E
[
I(A1 = a1)
f(A1 = a1|L1)E{Y2,(a1,a2)|A1, L2}
]
= E
[
E
{
I(A1 = a1)
f(A1 = a1|L1)Y2,(a1,a2)
∣∣∣∣L1}]
= E
[
P (A1 = a1|L1)
f(A1 = a1|L1)E{Y2,(a1,a2)|L1}
]
= E
[
E{Y2,(a1,a2)|L1}
]
= E{Y2,(a1,a2)} (1.39)
where the first equality is due to consistency of exposure regime (1.8), the second,
fih and last to conditional expectation, and the third and sixth to SRA (1.9) at
times s = 2 and s = 1 respectively. The weighted outcome is only defined under
positivity assumption (1.10).
The weighting procedure shows that the parameters of a MSPHM can be
estimated by Inverse probability of exposure (IPE) weighting. This is indeed how IPE-
weighted estimation under a MSPHM adjusts for confounding of the association
between exposure and outcome by time-dependent variables, not by including
these variables in the functional part of the regression model (as in stratified
models), but by using them to estimate the probability of exposure at each time
and subsequently weighting observations by the inverse of these probabilities in an
unadjusted analysis of the association between exposure and outcome. The weights
can be interpreted as the number of copies of each observation that are necessary
to form a pseudo-population in which there is no time-dependent confounding,
but in which the causal eect of exposure on outcome is the same.
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Similarly, one can further adjust the IPE-weighted estimator under the MSPHM
for bias due to informative censoring by calculating supplementary weights derived
from regression models that predict censoring based on time-varying subject
characteristics. As before, this Inverse probability of censoring (IPC) weighting will
create a pseudo-population in which A, L and C are unassociated. Because of this,
the pseudo-population reflects the hypothetical situation in which all subjects
would remain under follow-up until the last observation time, reflecting a situation
without drop-out. IPC-weighting is only valid under ICA (1.12).
In practice, a MSPHM is fied by using a pooled logistic regression model for
the eect of exposure on the discrete-time hazard of outcome at t
P (Yt|Yt−1 = 0, at, L0; βmsm) = expit{γmsm(at, L0; βmsm)} (1.40)
Model (1.40) is fied to data that is inversely weighted at each t for the combined
stabilised conditional probabilities of having observed exposure status and being
uncensored until t, expressed as follows:
Wmsmt = W
a,msm
t ×W c,msmt (1.41)
with
W a,msmt =
t∏
s=1
pias (Ls)
pias (L0)
(1.42)
W c,msmt =
t∏
s=1
pics(As, Ls)
pics(As, L0)
(1.43)
pias (.) = P (As = as|As−1 = Cs−1 = 0, .) (1.44)
pics(.) = P (Cs = 0|Cs−1 = 0, .) (1.45)
Probabilities (1.44,1.45) are estimated from separately constructed pooled logis-
tic regression models models for the discrete-time hazard of respectively At = at
and Ct = 0. To prevent extreme weights, inverse conditional probabilities for indi-
vidual patient days are stabilised with probabilities pias (L0) and pi
c
s(As, L0), derived
from pooled logistic regression models similar to the ones above, but diering in
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U0 L1 A1 C1
L2 A2 C2 Y2
Figure 1.7: Causal directed acyclic graph depicting association between A1 and Y2 and
between A2 and Y2 aer Inverse probability of exposure and Inverse probability of
censoring weighting.
that these adjust for baseline confounders L0. The stabilisation is such that the
weights Wt will be equal to 1 when Lt is unassociated with A in the data (Yu and
van der Laan, 2006). When probabilities for exposure and for censoring need to be
estimated from observed data, estimation under a MSPHM will be only valid if
these models are correctly specified.
Calculation of MSPHM (1.40) is done using the Generalised estimating equa-
tions (Liang and Zeger, 1986) technique with independent working correlation
structure, whose approximate variance estimator using the sandwich formula yields
confidence intervals for the causal parameters of model (1.37). These intervals will
be conservative when they do not take into account estimation of the parameters
of the models used for calculation of IPE- and IPC-weights (Robins and Herna`n,
2009). As explained earlier, model (1.40) on weighted data is equivalent to MSPHM
(1.37) for the counterfactual hazard of Yt,a. A MSPHM for Yt,a can be fied using
standard statistical routines, which represents a major advantage relative to other
statistical estimation routines for counterfactual outcomes, and which has lead to
widespread use and implementation of MSPHMs in the literature.
The situation once this combined IPE-IPC weighting is applied and this pseudo-
population is created can be visualised in the causal diagram of Figure (1.1) as
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follows: arrows into exposure and censoring variables A2, A1, C2 and C1 will
be removed, as a result of which there is no further confounding of the A − Y
association through non-causal paths passing through L2, L1 and U0, as in the
adapted causal DAG of Figure (1.7). Because of this, there is no further need
to adjust for L1 and L2 in the analysis. As such, i.e. by avoiding adjustment
via stratification-based methods, we can avoid inducing non-causal associations
between A and Y , which initially arose because of conditioning on L2. The causal
eects of interest as shown in Figure 1.2 can therefore be unbiasedly estimated.
The use of a MSPHM to estimate the counterfactual hazard for mortality suers
from the weakness that goes with the interpretation of hazards. As mentioned
above, the discrete-time hazard for the outcome Y , P (Yt = 1|Yt−1 = 0), is defined
as the time-dependent probability of Y at a time t conditional on not having expe-
rienced Y until t− 1. Such conditioning on being outcome-free until t− 1 will lead
to non-causal association and additional selection bias of the exposure-outcome
relation (Herna`n, 2010). The problem is visualised in Figure 1.8, which is derived
from the causal DAG of Figure 1.7 and updated with the inclusion of Y1, the out-
come variable at t = 1, to only show the non-casual paths between A1 and Y2
through U0. Note that the hazard’s conditioning on the past (Y1 = 0) is visualised
through the square surrounding the variable. The causal DAG shows that even
when cancelling all relevant non-causal paths between joint exposure (A1, A2)
and Y2, the remaining paths between exposure A1 and unmeasured prognostic
variables U0 will be responsible for residual non-causal associations between A1
and Y2 through conditioning on collider Y1 in this particular path. To avoid this
diiculty in interpretation, one can use the fied MSPHM to predict conditional
counterfactual hazards for specific exposure regimes, and then use these to calcu-
late the corresponding risk of counterfactual survival for these regimes, as shown
earlier using expression (1.5). Estimating the mean dierence of risk of survival
with a corresponding 95% confidence interval could then proceed by a series of
bootstrap samples. Estimation of lag eects could proceed by calculating risk
dierences at specific end-of follow-up times that correspond with the onset of
exposure of the studied regime and with the lag time used by the MSPHM.
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U0 A1 Y1 Y2
Figure 1.8: Causal directed acyclic graph depicting non-causal association between expo-
sure A1 and outcome Y2 through intermediate outcome Y1.
1.4.3 Structural nested accelerated failure time models
The Accelerated failure time model (Kalbfleisch and Prentice, 2002; Cox and Oakes,
1984) directly models the survival time T , in contrast to previously described
proportional hazard models for the hazard rate. An Accelerated failure time model
(AFTM) for a non-counterfactual outcome is of the form
T
d
=Tb × exp(ψ′Z) (1.46)
where Z ≡ (L,A) is a vector of measured covariates, ψ a vector of parameters, and
Tb the baseline survival time of subjects for which all covariates equal zero. The
factor exp(ψ′Z) can be seen as an accelerating factor that contracts or expands
baseline survival time Tb as a function of a subject’s covariates Z . The “
d
= ” stands
for equality in distribution, indicating that the equality holds for the respective
distribution functions of the random variables (or functions thereof) in le and
right parts of (1.46) .
A Structural nested accelerated failure time model (SNFTM) (Robins, 1992) adapts
model (1.46) towards a counterfactual outcome and time-dependent exposure. A
SNFTM for time-dependent exposure At is of the form
Tt,0
d
= (t− 1) +
T∑
u=t
exp{γsnm(Au, Lu;ψ0)}
for T ≥ t (1.47)
with Tt,0 the counterfactual survival time corresponding to observed exposure
history At until t− 1 but set to zero exposure at t and thereaer, γsnm() a known
function, and ψ0 the unknown true parameter vector of dimension p that describes
44
11.4. Estimators of joint causal eects
the causal eect of exposure on log survival time scale. That this is an accelerated
failure time model is obvious by virtue of it being derived from model (1.46). It is
called structural because it models the counterfactual outcome Tt,0. See further
why it is called a nested model. The parametrisation of the above SNFTM need not
be restricted to the exposure A. It can be extended to any function of measured
variables A and L as long as ψ0 ≡ 0 and at = 1 implies T0 d=T (with T1,0 ≡ T0).
The fact that interactions of exposure with time-dependent confounders L are
allowed, represents a major advantage of SNFTMs over MSPHMs.
Going back to the example that motivated this study, we can use model (1.47)
to verify what would happen with the distribution of survival times under a hy-
pothetical intervention that would eliminate the onset of HAI. By mapping the
distribution’s observed survival time T into the counterfactual survival time T0
under the absence of exposure, the SNFTM’s ψ0 parameter directly gives the causal
eect of exposure on survival time. Because of this, the causal null hypothesis
H0 : T
d
=T0 corresponding to a zero eect of exposure on survival will correspond
to testing ψ0 = 0.
Consider SNFTM (1.46) with γsnm(At, Lt;ψ0} = ψ0At indexed by one-dimensional
causal parameter ψ0. For a subject with observed survival time T = 2 and being ex-
posed at all times t = 1, 2 [giving exposure history a = (a1, a2) = (1, 1)], observed
survival times will be mapped into counterfactual survival times as follows:
T2,0 = 1 + exp(ψ0a2) = 1 + exp(ψ0)
T1,0 = exp(ψ0a1) + exp(ψ0a2) = 2exp(ψ0) (1.48)
When the objective is to measure the joint eect of time-varying exposure at t
and t− 1, we can postulate a SNFTM with γsnm(At, Lt;ψ0} = ψ01(1− At−1)At +
ψ02At−1At indexed by causal parameter vectorψ
0 = (ψ01, ψ
0
2). Continuing our exam-
ple, the relevant part of the exposure history at t = 2 then becomes (a0, a1, a2) =
(0, 1, 1). Counterfactual survival times will then become
T2,0 = 1 + exp{ψ01(1− a1)a2 + ψ02a1a2}
= 1 + exp(ψ02) (1.49)
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T1,0 = exp{ψ01(1− a0)a1 + ψ02a0a1}
+ exp{ψ01(1− a1)a2 + ψ02a1a2}
= exp(ψ01) + exp(ψ02) (1.50)
The above creation of counterfactual survival times under model (1.47) explains
why it is nested ; this is because the SNFTM creates counterfactual survival times
recursively from t = Tm to t = 1, and conditional on covariate and (possibly)
confounder history (At, Lt), which can be described as nested sets of variable
history, the ones at t nested within those at t− 1 etc.
Estimation of ψ0 proceeds through G-estimation (Robins, 1992): from a grid of
candidate ψ’s that are plausible, those values are sought that, aer calculating
Tt,0(ψ) through SNFTM (1.47), give zero association with the exposure in a pooled
logistic regression model for the conditional eect of Tt,0(ψ) on the discrete-time
hazard of exposure
E(At|At−1 = Y t−1 = 0t−1, Lt) = expit[ψA′L Lt + ψA
′
T gt{Tt,0(ψ), Lt}] (1.51)
in whichE(At|At−1, Lt) is the conditional discrete-time hazard of exposure, ψA an
unknown parameter vector, and gt() a vector function of Tt,0(ψ) with dimension
equal to dim(ψ). By using SRA (1.9), we will search for ψ values that yield ψˆAT = 0
when fiing model (1.51), a procedure that will be equivalent to estimating ψ0.
We demonstrate how the mapping of the counterfactual survival time Tt,0(ψ)
at t = 1 and t = 2 by means of G-estimation leads to unbiased estimates of the
ψ0. To do so, we again rely on causal diagrams. However, because a causal DAG
assumes an underlying nonparametric model, which is in contrast with the use of
a parametric SNFTM, the demonstration that follows is only informal. Figure 1.9
is derived from the causal DAG of Figure 1.1 but with Y replaced by T , and aer
adjusting for non-administrative censoring (visible by absence of arrows going
into Ct at t = 1, 2). Eliminating exposure at t = 2 through SNFTM (1.47) leads to
counterfactual survival time T2,0, this will result in removal of outgoing arrow of
A2 into T2,0 in causal diagram (a) of Figure 1.9. G-estimation will ensure that A2
and T2,0 are independent conditional on exposure and confounder history (A1, Lt)
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at t = 2. Indeed, by conditioning on L2, L1 and A1, visible in causal diagram (a) of
Figure 1.9 through squares around these variables, all non-causal paths betweenA2
and T2,0 will be blocked. Counterfactual survival time T1,0 will be created by further
removing the eect of exposure at t = 1, G-Estimation now verifies conditional
independence between T1,0 and A1 (given L1), visible through blocked non-causal
paths between these two variables in causal diagram (b) of Figure 1.9. Note that
diagram (b) shows outgoing arrows of A1 to allow for a null direct eect of A1 on
T1,0 by balancing the paths A1 → T1,0 and A1 → L2 → T1,0
Since SNFTM (1.47) only relies on a selective group of subjects with observed
or administratively censored survival time, we will explain in the next Section
how the G-estimation procedure is adjusted for this. This includes G-estimation
of ψ0 under SNFTM (1.51) using an estimating function, and how this leads to
approximate estimates of its asymptotic variance. Also, see Chapter 5 for details
on how SNFTM (1.47) will be adapted to handle survival times T that are censored
due to administrative end of follow-up.
1.4.4 Semiparametric eiciency
The previous sections introduced models along with estimation methods that
deliver asymptotically unbiased estimates in the presence of measured time-
dependent confounding of the exposure-outcome relationship. In this last section,
we study asymptotically unbiased estimators which have minimal variance as
well. What follows is for the sake of completeness and therefore only for the
interested reader, because it will be only used to support particular derivations
in the Appendices of Chapters 4 and 5. More specifically, we use results from
semiparametric inference that allow us to find unbiased and eicient estimators
for the causal parameters of MSPHMs and SNFTM. By applying these to SNFTM
(1.47) for example, we tackle the problem that the default estimators under this
model only use data from subjects with either observed survival time or whose
outcome was not observed at the end of follow-up. We outline the most important
results in the following paragraphs, see the monograph of Tsiatis (2006) and the
master thesis of Vermeulen (2011) for in-depth explanations and proofs.
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U0 L1 A1 C1
L2 A2 C2 T2,0
(a)
U0 L1 A1 C1
L2 A2 C2
T1,0
(b)
Figure 1.9: Causal directed acyclic graph depicting association between exposure A and
survival time T in a G-estimation procedure under a Structural nested accelerated
failure time model: non-causal paths between (a) exposure A2 and counterfactual
outcome T2,0, and (b) exposure A1 and counterfactual outcome T1,0.
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Regular and asymptotically linear semiparametric estimators
Assuming complete data (no missingness) for the time being, we consider our data
(X, Y ) [with (U,A, L) = X] as realisations of a semiparametric statistical model
with joint density pX,Y (x, y;ψ, η), or
(X, Y ) ∼ pX,Y (x, y;ψ, η) (1.52)
where pX,Y (x, y;ψ, η) belongs to the class of densities P identified by the q-
dimensional parameter of interest ψ and nuisance parameter η belonging to infinite-
dimensional set H , as in
P = {pX,Y (x, y;ψ, η) : ψ ∈ Θ ⊂ Rq, η ∈ H} (1.53)
In the above, nuisance refers to our understanding that the estimation of parameter
η is merely a nuisance, ie. not the objective of the analysis.
For estimation of ψ, we will consider an Asymptotically linear estimator (ALE) ψˆ
for the true parameter ψ0; that is, an ALE estimator obeys
n1/2(ψˆ − ψ0) = n−1/2
n∑
i=1
IF F (Xi, Yi;ψ
0) + op(1) (1.54)
with IF F the q-dimensional full-data influence function of the estimator ψˆ for ψ0,
and having propertiesE{IF F (X, Y ;ψ0)} = 0q×1 andE{IF F (X, Y ;ψ0)IF F ′(X, Y ;ψ0)}
being finite and nonsingular. The function IF F (Xi, Yi) is referred to as the i-th
influence function or the influence function of the i-th observation. Also, op(1) is a
stochastic variable that converges to zero in probability as n goes to infinity.
An ALE has a unique influence function IF F and is Consistent and asymptotically
normal (CAN), as in
ψˆ
p−→ ψ0 (1.55)
n1/2(ψˆ − ψ0) d−→ N{0, E(IF F IF F ′)} (1.56)
with “
p−→” meaning convergence in probability, and “ d−→” convergence in distribution.
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(1.55) implies that an ALE is asymptotically normal with asymptotic variance equal
to the variance of its influence function. Finally, we impose suitable regularity
conditions for ψˆ (Tsiatis et al., 2011)[Section 3.1], and therefore refer to these as a
Regular and asymptotically linear (RAL) estimator.
M-estimators are an example of RAL estimators. These are characterised by
m(X, Y ;ψ), a q-dimensional function of (X, Y ) andψwith propertiesE{m(X, Y ;ψ0)} =
0q×1 and with finite and nonsingular second moments. The m-estimator ψˆn is then
defined as the solution to
∑n
i=1m(Xi, Yi;ψ) = 0.
Geometry of full-data influence functions
The influence functions for ψ0 can be presented as points (or vectors) in a Hilbert
space of mean-zero q-dimensional functionsHq. This is an infinite-dimensional
abstract geometric function space, with the properties of having an inner product
and norm defined as follows
< h1, h2 > = E(h
′
1h2) (1.57)
||h|| = < h, h >1/2 (1.58)
with h1, h2, h ∈ Hq. From the definition, the inner product corresponds to the
covariance of functions h1 and h2, therefore also called covariance inner product. Or-
thogonality between two influence functions (h1 ⊥ h2) is defined as< h1, h2 >= 0.
The norm ||h|| allows to define distance from the origin of the vectors inHq, and
corresponds to the variance of influence function h. By defining covariance and
variance in terms of geometric properties ofHq, our objective will be to find and
evaluate RAL estimators for ψ0 with minimal variance. This will be done by con-
structing the influence function for our estimator that corresponds to the point
closest to the origin ofHq, hereby relying on the correspondence between norm
(distance) and variance.
Leing θ = (ψ, η), and considering for the moment a finite r-dimensional
nuisance parameter η, with p = q + r, define the score vector for (X, Y ) ∼
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pX,Y (x, y; θ) as
Sθ(X, Y ; θ
0) =
∂ log pX,Y (x, y; θ)
∂θ
∣∣∣∣
θ=θ0
(1.59)
or the p-dimensional vector of partial derivatives of the log-density with respect to
θ and evaluated at the true parameter value θ0. The finite-dimensional subspace
ofHq spanned by score vector Sθ(X, Y ; θ0) is called the tangent space J :
J = {Bq×pSθ(X, Y ; θ0) : Bq×p ∈ Rq×p} (1.60)
Sθ factorises into {S ′ψ(X, Y ; θ0), S ′η(X, Y ; θ0)}′ with Sψ the q-dimensional vector
of partial derivatives of the log-density with respect to parameter of interest ψ and
Sη the r-dimensional vector of partial derivatives of the log-density with respect
to nuisance parameter η. Define the parametric nuisance tangent space Λ as the
finite-dimensional subspace ofHq spanned by Sη:
Λ = {Bq×rSη(X, Y ; θ0) : Bq×r ∈ Rq×r} (1.61)
and J = Jψ ⊕ Λ, with Jψ the tangent space of the parameter of interest ψ and
M ⊕N indicating the direct sum of subspaces M,N ⊂ Hq.
Now returning to the case of an infinite-dimensional parameter η, the semipara-
metric nuisance tangent space Λ becomes the mean-square closure of all nuisance
tangent spaces Λγ = {Bq×rSγ(X, Y ;ψ0, γ0) : Bq×r ∈ Rq×r} of all paramet-
ric submodels Pψ,γ ⊂ P , with P the class of densities defined by (1.52) and
Sγ(X, Y ;ψ
0, γ0) the score vector for the finite r-dimensional nuisance parameter
γ of a parametric submodel Pψ,γ . That is, Λ ⊂ Hq is the space of all q-dimensional
functions h(X, Y ) ∈ Hq for which there exists a sequence {BjSγj(X, Y )}+∞j=1 such
that
||h(X)−BjSγj(X, Y )||2 → 0 as j →∞ (1.62)
for a sequence of parametric submodels Pψ,γj and Bj ∈ Rq×rj when γj ∈ Rrj .
Defining the semiparametric nuisance tangent space as above will be essential
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in finding the eicient influence function. It can be shown that an influence function
IF F of a semiparametric RAL estimator ψˆ has the following properties:
E{IF F (X, Y )S ′ψ(X, Y ;ψ0, η0)} = Iq×q (1.63)
Π{IF F (X, Y )|Λ} = 0, or IF F ⊥ Λ (1.64)
with Π[IF F (X, Y )|Λ] the orthogonal projection of the influence function vector
IF F onto the nuisance tangent space Λ. The eicient influence function is then
found by considering the semiparametric eicient score Sψ,e(X, Y ;ψ0, η0) in (1.63),
given by
Sψ,e(X, Y ;ψ
0, η0) = Sψ(X, Y ;ψ
0, η0)− Π[Sψ(X, Y ;ψ0, η0)|Λ] (1.65)
which, as shown in Figure 1.10, is the residual obtained by subtracting from the
score vector Sψ(X, Y ;ψ0, η0) its orthogonal projection onto the semiparametric
nuisance tangent space Π[Sψ(X, Y ;ψ0, η0)|Λ]. This will deliver the eicient full-
data influence function IF Fe(X, Y ;ψ
0, η0), or the unique influence function within
Jψ ⊕ Λ with closest distance to the nuisance tangent space Λ, given by
IF Fe(X, Y ;ψ
0, η0) = E(SeS
′
e)
−1
Se(X, Y ;ψ
0, η0) (1.66)
Deriving an optimal estimator for the restricted moment model
We show how eicient full-data influence function (1.66) leads to an estimator for
ψ. First, consider the Restricted moment model (RMM) defined by
E(Y |X) = µ(X;ψ), (1.67)
which models the conditional expectation of Y given X as a known function of
X and p-dimensional parameter ψ. Function (1.67), which can be rewrien as
E{Y − µ(X,ψ)|X} = 0, formulates the sole restriction on the joint density of
X and Y . In what follows, we will study RMMs with µ(X, θ) = expit(ψ′X∗),
X∗ = (1, X)′ and binary Y , which then becomes a logistic regression model.
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Sψ
Π(Sψ|Λ)
Sψ,e = Sψ − Π(Sψ|Λ)
Λ
Hq
Figure 1.10: Orthogonal projection of the score vector Sψ onto the semiparametric nui-
sance tangent space Λ and derivation of the semiparametric eicient score Sψ,e.
We consider joint densities for variables (Y,X) that can be wrien as
pY X(y, x;ψ, η) = η1{y − µ(x;ψ), X}η2(x), (1.68)
with
η1{y − µ(x;ψ), X} = pY−µ|X{y − µ(x;ψ)|x} (1.69)
η2(x) = pX(x) (1.70)
or η1{y − µ(x;ψ), X} the conditional density of Y − µ(X;ψ) given X with re-
striction E(Y − µ(X;ψ)|X) = 0, and η2(x) the density of X . In the above, η1(.)
and η2(.) can be viewed as infinite-dimensional nuisance parameters.
By deriving the semiparametric nuisance tangent space Λ, and then using
criteria (1.63-1.63) for RAL full data influence functions for parameter ψ of RMM
(1.67), the class of RAL influence functions is found to be (Tsiatis et al., 2011)[Section
4.5] {
[E{A(X)D(X)}]−1A(X){Y − µ(X,ψ)}
}
(1.71)
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with A(X) an arbitrary (non-trivial) p-dimensional function of X and D(X) =
∂µ(X,ψ)/∂ψ. This leads to RAL m-estimator ψˆn for ψ that solves estimating
equation
n∑
i=1
A(Xi){Yi − µ(Xi, ψ)} = 0 (1.72)
also known as Generalised estimating equations (GEE) (Liang and Zeger, 1986),
with ψˆn a GEE-estimator. The eicient influence function is found by deriving the
eicient score, which becomes
Sψ,e(Y,X) = D(X)
′V (X)−1{Y − µ(X,ψ)} (1.73)
with V (X) = var(Y |X) the conditional variance of Y given X . The eicient
influence function then becomes
IF Fe(Y,X) = [E{D(X)′V (X)−1D(X)}]−1D(X)′V (X)−1{Y − µ(X,ψ)}
(1.74)
yielding an optimal estimator ψˆn for ψ as the solution to estimating equation
n∑
i=1
D(Xi)
′V (Xi)−1{Yi − µ(Xi, ψ)} = 0 (1.75)
Applying the above to a logistic regression model, under which D(X) =
X∗V (X) and V (X) = µ(X,ψ){1 − µ(X,ψ)}, we obtain the optimal estimat-
ing equation
n∑
i=1
X∗i {Yi − µ(Xi, ψ)} = 0 (1.76)
We now make the link to SNFTM (1.47) of Section 1.4.3. The G-estimation
procedure of the causal parameter of the SNFTM assesses conditional indepen-
dence under SRA (1.9) between gt{Tt,0(ψ)}, the p-dimensional function of the
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counterfactual survival time, and exposureAt under the pooled conditional logistic
regression model for the discrete-time hazard of exposure (1.51). We now consider
function
UT,F,snm(ψ) =
T∑
t=1
U F,snmt (ψ) (1.77)
with
U F,snmt (ψ) = gt{Tt,0(ψ)}{At − E(At|At−1, Lt;ψA)} (1.78)
The above function UT,F,snm(ψ), with dimension equal to that of ψ, is the part
within the summation of estimating equation (1.76), but applied to estimation of
parameterψAT of the gt{Tt,0(ψ)} vector in pooled logistic regression model (1.51) for
the conditional discrete-time hazard of exposure. Under SRA (1.9), the hypothesis
ψ = ψ0 will correspond to ψAT = 0 in (1.51). The estimating equation
U F,snm(ψ) =
n∑
i=1
UT,F,snmi (ψ) = 0. (1.79)
will then deliver an asymptotically unbiased estimator ψˆ of causal eect parameter
ψ0. The function U F,snm(ψ) = 0 can be viewed as an unstandardised score statistic
for the null hypothesis η = 0 in model (1.51). Because n−1/2U(ψ) is asymptotically
normally distributed with mean zero and variance given by Σ{UT,F,snmi (ψ)}, the
variance-covariance matrix of UT,F,snmi (ψ), optimisation of U
T,snm(ψ) is usually
done by calculating the test statistic
S = n−1UF,snm(ψ)′Σ{UT,F,snmi (ψ)}−1UF,snm(ψ) (1.80)
The point estimate ψˆn of ψ0 is the value of ψ that gives S = 0. The score statistic
can be also used to obtain 95% confidence bounds for ψˆn, by finding values around
ψˆn that give S(ψ) = χ20.95(p), or the Chi-square statistic corresponding with
cumulative probability of 0.95 and p degrees of freedom. Alternatively, consider
following Taylor expansion of U(ψˆn) ≡ UF,snm(ψˆn) around ψ0:
0 = n−1/2U(ψˆn) = n−1/2U(ψ0) + n−1
∂U(ψ0)
∂ψ
n1/2(ψˆ − ψ0) + op(1) (1.81)
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which leads to the following version of equation (1.54) showing asymptotic linearity
of ψˆ:
n1/2(ψˆn − ψ0) = −n1/2
{
∂U(ψ0)
∂ψ
}−1
U(ψ0) + op(1); (1.82)
and the following approximation for the asymptotic variance of ψˆ:
Σ(ψˆn) = n
{
∂U(ψˆn)
∂ψ
}−1′
Σˆ{Ui(ψˆn)}
{
∂U(ψˆn)
∂ψ
}−1
(1.83)
also called the sandwich variance (Robins, 1992; Tsiatis, 2006). In the above, we
assumed for the sake of exercise that the nuisance parameter ψA of the exposure
model (1.51) is known, ie. does not need to be estimated. We explain in Chapter 5
how we account for estimation of this parameter.
Geometry of observed-data influence functions
When data are subject to missingness, the objective of the analysis becomes to
estimate the causal eect parameter ψ0 in the scenario where no missing data
would occur. As mentioned above, the full data (C,X, Y ) contains the missingness
variable C that has value 1 when variable Y for this observation is missing and 0
otherwise. The density of the full data becomes
PC,X,Y (c, x, y;φ, ψ, η) = P (C = c|X, Y ;φ)PX,Y (x, y;ψ, η) (1.84)
with P (C = c|X, Y ;φ) the density of the missingness mechanism identified by
parameter vector φ.
The observed data is {C,X, (1 − C)Y }. To generalise the notation for the
missingness mechanism in the presence of longitudinal data, we define the new
variable C that either denotes the time-point t at which censoring of outcome
variable Y occurs, or has value∞ in case the outcome event Y = 1 is observed.
We then describe the observed data as combinations of variable C and GC(x, y),
the function (with realised value gc) that maps the full data into the observed data,
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or
{Ci, GCi(Xi, Yi)} i = 1, .., n (1.85)
which will give P (C|X, Y ) = P (C|X) under ICA (1.12) and will lead to vectors
{∞, (X, Y )} and {t, (X)} with t = 1, .., Tm. The observed data density can now
be obtained by
PC,GC(X,Y )(c, gc;φ, ψ, η) =
∫
y:Gc(x,y)=gc
P (C = c|x, y;φ)PX,Y (x, y;ψ, η)dy
=
∫
y:Gc(x,y)=gc
P (C = c|x;φ)PX,Y (x, y;ψ, η)dy
= P (C = c|x;φ)
∫
y:Gc(x,y)=gc
PX,Y (x, y;ψ, η)dy
(1.86)
Note that the model for the missingness mechanism P (C = c|X = x;φ) does
not depend on the data that gets mapped to being missing, and therefore can be
placed outside of the integral. Due to this, the log-density of the observed data
gets decomposed into
log P (C = c|X = x;φ) + log
∫
y:Gc(x,y)=gc
PX,Y (x, y;ψ, η)dy (1.87)
which implies that with missing data, the observed-data nuisance tangent space
spanned by the score vectors of the two nuisance parameters φ and η can be
decomposed into the direct sum Λ = Λφ⊕Λη , with Λφ and Λη the semiparametric
nuisance tangent spaces for parameters φ and η respectively, and with Λφ ⊥ Λη;
see Tsiatis et al. (2011)[Section 8.3] for proof.
When considering the geometry of full-data influence functions IF F (X, Y ;ψ0, η0)
for parameter ψ0 and deriving Λ⊥η , the orthogonal complement of the nuisance
tangent space for parameter η, we arrive at observed-data influence functions
IF obs of the form
I(C =∞)
P (C =∞|X, Y ;φ)IF
F (X, Y, ψ0, η0) + L2{C, GC(X, Y )} (1.88)
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with
Eφ[L2{C, GC(X, Y )}|X, Y ] = 0 (1.89)
The first part of influence function IF obs diers from a typical full-data influence
function IF F in that it only takes into account complete cases (having C = ∞),
which are inversely weighted by P (C =∞|X, Y ;φ), their conditional probability
of being observed. The second part of IF obs is L2{C, GC(X, Y )}, an arbitrary
q−dimensional function with specific properties of using observed data (therefore
from complete as well as censored cases), and having mean zero under the full
data distribution and the true model for censoring. Because the function L2
augments the first part of influence function IF obs with data from censored cases,
the space Λ2 of all functions L2 is called the “augmentation space”. Following from
these arguments, an estimator that is derived from influence function IF obs with
function L2 set to zero will be called an Inverse probability of censoring weighted
(IPCW) estimator, while an estimator using the two parts of IF obs will be called an
Augmented Inverse probability of censoring weighted (A-IPCW) estimator.
Further projecting influence function IF obs (1.88) onto Λ⊥φ , the orthogonal
complement of the nuisance tangent space for parameter φ, as in{
I(C =∞)
P (C =∞|X, Y ;φ)IF
F + L2
}
− Π
{
I(C =∞)
P (C =∞|X, Y ;φ)IF
F + L2
∣∣∣∣Λφ} (1.90)
and using that Λφ ⊂ Λ2, we obtain [see Theorem 10.1 of (Tsiatis, 2006) for details]{
I(C =∞)
P (C =∞|X, Y ;φ)IF
F
}
− Π
{
I(C =∞)
P (C =∞|X, Y ;φ)IF
F
∣∣∣∣Λ2} (1.91)
which is the orthogonal complement of the first part of complete-case influence
function (1.88) aer projecting it onto augmentation space Λ2. Estimators derived
from influence function (1.91) have been shown to be optimal within the class of
semiparametric RAL observed-data estimators (1.88) under the model defined by
the restrictions of the joint density pX,Y (x, y;ψ, η) and censoring model P (C|X =
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x;φ) , where “optimal” refers to the corresponding estimator having smallest
asymptotic variance.
An IPCW G-estimator for the structural nested accelerated failure time
model
In the previous section, we created an estimator for the causal parameter ψ0 of a
SNFTM when no missingness of the outcome variable Y occurs. In the presence of
censoring of Y , we use the form of observed-data influence function (1.88) with
function L2 set to zero to create estimating function
UT,obs,snm(ψ) =
T∑
t=1
I(CT = 0)
W c,snmt
U F,snmt (ψ) (1.92)
with
W c,snmt =
T∏
s=t
pics(L,A;φ) (1.93)
and
pics(L,A;φ) = P (Ct = 0|Ct−1 = 0, At, Lt;φ) (1.94)
in which U F,snmt (ψ) is the full-data estimating function for causal parameters under
a SNFTM as defined in (1.78), CT = 0 and Ct = 0 indicates subjects being
uncensored at times T and t respectively, pics(L,A;φ) is the conditional probability
of being uncensored at time t, and W c,snmt the cumulative conditional probability
of remaining uncensored for the remainder of the subject’s survival time T . The
solution to estimating equation U obs,snm =
∑n
i=1 U
T,obs,snm
i (ψ) = 0 will deliver an
Inverse probability of censoring weighted (IPCW) G-estimator under a SNFTM
indexing causal parameter ψ0 .
Estimating equation (1.92) only uses data from complete cases and will be
therefore ineicient. In Chapter 5 we will explore strategies on how to develop
an Augmented Inverse probability of censoring weighted (A-IPCW) G-estimator
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under a SNFTM that also uses data from censored cases.
An IPECWestimator for themarginal structural proportional hazardsmodel
An estimator for the causal parameter β of a MSPHM as estimated by an Inverse
probability of exposure and censoring weighted (IPECW) pooled logistic regression
model for the discrete-time hazard of the outcome, can be constructed by taking
as estimating function
UT,msm(β) =
T∑
t=1
∑
at
I(At = at)I(Ct = 0)
Wmsmt
×(at, L0)′{Yt − P (Yt|Yt−1 = Ct−1 = 0, at, L0; β)} (1.95)
and then solving
Umsm(β) =
n∑
i=1
UT,msmi (β) = 0 (1.96)
for β. In (1.95), Wmsmt is, as defined earlier in (1.41), the cumulative multiplied
conditional probabilities of the observed exposure regime A = a and of remaining
uncensored until time t.
From the above, we see that the results that lead to the derivation of semipara-
metric estimators for missing data can be used to construct estimators for average
causal eects. This is done by considering the potential outcome under a particular
exposure regime as an outcome that is subjected to missingness. The exposure
variable then acts as an indicator of missingness, using that for each subject the
observed value of exposure will mark the actually observed potential outcome.
This way, the Ignorable censoring assumption (ICA) (1.12) and the Sequential
randomisation assumption (SRA) (1.9) are actually analogues of a missing data
estimation problem, the former for identification of outcomes that are unobserved
due to censoring, the laer for identification of unobserved potential outcomes.
The same analogy holds for the assumptions of Positivity of risk of remaining
uncensored (1.13) and of exposure risk (1.10). This way, replacing the censoring by
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the exposure indicator in equation (1.86) and using SRA will lead to an observed
data likelihood that forms the basis for G-computation algorithm (1.33). Likewise, a
similar weighted complete-case estimator as (1.88) can be developed by considering
a mapping from observed data into full data function spaces, with the laer now
denoting the space of influence functions based on potential outcomes. This is
the basis for the Inverse probability of exposure and censoring weighted (IPECW)
estimator, defined as the solution to estimating equation (1.96), and on which we
relied in Section (1.4.2) to derive causal parameters under a MSPHM.
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CHAPTER 2
Infections acquired in intensive care units: results of the
national surveillance in Belgium, 1997-2010
This chapter is based on the following article: Mertens, K., Morales, I. and Catry, B.
(2013) ”Infections acquired in intensive care units: results of national surveillance
in Belgium, 1997-2010,” Journal of Hospital Infection, 84(2): 120-5.
Summary
This article provides the methodology and results from the Belgian surveillance
for infections acquired in intensive care units (ICU) for the period 1997-2010. Since
1997, ICUs within acute care hospitals are encouraged by federal law to participate
to national multicentric prospective observational surveillance. This allows acute
care hospitals to follow locally their infection incidence and enable for comparison
of incidence with national and European reference data. A protocol and soware
tool for data collection was developed, case definitions and methodology follows
those from the European center for disease prevention and control. For 2010, 18
hospitals contributed data on 59 observation quarters, 6 478 ICU patients and 52 593
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ICU patient days. The mean incidence for ICU-acquired pneumonia and intubation-
associated pneumonia (IAP) was 13 per 1000 patient days and 12 per 1000 intubation
days, respectively. The mean incidence for ICU-acquired, central vascular catheter-
associated (CAB), and central vascular catheter-associated primary bloodstream
infections (CAPB) were 3.2 per 1000 patient days, 2.6 per 1000 catheter days, and
3.2 per 1000 catheter days, respectively. During 1997-2010, stable trends of ICU-
acquired pneumonia and bloodstream infections were observed, together with
decreasing trends for IAP and CAB, and a stable trend for CAPB.
2.1 Introduction
The risk for acquiring Healthcare-associated infection (HAI) in Intensive care unit
(ICU) is higher than in other hospitals wards, due to the patient’s severe underlying
health conditions and increased exposure to medical interventions and invasive
devices (Gordts et al., 2010; Torres et al., 2009; Valles and Ferrer, 2009). The
association of infection with morbidity and mortality in ICU is also substantially
higher compared with other wards (Vrijens et al., 2012). Surveillance of HAI is
defined as the continuous and systematic collection, analysis and interpretation
of data on the occurrence of these infections, their risk factors and outcome
parameters, and is widely acknowledged as a valuable component in a strategy for
the prevention and control of this type of infection (Gastmeier et al., 2000a; Gaynes
et al., 2001; Haley et al., 1985). This article aims to provide the methodology and
output of the Belgian National surveillance of infections acquired in intensive care
units (NSIH-ICU) for the period 1997-2010.
2.2 Materials & Methods
2.2.1 Legal context
The NSIH-ICU protocol was developed in 1997 by the “National surveillance of
infections in hospitals (NSIH)” program of the Scientific institute of public health
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(IPH) in close collaboration with the Belgian Society of Internal Medicine, and
launched with a financial incentive to encourage participation. In 2004, the protocol
was modified according to the Hospitals in Europe link for infection control through
surveillance (HELICS) project (Suetens et al., 2007).
Since 2007, Belgian national surveillance of HAI is outlined in the law (Belgisch staatsblad,
2007) and includes, besides the surveillance of ICU-acquired infections, 7 other
HAI surveillance protocols. The objective of national surveillance is (1) to provide
the necessary standards, definitions and tools for the organisation of surveillance
and the follow-up of results within the healthcare seing (local objective), and
(2) to set-up a national database of surveillance data (national objective). This
enables participating hospitals or wards to compare their results with those from
the national population (benchmarking), and allows national stakeholders such
as the Belgian antibiotic policy coordination commiee (Goossens et al., 2008) to
monitor national trends.
2.2.2 Data collection
Collection of surveillance data on the occurrence of HAI is performed prospectively
and during a minimum observation period of 3 months. Followed infections are
ICU-acquired pneumonia, Bloodstream infection (BSI), urinary tract infection and
catheter-related infection. An infection is defined as ICU-acquired when occurring
aer day 2 within the unit. Infections occurring aer discharge from the ICU are
excluded, due to the time-consuming nature of organising such type of surveillance.
Device-associated infections are defined as having a relevant invasive device in the
two days preceding the onset of infection, with relevant device being endotracheal
intubation for pneumonia and Central vascular catheter (CVC) for BSI. For BSI,
the origin of the infection (unknown, catheter, secondary) is to be encoded as well,
thus allowing calculating the number of primary BSI (catheter or unknown origin).
Case definitions are those implemented in 2004 by the HELICS project as taken
over in 2007 by the European center of disease prevention and control (ECDC).
Infection data is further completed by denominators which can be collected in
two ways. In the light version of the protocol, aggregated denominators such as
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the number of patients admied and patient days are specified directly, whereas in
the standard version they are calculated through data on each individual patient
staying in the ICU for more than two days (for whom risk factors and outcome
variables at admission, during hospital stay and at discharge, irrespective of devel-
oping an infection or not are recorded). All surveillance data entry is performed by
means of the locally installed NSIHwin soware, which is developed by the NSIH
program itself, regularly updated, and freely available to participants.
2.2.3 Output variables & analysis
Both (light and standard) versions of the protocol allow the calculation of the
cumulative incidence (number of newly infected patients over total patients) and
the incidence density (number of new infections per 1000 patient days) for each
infection type, as well as the incidence densities of intubation-associated pneu-
monia over intubation days, of Central vascular catheter-associated bloodstream
infections (CAB) over CVC days, and of CVC-associated primary BSI per 1000 CVC
days. The standard version of the protocol allows finer adjustment of infection
incidence for the case-mix of the ICU population case-mix and the degree of in-
vasive device use. Participating hospitals receive a confidential feedback report
shortly aer sending their data to the NSIH program.
The indicators in this paper that we present on the incidence of infection and on
the mean patient length of stay and invasive device use, are aggregated nationally
and annually by means of the annual pooled database mean.
2.2.4 Cohort analysis
In order to analyse the evolution of particular indicators within a stable group
of hospitals, a cohort of hospitals that participated during at least half of all
surveillance periods was established. A trend analysis was done on the database
mean of each type of infection incidence density, and this from a logistic regression
model for the linear (on the logarithmic scale) trend of the daily odds of infection
on patient- or device day-discretised data, and having the year as a single ordinal
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predictor. To correct for the variability of infection incidence across hospitals,
separate models were fied for the hospital mean, and using Generalised estimating
equations (GEE) (Liang and Zeger, 1986). Similar trend analyses were carried out
on the mean length of stay in the ICU using linear regression, and for the daily
odds of invasive device use (intubation and CVC) using logistic regression. Each
model’s coeicient for the yearly trend was recalculated to represent the change
for the whole period (1997-2010).
All data are analysed by means of the statistical soware package STATA
v10 (STATA, 2007).
2.3 Results
A Total of 18 acute care hospitals participated to the NSIH-ICU surveillance in 2010,
referring to an observation period of 59 trimesters, 6 478 ICU-patients and 52 593
ICU-patient days, 12 792 intubation and 24 763 CVC days. Although participation
has steadily decreased since 1998, the number of surveillance periods illustrates
relative intense or continuous monitoring among participating units (Figure 2.1).
Note that participation denotes the number of hospitals, with several hospitals
participating with more than one ICU (data not shown).
Figure 2.2 shows the annual evolution of mean length of stay in the ICU (le),
use of invasive intubation (middle) and use of CVC (right). The mean length of stay
has seen a substantial increase over the years: from 6.5 days in 1997 to 8.1 days
in 2010. A relative stable trend was seen for invasive intubation use, from 318 to
389 days per 1000 patient days between 1997 and 2010. For CVC use, a decreasing
trend from 742 to 615 CVC days per 1000 patient days was seen between 1997 and
2001, and a steady increase aerwards until 751 CVC days per 1000 patient days
in 2010.
In 2010, the mean cumulative incidence of ICU-acquired pneumonia was 8.5%,
the mean incidence density was 13 per 1000 patient days and 12 intubation-
associated pneumonia per 1000 intubation days. The longterm evolution for pneu-
monia incidence (Figure 2.3) suggests a stable trend for ICU-acquired pneumonia
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Figure 2.1: Evolution of participation and number of observed patients and patient days
for the National surveillance of infections acquired in intensive care units (NSIH-ICU).
with incidences ranging between 7 and 15 per 1000 patient days. For intubation-
associated pneumonia incidence, a substantial decrease was seen from 27 (in 1997)
to 12 (in 2010) per 1000 intubation days.
The mean cumulative incidence of ICU-acquired BSI in 2010 was 2.5%, its mean
incidence density was 3.2 per 1000 patient days, 2.6 CVC-associated BSI per 1000
CVC days, and 2.3 CVC-associated primary BSI per 1000 CVC days. Figure 2.4
shows a stable long term evolution of ICU-acquired BSI in the range of 2 to 4
per 1000 patient days. The evolution of the incidence of catheter-associated BSI
suggests a decreasing trend from 4.7 (1997) to 2.6 (2010) per 1000 CVC days. A
lesser decreasing trend was seen among CVC-associated primary BSI, from 3.0
(1997) to 2.3 (2010) per 1000 CVC days.
For both intubation-associated pneumonia and catheter-associated BSI, a low
point in incidence (especially median) was reached directly aer the introduction
of the new HELICS case definitions in 2004. During a transient period, missing data
were seen for the new variable ”invasive device use” upon which the definition of
intubation- or catheter association was based (data not shown), and which could
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Figure 2.2: Evolution of mean length of stay, use of invasive intubation, and use of central
vascular catheter (CVC) in intensive care units in Belgium, National surveillance of
infections acquired in intensive care units (NSIH-ICU).
69
Chapter 2. Infections acquired in intensive care units
2
Figure 2.3: Evolution of incidence of intensive care unit acquired and invasive intubation-
associated pneumonia in Belgium, National surveillance of infections acquired in inten-
sive care units (NSIH-ICU).
explain this lowered incidence.
During 1997-2010, a total of 22 hospitals participated during at least 8 years.
Their types were similar to the national distribution with 85% general, 10% teaching,
and 5% university hospitals. This cohort contributed annually between 5 000 and 7
000 ICU admissions with at least 2 days of ICU stay and between 30 000 and 50
000 corresponding patient days in the ICU. On average, hospitals in this cohort
contributed data for at least 3 surveillance periods per year of participation. Table
2.1 shows the results of the trend analysis. The mean length of stay shows a steady
yearly increase, with a total increase of 1.8 days for the whole period. The use
of invasive intubation in the cohort showed a 9% decrease in odds, while CVC
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Figure 2.4: Evolution of incidence of intensive care unit acquired bloodstream infection,
central vascular catheter associated bloodstream infection, and central vascular catheter
associated primary bloodstream infection in Belgium, National surveillance of infections
acquired in intensive care units (NSIH-ICU).
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Indicator Pooled mean Me/OR (95% CI) Hospital mean Me/OR (95% CI)
Length of stay (mean
days)
1.8 (1.7 to 1.9)*** 1.8 (0.097 to 3.5)*
invasive device use (daily odds)
intubation 0.91 (0.89 to 0.93)*** 0.92 (0.60 to 1.4)
CVC 1.2 (1.2 to 1.2)*** 1.3 (0.52 to 3.0)
pneumonia (daily odds)
ICU-acquired 1.5 (1.4 to 1.7)*** 1.5 (0.57 to 4.2)
intubation-
associated
0.63 (0.55 to 0.71)*** 0.63 (0.34 to 1.2)
bloodstream infections (daily odds)
ICU-acquired 1.2 (1.0 to 1.4)* 1.2 (0.67 to 2.1)
CVC-associated 0.78 (0.64 to 0.95)* 0.78 (0.47 to 1.3)
CVC-associated pri-
mary
1.1 (0.91 to 1.4) 1.1 (0.76 to 1.7)
Table 2.1: Trends of incidence of hospital-acquired infections, device-associated
infections, mean length of stay and invasive device use in intensive care units in
Belgium, 1997-2010; Me/OR = Mean increase for the whole period for length of
stay in days, Odds for device use or infection ratio for all other indicators; 95% CI
= 95% confidence interval and type I error level (p-value) of null hypothesis test of
trend coeicient; ICU = Intensive care unit; intubation = endotracheal intubation;
CVC = central vascular catheter; *p-value<.05, **p-value<.01, ***p-value<.001
represent significance level from Wald-test; Results derived from a cohort of 22
acute care hospitals that participated to the national surveillance of ICU-acquired
infections in Belgium.
use showed a 20% increase in odds for the whole period. The evolution of mean
infection rates of the cohort is largely in line with those of the total group of
participants, with a 50% increase from 1997 to 2010 for ICU-acquired pneumonia
and 30% increase for BSI, 37% decrease for intubation-associated pneumonia, 22%
for CVC-associated BSI, and a stable trend for CVC-associated primary BSI (10%
increase). These periodic trends were similar for the models for database mean and
hospital mean. However, because the cohort had substantial variability of rates
across hospitals, none of the periodic trends for the hospital mean (except mean
length of ICU stay) achieved statistical significance.
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2.4 Discussion
During the last 20 years many European countries have installed regional or
national surveillance of ICU-acquired infections (Agodi et al., 2010; Carlet et al.,
2009; Malacarne et al., 2008; van der Kooi et al., 2007; Zuschneid et al., 2007).
Most of these networks use a standardised protocol that was derived or adapted
from HELICS methodology, and because results are annually reported to ECDC,
their epidemiological reports allow valid comparisons between networks as well as
against a European reference. The incidence of pneumonia as estimated by the
Belgian NSIH-ICU surveillance is higher than the overall European estimates for
2009 with 7.1% ICU patients with pneumonia, 7.8 ICU-acquired pneumonia per
1000 patient days and 14.5 intubation-associated pneumonia per 1000 intubation
days (ECDC, 2011). Belgium has a relative low average length of ICU stay (in 2009:
7.8 days compared to 10.4 for Europe) as well as a low invasive intubation rate (37.4
per 100 patient days as compared to 54.9 for Europe).
The incidence of ICU-acquired pneumonia and BSI underwent a stable to light
increasing trend in the period 1997-2010, but at the same time the mean length of
stay of patients that were followed for this surveillance increased substantially. The
incidence of both intubation-associated pneumonia and CVC-associated BSI, oen
the focus of targeted infection prevention programs (Bonten, 2011; Pronovost
et al., 2006), showed a decreasing trend over the years. For pneumonia this is
accompanied with a decrease in intubation use over the years, while for BSI an
increased use of catheterisation is seen. The incidence of CVC-associated primary
BSI - which excludes infections from secondary origin, and therefore focuses on
the (most) preventable fraction - showed a decreasing trend in the overall group of
participants, but this was not seen in the group of hospitals with most frequent
participation.
While interpreting these results, the following points need to be taken into
account. First, participation to the NSIH-ICU surveillance has decreased over
the years, and undoubtedly, this might influence the interpretation of national
incidences as data could have been contributed by a potentially selective subset of
hospitals. One reason for this declining participation is the increased number of
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hospital mergers which has lowered the number of eligible acute care hospitals
over the years. To illustrate this, at the beginning of the national surveillance in
1997, 170 hospitals were eligible for participation, but this was reduced to 116
hospitals in 2011. Simultaneously, since 1997, other surveillances have been added
to the list of national surveillances. Annual participation to the surveillances of
Meticillin-resistant Staphylococcus aureus and Clostridium diicile became manda-
tory thereby prioritising these over other national programs such as the NSIH-ICU
surveillance. Other factors such as the availability of local systems and pressure
from consumer organisations to force public disclosure might also have resulted
in lower participation. This limited but steady number of participants should be
interpreted positively under the hypothesis that hospitals participating under the
actual optional regime are more motivated as compared to earlier times when this
surveillance was mandatory in certain regions of the country.
Second, the overall evolution of infection incidence among the overall group of
hospitals was confirmed in the cohort of hospitals that participated during half of
all surveillance periods. But, while such cohort analysis does not suer from biases
due to hospitals with infrequent participation and contributing extreme incidence,
it remains driven by the limited number of hospitals that participated in recent
years.
Third, relevant percentiles (25th, 50th, 75th) of the annual national distribution
of hospital means for each indicator were not presented but showed substantial
variation of annual rates between hospitals. This is confirmed by the trend analysis
of the cohort data where none of the statistical significant trends of the pooled
national means were confirmed by the analysis of hospital means. Such variation
is also informative for the improvement that still can be achieved in the prevention
of hospital-acquired infections in a multicentric context.
Hospitals participate in the underlying surveillance project based on its main
objective: to decrease infection rates. However, looking at the trends presented
in this article, this objective is only partly fulfilled. When trying to evaluate the
added value of a national surveillance, the following points need to be made.
First, the evidence surrounding the hypothesis that ”surveillance reduces infection
rates” defines surveillance as the periodic monitoring accompanied by discussion
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and interpretation of its results. The national surveillance project in itself only
guarantees the first part of this process, because no information was collected on
how participants used the collected data internally. Second, improved case-finding
as well as variation in case mix might have influenced the observed trends. Third,
evaluation of the long term impact of a national surveillance program should not
only be based on the changed rates of its targeted infection types, but equally
on the impact of these infections on mortality and morbidity outcomes. Fourth,
analysing only the group of participating hospitals does not constitute a correct
impact assessment because it lacks a proper control group. None of the mentioned
points were the objective of this study.
In summary, acute care hospitals in Belgium are encouraged to participate to
national surveillance. Its standardised tools allow following locally the incidence
of ICU-acquired infections, and enable for comparison of hospital incidence with
national and European reference data. For the entire period 1997-2010 and the
total group of participants, we see stable trends for the incidence of ICU-acquired
infection and decreasing trends for the incidence of device-associated infection.
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CHAPTER 3
Marginal structural models to estimate the aributable
eect of ICU-acquired infections on mortality
This chapter is based on an unpublished article wrien in collaboration with S.
Vansteelandt, I. Morales and B. Catry.
Summary
The assessment of the aributable eect of Intensive care unit (ICU) acquired
infection on mortality remains a controversial topic, this is partly assumed to be
due to the choice of statistical methodology. Also, the eect of infection early
versus late aer its onset has never been estimated separately. We estimate these
eects using methods from the field of causal inference. Unbiased eect estimation
requires adjustment for baseline and time-varying risk factors of mortality and
infection and additionally requires accommodating informative censoring of the
survival time due to selective drop-out of patients. This is realised by fiing
Marginal structural proportional hazards models. Data on 16 366 patients was
derived from a national multicentric surveillance study (Belgium). Our analysis
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yields adjusted hazard ratios of mortality of exposed versus unexposed patients
equal to 1.1 [95% Confidence interval (CI) 0.8 to 1.5] for pneumonia and 1.5 (95%
CI 0.9 to 2.6) for Bloodstream infection (BSI). Only the group of patients with
intermediate severity at admission (Simplified acute respiratory score II 20-39) had
increased aributable mortality for both pneumonia and BSI. The two types of
infection diered in terms of the variation of their post-infection risk for mortality.
For pneumonia, dierent aributable mortality was seen early (protective) versus
late (harmful) aer infection onset, a risk inversion that was not found for BSI.
3.1 Introduction
Despite the apparent negative eect on a patient’s health status, the assessment
of the aributable eect of Healthcare-associated infection (HAI) on mortality - i.e.
the mortality risk due to the presence of infection - remains a controversial topic,
with several studies describing estimates of the relative eect of infection on the risk
of mortality ranging from being neutral to extremely risk increasing (Bercault and
Boulain, 2001; Fagon et al., 1993; Girou et al., 1998; Heyland et al., 1999; Papazian
et al., 1996; Timsit et al., 1996). One possible factor explaining this controversy
is the failure to adjust (appropriately) for time-varying risk factors of infection,
which are indicative of the subject’s health status (such as severity scores) or the
therapeutic activity that the subject did undergo during that period (Carlet, 2001;
Carlet et al., 2001). Because patients who acquire infection generally have a poorer
health condition than patients who do not, the analysis should adjust for time-
varying risk factors associated with both infection-exposure and mortality to the
extent possible, in order to achieve comparable groups of exposed and unexposed
subjects. Failure to do so, for example by estimating a crude (unadjusted) eect
or by merely adjusting for confounding variables collected at admission to the
hospital, may yield biased eect estimates.
Adjustment for confounding commonly happens by stratification; that is, by
including confounders as predictors in a regression model for the association
between infection and mortality. In this article, confounding adjustment is instead
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realised via weighted proportional hazards regression. Specifically, we will fit a
Marginal structural proportional hazards model (MSPHM) (Herna`n et al., 2001;
Robins and Herna`n, 2009), which belongs to a class of causal models for analysing
the eect of time-varying exposures. This model will prevent two sources of bias
that previous studies for the aributable eect of infection on mortality relying
on stratification-based regression models suer from and have thus far failed
to acknowledge: time-dependent confounding and selective drop-out which can
be explained by measured time-varying patient characteristics. Such standard
stratification-based approaches which adjust for time-dependent confounders
induce bias whenever, as is most likely the case in our seing, the considered
confounders (for example daily use of mechanical ventilation) in the regression
model are themselves aected by the exposure to infection. Technically, it can be
shown that, by using such models, one can unbiasedly estimate the adjusted eect
of the exposure at time t on the outcome at t, but not of the adjusted eect at
previous times because adjustment for time-dependent confounders at twill distort
the estimation of the exposure eect at previous times. This aributable lagged
eect of infection on mortality has hardly been studied until now but is of particular
interest as it gives further guidance on the clinical burden of infection (Muscedere
et al., 2010). For example, it could provide insight in the result of anti-infectious
treatment, as an outspoken harmful (beneficial) aributable eect of infection on
risk for mortality in the first few days aer onset could signify the failure (success)
of a treatment.
Furthermore, standard proportional hazards regression approaches (which in-
clude baseline patient characteristics) also suer from bias through selective
dropout because they eectively assume that discharge from the hospital (i.e.
censoring of the survival time), while possibly related to the baseline patient char-
acteristics included in the substantive model of interest, is not further related to the
actual survival time (Herna`n et al., 2004). This assumption of “Ignorable censoring
conditional on baseline characteristics” is clearly violated because patients are
discharged for reasons (prognostic factors) closely related to the endpoint under
study (mortality). Because the patients who drop out thus represent a selective
subset of the total group of patients in terms of prognostic factors arising before
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the time of discharge, the analysis additionally needs to adjust for these variables.
3.2 Materials and methods
3.2.1 Study population and data collection
Follow-up data was obtained for a group of 46 Intensive care units (ICUs) that
participated during a minimum three-month period to the National surveillance
of infections acquired in intensive care units (NSIH-ICU) (Mertens et al., 2013)
(Belgium) during the years 2002 and 2003. Besides data on occurring HAI, a
participating ICU also needed to collect follow-up data for all patients admied
during the 3 month surveillance period. This includes intrinsic risk factors collected
at baseline as well as data on daily exposure to invasive devices and antimicrobial
treatment. HAIs were considered ICU-acquired if they occurred aer the 2nd day
of stay in the ICU. The target population for follow-up was therefore all patients
with at least 3 ICU patient days. ICU follow-up was administratively censored
to 30 days, meaning that patients who stayed longer than 30 days in the ICU,
have a censored survival time of 30 days. Infected patients (cases) were those who
suered from one or more episodes of ICU-acquired pneumonia or Bloodstream
infection (BSI) during their ICU stay. Case definitions for pneumonia and BSI
followed those from the Hospitals in Europe link for infection control through
surveillance (HELICS) European standard protocol (Suetens et al., 2007).
3.2.2 Statistical analysis
In this article, MSPHMs (Herna`n et al., 2001) are models for the marginal eect of
an infection path (for example infection at day 5, or absence of infection through-
out the stay in the hospital) on the counterfactual hazard for mortality under this
infection path. The term ”Marginal” implies that the hazard for mortality is aggre-
gated over all levels of measured time-dependent confounders. The counterfactual
hazard for mortality under this infection path is defined as the mortality that
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a subject would experience when being (hypothetically) exposed to a particular
infection path, counterfactual to the one actually received. This model allows to
contrast for the same population the counterfactual hazards under dierent infec-
tion paths (including the one under absence of infection), therefore its coeicients
indexing infection-exposure have a causal interpretation. By using models for
counterfactual outcomes, we assume that such outcomes are defined and have
realistic interpretation (Herna`n, 2005). Formulating counterfactual outcomes is
not new in the literature on this subject (Fagon et al., 1993; Bekaert et al., 2009,
2011; Bonten et al., 2004; Fagon et al., 1996; Rello and Valles, 1998; Vansteelandt
et al., 2009), the rationale is that ICU-acquired infection is generally considered as
a preventable adverse event, and, as such, we consider counterfactual outcomes to
be generated under ”the set of interventions that would prevent infection from
taking place”. Specifically, in the context of time-varying confounders, all variables
considered to be part of such interventions should be le out of the adjustment
process. The intrinsic baseline and extrinsic time-dependent covariates used to
adjust the infection-mortality association are listed in Table 3.1.
Our MSPHM is essentially a proportional hazards model for mortality involving
time-dependent infection status and baseline covariates, but no further time-
varying covariates. In the model fiing process, each patient day is upweighted
according to combined Inverse probability of exposure (IPE) and Inverse probability
of censoring (IPC) probabilities until that day. Exposure is here defined as exposure
to HAI, and censoring as discharge alive from ICU. This weighting procedure
estimates the counterfactual outcomes mentioned above (Robins and Herna`n,
2009; Herna`n and Robins, 2006), it therefore overcomes the need to adjust via
stratification and hence yields estimates that are not prone to the mentioned
biases of standard regression methods. Exposure weights are applied to adjust
for time-dependent confounders of the infection-mortality association, censoring
weights were used to adjust for selective drop-out of patients being discharged
alive before the administrative censoring date of 30 days. The procedure for the
construction of weights is described in Appendix 3.5.1; this involves uni- and
multivariate analysis to identify risk factors for onset of infection and censoring,
as well as using these models to predict daily risks of infection and censoring and
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Baseline indicator vari-
ables
gender, multiple trauma, acute coronary care
Baseline category vari-
ables
age (categories<40, 40-59, 60-69, 70-74,≥ 80), SAPS
II score* (categories <20 / 20-39 / 40-59 / ≥ 60), in-
fection at admission (categories none / lower respi-
ratory tract infection / bacteraemia / other / multi-
ple infection), type of admission (categories medical
/ scheduled surgery / unscheduled surgery), antibi-
otic utilisation in 48 before or aer admission (cat-
egories none / prophylactic antibiotic / therapeutic
antibiotics / combination), prior surgery (categories
no surgery / elective surgery / urgent surgery)
Time-varying indicator
variables
mechanical ventilation, central vascular catheter,
presence of a naso or oro-intestinal tube, feeding
through a naso or oro-intestinal tube, parenteral
feeding, stoma feeding, antibiotic therapy, antibi-
otic profylaxis, oral intubation, nasal intubation, tra-
cheotomy intubation, surgery
Table 3.1: Baseline and time-varying covariates used to adjust
the aributable eect of ICU-acquired pneumonia and blood-
stream infection on mortality, using data from the National
surveillance Of ICU-acquired infections, Belgium, 2002-2003;
*SAPS = Simplified acute physiology score; ICU=Intensive
care unit.
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subsequent construction of weights.
MSPHMs for the eect of infection on mortality were fied separately for
pneumonia and BSI. Four models were fied for each type of infection, the first
indexed the eect as one parameter, the second stratified this eect for categories
of Simplified acute physiology score II (SAPSII) score (Le Gall et al., 1993), and the
third and fourth stratified the two previous ones for timing of death aer infection
by adding separate parameters before and aer the 5th day of infection. These
last two models therefore allowed to estimate a possible lag eect of infection
on mortality. To apply weighting of individual patient days, model construction
was based on a pooled logistic regression model that treated each patient day
in the ICU as a single observation (the same approach was used for the models
that generated the weights)(D’Agostino et al., 1990). All models were fied using
Generalised estimating equations (GEE) (Liang and Zeger, 1986), requiring an
independent working correlation structure between repeated outcomes from the
same patient (Vansteelandt, 2007). Models were also stratified for a categorical
variable encoding the hospital or ICU that contributed data. All model construction
and fiing was done using STATA v10’s logistic command (STATA, 2007).
3.3 Results
For this study, 16 366 ICU admissions, contributing 108 328 ICU days of patients
staying more than 2 days in the ICU were available for analysis. The median
length of stay in ICU was 4 days, and for infected patients, the mean ICU stay
prior to the first infection was 6 days. Of the 960 (5.9%) patients with one or more
pneumonia-episodes, 277 (29%) died, compared to 1 524 deaths (9.9%) that occurred
in 15 406 (94%) pneumonia-free patients. Of all pneumonia episodes 689, (73.8%)
were associated with mechanical invasive ventilation. Of the 299 (1.8%) patients
with one or more BSI episodes, 83 (5%) died, as compared to 1 594 deaths (9.9%)
that occurred in 16 067 (98%) patients remaining BSI-free. Of all BSI episodes,
284 (95%) were associated with Central vascular catheter (CVC) use, while 195
(65%) were of primary (unknown or CVC) origin. Figure 3.1 shows data for the first
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Figure 3.1: Evolution of patients under follow-up, with ICU-acquired pneumonia, ICU-
acquired bloodstream infection and that died in the ICU during days 3-30; Percentages
or per mils are calculated on the total of 16 366 patients admied to ICU. Under Follow-
up: % alive at the start of each day; Cumulative Death: ‰that died until particular day;
Cumulative pneumonia: ‰with pneumonia until that day; Cumulative bloodstream
infection: ‰of patients with bloodstream infection until that day.
30 days of ICU follow-up. Daily pneumonia, BSI and death rates were relatively
stable throughout follow-up. It was found that at day 5, already 60% of the initial
group had le the ICU, and 85% at day 20. This is indicative for the huge level
of censoring taking place during the first days of ICU follow-up, and the need to
adjust for this.
Tables 3.2-3.6 show the results of the multivariate models for the hazard of pneu-
monia, BSI, and censoring, used for calculation of IPE and IPC weights. The models
for the hazard of pneumonia and BSI show that exposure to CVC, ventilation,
intubation and prophylactic antibiotic use was associated with an increased risk
for acquiring pneumonia, and that exposure to CVC, stoma, parenteral and tube
feeding, intubation, and prophylactic and therapeutic antibiotic use was associated
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with an increased risk for acquiring BSI. Besides the expected protective eect of
SAPSII score category, the model for ICU discharge alive (censoring) shows protec-
tive eects for virtually all invasive device procedures and types of antibiotic use.
This supports our consideration of time-varying exposure to therapeutic activity
as a proxy for a patient’s daily underlying health status, thus being indicative for
worse prognosis (lengthening ICU stay).
Inspection of IPE weights revealed that these remained relatively stable, having a
minimum-maximum range at 30 days of (0.1 to 9.5) with median 1.0 for pneumonia
and (0.17 to 11.6) with median 1.0 for BSI. However, a subset of patients with very
small predicted conditional probabilities of being discharged from the ICU yielded
unstable IPC weights with range (1e-11 to 1e+19) and median 0.94. As shown
in figure 3.2, the range of percentiles 1 to 99 of the combined IPE-IPC weights
(infection and exposure) distribution remained fairly stable (relative to the large
sample size) over the course of study lengths, having ranges (0.012 to 14.9) and
(0.015 to 14.5) at 30 days for pneumonia and BSI respectively. Combined IPE-IPC
weights were therefore truncated towards the above range, by seing the value of
weights greater (lower) than percentile 99 (1) to the value of percentiles 99 (1) (Cole
and Herna`n, 2008).
The MSPHMs for the aributable eect of infection on mortality were strat-
ified on baseline confounders “age category”, “SAPSII score category”, “type of
admission” and “antibiotic use at ICU admission”. The model for the eect of
pneumonia yielded a Hazard ratio (HR) of 1.1 [95% Confidence interval (CI) 0.76
to 1.5], while the model for the eect of BSI gave a HR 1.5 (95% CI 0.9 to 2.6)
(Table 3.7). Stratifying the infection eect for SAPSII categories (Table 3.7, model 2)
gave higher eects for the group of patients admied with scores between 20-39
(intermediate category), and this for pneumonia (HR 2.3; 95% CI 1.4 to 3.8) and
BSI (HR 3.4; 95% CI 1.4 to 7.9).
When looking at aributable mortality at dierent times since onset of infection
(Table 3.7, model 3), we see a protective eect in the first 4 days aer onset of
pneumonia (0.59; 95% CI 0.3 to 1.1), and a stronger harmful eect from day 5 on
(1.5; 95% CI 0.93 to 2.3). Such contrast was not found for BSI (1.4; 95% CI 0.78 to
2.5 versus 1.7; 95% CI 0.8 to 3.6). Furthermore, the aforementioned elevated eects
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R
isk
factor
Type
A
djusted
hazard
ratio
(95%
C
I)
Pneum
onia
B
loodstream
infection
D
ischarge
alive
from
IC
U
D
ay
in
IC
U
Single
1.27
(1.20
to
1.35)***
1.25
(1.16
to
1.34)***
1.57
(1.52
to
1.61)***

adratic
0.99
(0.99
to
1.00)***
0.99
(0.99
to
1.00)***
0.98
(0.98
to
0.98)***
Ventilation
Episode
1.91
(1.36
to
2.69)***
n/a
0.16
(0.14
to
0.20)***
Ever
1.41
(1.06
to
1.88)*
n/a
1.23
(1.05
to
1.44)*
D
ays
n/a
n/a
n/a
C
entralvascular
catheter
Episode
n/a
2.46
(1.24
to
4.88)**
n/a
Ever
3.10
(2.23
to
4.30)***
2.26
(0.90
to
5.68)
0.80
(0.74
to
0.87)***
D
ays
0.96
(0.92
to
1.00)*
n/a
0.97
(0.95
to
0.98)***
Stom
a
feeding
Episode
n/a
1.54
(0.82
to
2.89)
0.69
(0.56
to
0.85)***
Ever
n/a
n/a
n/a
D
ays
n/a
n/a
n/a
Parenteralfeeding
Episode
n/a
2.09
(1.56
to
2.80)***
0.50
(0.42
to
0.58)***
Ever
1.43
(1.11
to
1.84)**
n/a
1.30
(1.11
to
1.53)***
D
ays
0.97
(0.94
to
1.01)
n/a
n/a
Feeding
through
tube
Episode
1.65
(1.35
to
2.03)***
2.29
(1.46
to
3.59)***
0.56
(0.51
to
0.61)***
Ever
n/a
0.61
(0.36
to
1.03)
1.09
(0.99
to
1.20)
D
ays
0.96
(0.94
to
0.99)*
n/a
n/a
Table
3.4:R
esults
for
tim
e-varying
risk
factors
(a)ofconstruction
ofm
odels
for
onset
ofpneum
onia,
bloodstream
infection,and
for
discharge
alive
from
IC
U
,used
for
calculating
inverse
probability
of
exposure
and
censoring
w
eights,N
ationalsurveillance
O
f
IC
U
-acquired
infections,B
elgium
,
2002-2003;E
ects
for
hospitalor
unit
not
show
n;n/a:coe
icient
not
used
in
the
regression
m
odel
(not
applicable);IC
U
=Intensive
care
unit;Episode/Ever/D
ays=type
by
w
hich
the
risk
factor
w
as
coded:
Episode=exposure
can
be
set
to
0
a
er
being
set
to
1,Ever=m
onotonous
exposure
(once
exposed,the
patientrem
ains
so
untilIC
U
discharge),D
ays=cum
ulative
exposure;*p-value<
.05,**=p-
value<
.01,***p-value<
.001
representing
significance
levelfrom
W
ald-test.
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R
isk
factor
Type
A
djusted
hazard
ratio
(95%
C
I)
Pneum
onia
B
loodstream
infection
D
ischarge
alive
from
IC
U
IC
U
-acquired
pneum
onia
Episode
n/a
n/a
n/a
Ever
n/a
n/a
0.27
(0.21
to
0.34)***
D
ays
n/a
n/a
1.1
(1.1
to
1.2)***
IC
U
-acquired
bloodstream
infec-
tion
Episode
n/a
n/a
n/a
Ever
n/a
n/a
0.36
(0.23
to
0.57)***
D
ays
n/a
n/a
1.1
(1.1
to
1.2)***
Table
3.6:R
esults
for
tim
e-varying
risk
factors
(c)ofconstruction
ofm
odels
for
onset
ofpneu-
m
onia,bloodstream
infection,and
for
discharge
alive
from
IC
U
,used
for
calculating
inverse
probability
ofexposure
and
censoring
w
eights,N
ationalsurveillance
O
fIC
U
-acquired
infec-
tions,B
elgium
,2002-2003;E
ects
for
hospitalor
unit
not
show
n;IC
U
=Intensive
care
unit;
Episode/Ever/D
ays=type
by
w
hich
the
risk
factor
w
as
coded:Episode=exposure
can
be
set
to
0
a
er
being
set
to
1,Ever=m
onotonous
exposure
(once
exposed,the
patient
rem
ains
so
until
IC
U
discharge),D
ays=cum
ulative
exposure;n/a:coe
icient
not
used
in
the
regression
m
odel
(not
applicable);*p-value<
.05,**=p-value<
.01,***p-value<
.001
representing
significance
level
from
W
ald-test.
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Figure 3.2: Daily distribution of combined inverse probability of infection (modelled
separately for pneumonia and bloodstream infection) and censoring weight, through
natural logarithms of percentiles 0, 1, 5, 95, 99, and 100.
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Bloodstream infection Pneumonia
# (%) Hazard ratio (95% CI) # (%) Hazard ratio (95% CI)
Model 1: overall infection eect
ICU-acquired infection 299 (100.0) 1.6 (0.94 to 2.6) 934 (100.0) 1.1 (0.76 to 1.5)
Model 2: Infection x SAPS II score
<20 17 (5.7) 2.2 (0.24 to 20) 74 (7.9) 1.3 (0.14 to 11)
20-39 112 (37.5) 3.4 (1.4 to 7.9)** 417 (44.6) 2.3 (1.4 to 3.8)**
40-59 108 (36.1) 1.4 (0.63 to 3.0) 305 (32.7) 0.90 (0.53 to 1.5)
≥ 60 62 (20.7) 1.1 (0.64 to 2.0) 138 (14.8) 0.71 (0.40 to 1.3)
Model 3: Infection x timing of death aer infection
Earlya 99 (33.1) 1.4 (0.78 to 2.5) 212 (22.7) 0.59 (0.32 to 1.1)
Latea 200 (66.9) 1.7 (0.80 to 3.6) 722 (77.3) 1.5 (0.93 to 2.3)
Model 4: Infection x SAPS II score x timing of death aer infection
<20, Early 4 (1.3) 3.54 (0.37 to 33.83) 20 (2.1) 1.98 (0.21 to 18.37)
<20, Late 13 (4.3) (no observed deaths) 54 (5.8) 0.14 (0.02 to 1.16)
20-39, Early 37 (12.4) 1.40 (0.41 to 4.85) 109 (11.7) 0.80 (0.28 to 2.28)
20-39, Late 75 (25.1) 6.48 (2.14 to 19.59)** 308 (33.0) 3.94 (1.96 to 7.90)**
40-59, Early 33 (11.0) 1.13 (0.37 to 3.44) 63 (6.7) 0.48 (0.21 to 1.09)
40-59, Late 75 (25.1) 1.55 (0.61 to 3.93) 242 (25.9) 1.23 (0.61 to 2.46)
≥ 60, Early 25 (8.4) 1.78 (0.87 to 3.64) 20 (2.1) 0.58 (0.18 to 1.85)
≥ 60, Late 37 (12.4) 0.81 (0.41 to 1.58) 118 (12.6) 0.84 (0.45 to 1.58)
Table 3.7: Aributable mortality eect Of ICU-acquired infection, using inverse
probability of exposure and censoring weighted proportional hazards mod-
els, National surveillance Of ICU-acquired infections, Belgium, 2002-2003;
ICU=Intensive care unit; CI=Confidence interval, # (%)=number (percentage of
total) of infections falling within the category; Early: occurring within the first
four days aer onset of infection, Late: occurring aer the fourth day aer
onset of infection; SAPS=Simplified acute physiology score; *p-value<.05,
**p-value<.01, ***p-value<.001 represent significance level from Wald-test.
of pneumonia and BSI among patients with intermediate SAPSII scores were due
to deaths occurring later aer infection onset (Table 3.7, model 4).
Based on calculated predictions from the MSPHM for the overall aributable
mortality eect, Figure 3.3 shows the estimated survival curves for the study
population in the hypothetical scenarios where all patients acquire infection at
day 3 in the ICU, as compared to when none of the patients acquires an infection.
For the model having a monotonous eect of infection, only the curves of patient
survival under exposure to BSI are clearly distinguishable and generally lower than
those of the patient population under absence of BSI. For the model including
lagged eects of infection, the survival curve for exposure to pneumonia crosses the
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Figure 3.3: Predicted survival curves for the patient population hypothetically acquiring
infection at day 3, and remaining infection-free; Le = eect of bloodstream infection;
Right = eect of pneumonia; Upper = monotonous eect of infection from day 3; Lower
= dierential infection eect for days 3/6 and days 7/max aer onset of infection; NB =
nosocomial (ICU-acquired) bloodstream infection; NP = nosocomial pneumonia; ICU =
intensive care unit.
curve for absence of pneumonia, which is indicative for the shi from protective
to harmful exposure eects around day 7 in the ICU.
Finally, Appendix 3.5.2 gives a description and results of a sensitivity analysis
in which the MSPHM is fied repeatedly under varying administrative censoring
times.
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3.4 Discussion
This article describes the estimation of the aributable eect of ICU-acquired infec-
tion on the risk for mortality using Inverse probability of exposure and censoring
weighted (IPECW) estimation under a MSPHM (Herna`n et al., 2001). Our analysis
showed a neutral risk of mortality for ICU-acquired pneumonia, and a marginally
higher risk for mortality for ICU-acquired BSI. Our analysis also demonstrated
that pneumonia had a marginally higher eect on mortality aer the fourth day of
infection that was in contrast to a protective eect during the first 4 days, which
is an inversion that was not seen for BSI. For both infection types, the group of
patients with intermediate SAPSII scores contributed the highest mortality eects,
both infection types consistently later aer infection onset.
To our knowledge, the study presented here is among the few to analyse eects
of infections in a national multicentric seing, and also among the first to use
weighted adjustment for time-dependent confounding and informative censoring
explained by measured time-varying prognostic factors in the seing of ICU sur-
vival. The use of this method must be seen in light of recent calls (Lambert et al.,
2011; Muscedere, 2009; Timsit et al., 2011) for using estimation techniques that
can adequately deal with the methodological pitfalls when estimating aributable
outcome of infection. Adjustment was made by weighting because stratification
for so-called intermediate time-varying confounders that act both as causes and
eects of exposure to infection will induce non-causal associations between infec-
tion and mortality (Herna`n et al., 2001; Robins, 2000). Moreover, while risk ratio
estimates from stratified methods have interpretation conditional on distinct levels
of time-dependent and -independent confounders, the marginal structural model
yields a causal estimate of the marginal (over time-dependent confounders) risk
ratio, which is more relevant for public health purposes.
Our model’s neutral overall aributable eect of pneumonia on mortality, al-
though dierently obtained and interpreted, is in line with reports using conven-
tional stratification-based methods but similarly relying on extensive adjustment
for time-independent and -dependent confounders (Heyland et al., 1999; Papazian
et al., 1996; Timsit et al., 1996; Kollef et al., 1995). It is also in line with results from
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randomised trials for the prevention of pneumonia (mostly ventilator-associated)
that demonstrated a decrease in infection incidence but without altering ICU mor-
tality (Muscedere et al., 2010). For BSI, a higher but still statistically non-significant
eect was found. Earlier reports on the eect of primary CVC-related BSIs found
mostly risk increasing but statistically insignificant eects individually (Digiovine
et al., 1999; Rello et al., 2000; Renaud and Brun-Buisson, 2001; Soufir et al., 1999),
which turned significant when aggregated into a meta-analysis (Siempos et al.,
2009). Of note is that a study by Renaud and Brun-Buisson (2001) showed a higher
aributable mortality eect for secondary BSI, which might explain the slightly
higher aributable mortality of our study (including primary and secondary BSI).
The higher aributable mortality among patients with intermediate SAPSII scores
was also previously reported, for both pneumonia and BSI (Bekaert et al., 2011;
Kim et al., 2005; Nguile-Makao et al., 2010).
Our results show that pneumonia and BSI behave dierently in terms of the
variation of the post-infection aributable hazard for mortality, with the former
showing protective risk immediately and harmful risk only longer aer onset,
but the laer instead showing harmful eects both immediately and later aer
onset. The phenomenon as observed for pneumonia of a progressively increased
risk for mortality once an infection is observed was recently also reported for
Ventilator-associated pneumonia (VAP) (Bekaert et al., 2011). It also explains some
of the more harmful aributable eect estimates for pneumonia in other reports
that used follow-up periods up to and above 100 days (Bercault and Boulain, 2001;
Nguile-Makao et al., 2010; Wolkewitz et al., 2009) as compared to the period of
30 days that we used here. Such studies with a higher length of follow-up will
not only observe more deaths in the total study population, but also progressively
more in later periods among infected patients if we extrapolate the increasingly
harmful mortality eect late aer infection onset.
The following limitations have to be taken into account when interpreting this
study’s results: first, we had no info on the adequateness of the appropriate treat-
ment of the studied infections. This would be an added value, specifically when
studying aributable mortality eects early and late aer infection onset. Second,
in relation to the previous argument, the design of a prospective surveillance study
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for HAI might in itself have contributed to a more neutral eect on mortality, due
to the fact that any infected patient under surveillance might benefit from the
increased aention towards the targeted types of infection. Third, time-dependent
confounders were limited to daily use of invasive devices and antimicrobial ther-
apy, no organ dysfunction score were used for adjustment but these might have
contributed to a finer adjustment. Finally, our analysis suered from the strong
association of invasive devices with probability of remaining in the ICU, leading to
highly variable and unstable IPC weights, and as a consequence wide confidence
intervals. Future research projects might investigate alternative methods for such
IPC weights, or techniques to make the analysis more optimal.
3.5 Appendix
3.5.1 Calculating the inverse probability weights
The MSPHM applies IPE weights to adjust for time-dependent confounders of the
infection-mortality association, and IPC weights to adjust for selective dropout of
patients being discharged alive before the administrative censoring date of 30 days.
Exposure weights are the inverse of a patient’s daily probability of having acquired
his or her observed infection-exposure until that day, conditional on confounder
history until then. These are derived by constructing a proportional hazards model
for the hazard of infection that includes the history of time-dependent and baseline
(time-independent) confounders for the infection-mortality association, and by
using the fied model to calculate predictions of the conditional probability of
acquiring infection at each day. An IPE weight at day t is therefore the reciprocal
of the estimated risk of acquiring infection at that day (or staying free of infection,
depending on the observed infection-status) multiplied from day 1 to t. A numerator
is calculated to make the weights more stable, and was constructed similarly,
except that the regression model only used time-independent confounders. The
construction of IPC weights is similar to that of IPE weights, except that now
proportional hazard models for censoring (defined as discharged alive from the
ICU) were constructed and used for predictions. A IPC weight at each particular
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day is informally the reciprocal of a patient’s probability of remaining in the ICU
until that day, given his or her time-dependent and -independent history (including
information on the infection status) up to that day.
All proportional hazard models are based on a pooled logistic regression model
that treated each patient day in the ICU as a single observation (D’Agostino et al.,
1990). Separate models were created for pneumonia and BSI, these only incorporate
the 1st possible infection episode for each patient. All models were fied using
GEE (Liang and Zeger, 1986), using an independent working correlation structure
between repeated outcomes from the same patient. Models were also stratified for
a categorical variable encoding the hospital or ICU that contributed data. All model
construction and fiing was done using STATA’s logistic (STATA, 2007) command.
Construction of the models for calculating the IPE and IPC weights starts with
identifying risk factors for infection, discharge alive from ICU and ICU-mortality,
and thus potential confounding factors for the infection-mortality and censoring-
mortality associations. Univariate models were therefore constructed for any of
the outcomes described above having any risk factor as a single predictor. Tables
3.8-3.12 show results from this analysis for time-independent factors (variables
collected at ICU admission) and time-dependent factors respectively. From Tables
3.10-3.12 we see that virtually all time-dependent invasive device exposures are
individually strongly predictive for staying in the ICU. Those risk factors having
an observed Wald test significance level of less than 0.05 were consequently used
in a stepwise backward removal procedure with significance level 0.1 in the models
for the prediction of inverse probability weights.
The constructed models for the hazard of pneumonia, BSI and discharge alive
from the ICU were used to calculate for each patient day the conditional prob-
ability of acquiring any of the above outcomes. The probabilities of acquiring
infection were converted towards the probability of the actual infection status
at each day, by subtracting the predicted probability from 1 in case of absence
of infection. Likewise, the conditional probability of remaining in the ICU was
obtained by subtracting the probabilities of discharge alive in the ICU from 1. The
estimated probabilities from day 1 to each particular day are multiplied to obtain
the probability of actual infection status and of remaining in the ICU up to each
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R
isk
factor
C
ategory
Patients
Patient
days
H
azard
ratio
(95%
C
I)
(%
)
(%
)
Pneum
onia
B
loodstream
infection
IC
U
m
ortality
D
ischarge
alive
from
IC
U
A
cute
coronary
care
N
o
13191
(78%
)
90532
(81%
)
Yes
3678
(22%
)
20710
(19%
)
0.75
(0.62
to
0.91)**
0.90
(0.65
to
1.25)
1.17
(1.03
to
1.33)*
1.29
(1.23
to
1.35)***
A
ge
category
<
40
1204
(7%
)
7913
(7%
)
40-59
3294
(20%
)
21612
(19%
)
0.97
(0.73
to
1.28)
0.92
(0.57
to
1.48)
2.34
(1.67
to
3.29)***
0.95
(0.88
to
1.03)
60-69
3349
(20%
)
22542
(20%
)
1.03
(0.79
to
1.36)
0.79
(0.49
to
1.28)
2.53
(1.81
to
3.54)***
0.90
(0.83
to
0.97)**
70-74
2617
(16%
)
17787
(16%
)
1.03
(0.78
to
1.37)
1.15
(0.72
to
1.85)
2.89
(2.07
to
4.05)***
0.87
(0.80
to
0.94)***
75-79
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(18%
)
20710
(19%
)
0.95
(0.72
to
1.25)
1.04
(0.65
to
1.67)
3.30
(2.37
to
4.60)***
0.82
(0.76
to
0.89)***
≥
80
3410
(20%
)
20678
(19%
)
0.77
(0.57
to
1.02)
0.58
(0.34
to
0.99)*
4.80
(3.46
to
6.67)***
0.93
(0.86
to
1.01)
A
B
use
before
adm
ission
N
one
9709
(58%
)
59812
(54%
)
Prophylactic
4296
(25%
)
25477
(23%
)
2.44
(2.10
to
2.83)***
1.12
(0.83
to
1.51)
0.52
(0.45
to
0.61)***
1.15
(1.10
to
1.21)***
Therapeutic
2815
(17%
)
25471
(23%
)
0.95
(0.80
to
1.13)
1.40
(1.08
to
1.82)*
0.97
(0.87
to
1.09)
0.55
(0.52
to
0.58)***
B
oth
49
(0%
)
482
(0%
)
3.87
(2.10
to
7.14)***
1.91
(0.56
to
6.58)
0.92
(0.46
to
1.82)
0.52
(0.37
to
0.74)***
Infection
at
adm
ission
N
one
12481
(74%
)
73201
(66%
)
LR
T
2553
(15%
)
22762
(20%
)
0.62
(0.52
to
0.73)***
1.14
(0.87
to
1.51)
1.54
(1.38
to
1.73)***
0.47
(0.45
to
0.50)***
B
SI
310
(2%
)
2864
(3%
)
0.47
(0.29
to
0.76)**
1.49
(0.84
to
2.64)
1.49
(1.15
to
1.93)**
0.44
(0.38
to
0.51)***
O
ther
1320
(8%
)
10313
(9%
)
0.52
(0.40
to
0.68)***
1.35
(0.94
to
1.93)
1.05
(0.88
to
1.26)
0.65
(0.60
to
0.69)***
M
ultiple
205
(1%
)
2102
(2%
)
0.85
(0.56
to
1.31)
2.16
(1.26
to
3.70)**
1.32
(0.96
to
1.81)
0.39
(0.33
to
0.47)***
Table
3.8:U
nivariate
analysis
oftim
e
independent
risk
factors
(a)for
the
onset
ofIC
U
-acquired
pneum
onia,bloodstream
infection,
and
of
m
ortality
and
discharge
alive
from
IC
U
;IC
U
=Intensive
care
unit;
Patient(day)s
(%
)=the
num
ber
(percentage
of
total)
of
patient(day)s
w
ithin
the
corresponding
risk
factor
level;
H
azard
ratio=derived
from
proportional
hazards
m
odels
for
the
indicated
outcom
e
(pneum
onia,bloodstream
infection,m
ortality,discharge
alive
from
IC
U
)having
the
corresponding
risk
factor
as
single
predictor;C
I=C
onfidence
Interval;A
B
=A
ntibiotic;LR
T=Low
er
respiratory
tract;B
SI=B
loodstream
infection;*p-value<
.05,
**p-value<
.01,***p-value<
.001
represent
significance
levelfrom
W
ald-test.
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Chapter 3. Marginal structural models to estimate aributable mortality eects
3
R
isk
factor
Type
Patients
Patient
days
H
azard
ratio
(95%
C
I)
(%
)
(%
)
Pneum
onia
B
loodstream
infection
IC
U
m
ortality
D
ischarge
alive
from
IC
U
Ventilation
Episode
10586
(63%
)
76902
(69%
)
3.84
(3.07
to
4.81)***
4.36
(2.74
to
6.94)***
1.17
(1.04
to
1.33)*
0.37
(0.36
to
0.39)***
Ever
81387
(73%
)
5.64
(4.32
to
7.36)***
6.01
(3.31
to
10.94)***
1.86
(1.59
to
2.19)***
0.42
(0.40
to
0.43)***
D
ays
1.11
(1.06
to
1.16)***
1.13
(1.05
to
1.21)**
1.03
(1.02
to
1.05)***
0.86
(0.85
to
0.87)***
C
V
C
Episode
7440
(44%
)
44625
(40%
)
2.83
(2.44
to
3.29)***
1.81
(1.39
to
2.36)***
1.88
(1.69
to
2.10)***
0.03
(0.03
to
0.03)***
Ever
65284
(59%
)
4.56
(3.73
to
5.57)***
2.54
(1.74
to
3.70)***
2.53
(2.19
to
2.92)***
0.32
(0.31
to
0.34)***
D
ays
1.11
(1.08
to
1.14)***
1.04
(1.01
to
1.07)**
1.05
(1.04
to
1.07)***
0.77
(0.76
to
0.78)***
Stom
a
feeding
Episode
304
(2%
)
2380
(2%
)
0.69
(0.41
to
1.15)
1.58
(0.92
to
2.71)
0.55
(0.37
to
0.81)**
0.58
(0.50
to
0.68)***
Ever
2687
(2%
)
0.70
(0.43
to
1.15)
1.47
(0.86
to
2.49)
0.58
(0.41
to
0.83)**
0.66
(0.58
to
0.76)***
D
ays
0.96
(0.89
to
1.02)
1.03
(0.99
to
1.09)
0.95
(0.91
to
0.99)**
0.98
(0.96
to
0.99)**
Parenteralfeeding
Episode
2527
(15%
)
18930
(17%
)
1.02
(0.86
to
1.21)
2.09
(1.61
to
2.69)***
0.73
(0.64
to
0.82)***
0.35
(0.32
to
0.37)***
Ever
24243
(22%
)
1.03
(0.87
to
1.21)
1.90
(1.45
to
2.49)***
0.83
(0.74
to
0.94)**
0.43
(0.41
to
0.46)***
D
ays
0.97
(0.95
to
0.99)**
1.03
(1.01
to
1.06)**
0.99
(0.97
to
1.00)**
0.91
(0.90
to
0.92)***
Feeding
through
tube
Episode
5956
(35%
)
39804
(36%
)
2.30
(1.99
to
2.67)***
1.93
(1.49
to
2.51)***
1.10
(0.99
to
1.22)
0.15
(0.14
to
0.16)***
Ever
51335
(46%
)
2.47
(2.11
to
2.91)***
1.71
(1.27
to
2.30)***
1.20
(1.08
to
1.34)***
0.44
(0.42
to
0.46)***
D
ays
1.05
(1.03
to
1.07)***
1.02
(0.99
to
1.04)
1.01
(1.00
to
1.02)*
0.87
(0.86
to
0.87)***
Feeding
tube
present
Episode
4873
(29%
)
36372
(33%
)
2.27
(1.96
to
2.63)***
1.25
(0.97
to
1.61)
0.99
(0.89
to
1.11)
0.16
(0.14
to
0.17)***
Ever
46003
(41%
)
2.48
(2.12
to
2.91)***
1.26
(0.95
to
1.67)
1.22
(1.09
to
1.37)***
0.34
(0.33
to
0.36)***
D
ays
1.07
(1.05
to
1.09)***
0.99
(0.96
to
1.01)
1.00
(0.99
to
1.02)
0.86
(0.85
to
0.87)***
Table
3.10:U
nivariate
analysis
oftim
e
dependentrisk
factors
(a)for
the
onsetofIC
U
-acquired
pneum
onia,bloodstream
infection,
and
ofm
ortality
and
discharge
alive
from
IC
U
;IC
U
=Intensive
care
unit;Patient(day)s
(%
)=the
num
ber
(percentage
oftotal)
of
patient(day)s
w
ithin
the
corresponding
risk
factor
level;H
azard
ratio=derived
from
proportionalhazards
m
odels
for
the
indicated
outcom
e
(pneum
onia,bloodstream
infection,m
ortality,discharge
alive
from
IC
U
)having
the
corresponding
risk
factor
as
single
predictor;C
I=C
onfidence
Interval;C
V
C
=C
entralvascular
catheter;Episode/Ever/D
ays=type
by
w
hich
the
risk
factor
w
as
coded:Episode=exposure
can
be
set
to
0
a
er
being
set
to
1,Ever=m
onotonous
exposure
(once
exposed,the
patient
rem
ains
so
untilIC
U
discharge),D
ays=cum
ulative
exposure;*p-value<
.05,**p-value<
.01,***p-value<
.001
represent
significance
levelfrom
W
ald-test.
100
33.5. Appendix
R
is
k
fa
ct
or
Ty
pe
Pa
ti
en
ts
Pa
ti
en
t
da
ys
H
az
ar
d
ra
ti
o
(9
5%
C
I)
(%
)
(%
)
Pn
eu
m
on
ia
B
lo
od
st
re
am
in
fe
ct
io
n
IC
U
m
or
ta
lit
y
D
is
ch
ar
ge
al
iv
e
fr
om
IC
U
SD
D
an
ti
bi
ot
ic
us
e
Ep
is
od
e
12
9
(1
%
)
77
5
(1
%
)
0.
93
(0
.4
5
to
1.
92
)
1.
09
(0
.3
4
to
3.
52
)
0.
94
(0
.5
5
to
1.
62
)
0.
16
(0
.1
0
to
0.
25
)*
**
Ev
er
12
26
(1
%
)
1.
21
(0
.6
9
to
2.
12
)
0.
65
(0
.2
0
to
2.
09
)
1.
08
(0
.7
3
to
1.
62
)
0.
54
(0
.4
5
to
0.
66
)*
**
D
ay
s
0.
98
(0
.9
1
to
1.
06
)
0.
95
(0
.8
4
to
1.
08
)
1.
01
(0
.9
7
to
1.
05
)
0.
92
(0
.8
9
to
0.
95
)*
**
Pr
of
yl
ac
ti
c
an
ti
bi
ot
ic
us
e
Ep
is
od
e
49
17
(2
9%
)
11
34
9
(1
0%
)
1.
53
(1
.2
3
to
1.
89
)*
**
0.
98
(0
.5
7
to
1.
66
)
0.
44
(0
.3
3
to
0.
60
)*
**
0.
47
(0
.4
4
to
0.
50
)*
**
Ev
er
29
38
3
(2
6%
)
2.
76
(2
.4
1
to
3.
16
)*
**
1.
11
(0
.8
6
to
1.
44
)
0.
58
(0
.5
1
to
0.
66
)*
**
1.
33
(1
.2
7
to
1.
38
)*
**
D
ay
s
1.
12
(1
.0
9
to
1.
15
)*
**
1.
01
(0
.9
5
to
1.
07
)
0.
90
(0
.8
5
to
0.
94
)*
**
1.
06
(1
.0
4
to
1.
08
)*
**
Th
er
ap
eu
ti
c
an
ti
bi
ot
ic
us
e
Ep
is
od
e
67
60
(4
0%
)
51
78
6
(4
7%
)
0.
44
(0
.3
8
to
0.
51
)*
**
0.
65
(0
.5
1
to
0.
84
)*
**
0.
81
(0
.7
3
to
0.
90
)*
**
0.
31
(0
.3
0
to
0.
33
)*
**
Ev
er
60
02
9
(5
4%
)
0.
46
(0
.3
9
to
0.
54
)*
**
0.
77
(0
.5
7
to
1.
04
)
1.
34
(1
.1
8
to
1.
53
)*
**
0.
31
(0
.2
9
to
0.
32
)*
**
D
ay
s
0.
91
(0
.8
9
to
0.
93
)*
**
0.
98
(0
.9
6
to
1.
00
)
1.
01
(1
.0
0
to
1.
02
)
0.
86
(0
.8
5
to
0.
87
)*
**
A
ny
an
ti
bi
ot
ic
us
e
Ep
is
od
e
10
85
3
(6
4%
)
63
14
7
(5
7%
)
0.
54
(0
.4
7
to
0.
63
)*
**
0.
67
(0
.5
2
to
0.
85
)*
**
0.
71
(0
.6
4
to
0.
79
)*
**
0.
29
(0
.2
8
to
0.
30
)*
**
Ev
er
81
00
4
(7
3%
)
1.
48
(1
.2
2
to
1.
79
)*
**
1.
09
(0
.7
6
to
1.
58
)
0.
98
(0
.8
5
to
1.
12
)
0.
50
(0
.4
8
to
0.
52
)*
**
D
ay
s
0.
93
(0
.9
2
to
0.
95
)*
**
0.
98
(0
.9
5
to
1.
01
)
0.
99
(0
.9
8
to
1.
01
)
0.
86
(0
.8
5
to
0.
87
)*
**
Tr
ac
he
ot
om
y
in
tu
ba
ti
on
Ep
is
od
e
71
6
(4
%
)
68
69
(6
%
)
0.
96
(0
.7
2
to
1.
28
)
1.
03
(0
.7
1
to
1.
49
)
0.
36
(0
.2
8
to
0.
45
)*
**
0.
33
(0
.2
9
to
0.
38
)*
**
Ev
er
74
89
(7
%
)
0.
94
(0
.7
1
to
1.
24
)
1.
09
(0
.7
7
to
1.
55
)
0.
45
(0
.3
7
to
0.
55
)*
**
0.
47
(0
.4
2
to
0.
52
)*
**
D
ay
s
1.
00
(0
.9
7
to
1.
04
)
1.
00
(0
.9
6
to
1.
03
)
0.
96
(0
.9
3
to
0.
98
)*
**
0.
96
(0
.9
5
to
0.
98
)*
**
N
as
al
in
tu
ba
ti
on
Ep
is
od
e
22
4
(1
%
)
87
0
(1
%
)
1.
76
(0
.9
8
to
3.
14
)
2.
59
(1
.1
5
to
5.
85
)*
1.
41
(0
.8
8
to
2.
24
)
0.
19
(0
.1
2
to
0.
29
)*
**
Ev
er
18
32
(2
%
)
1.
30
(0
.8
1
to
2.
11
)
2.
34
(1
.3
0
to
4.
22
)*
*
0.
81
(0
.5
3
to
1.
22
)
0.
79
(0
.6
7
to
0.
92
)*
*
D
ay
s
1.
03
(0
.9
6
to
1.
10
)
1.
08
(1
.0
1
to
1.
15
)*
0.
99
(0
.9
3
to
1.
04
)
0.
93
(0
.9
0
to
0.
96
)*
**
Ta
bl
e
3.
11
:U
ni
va
ri
at
e
an
al
ys
is
of
ti
m
e
de
pe
nd
en
tr
is
k
fa
ct
or
s
(b
)f
or
th
e
on
se
to
fI
C
U
-a
cq
ui
re
d
pn
eu
m
on
ia
,b
lo
od
st
re
am
in
fe
ct
io
n,
an
d
of
m
or
ta
lit
y
an
d
di
sc
ha
rg
e
al
iv
e
fr
om
IC
U
;I
C
U
=I
nt
en
si
ve
ca
re
un
it
;P
at
ie
nt
(d
ay
)s
(%
)=
th
e
nu
m
be
r
(p
er
ce
nt
ag
e
of
to
ta
l)
of
pa
ti
en
t(
da
y)
s
w
it
hi
n
th
e
co
rr
es
po
nd
in
g
ri
sk
fa
ct
or
le
ve
l;
H
az
ar
d
ra
ti
o=
de
ri
ve
d
fr
om
pr
op
or
ti
on
al
ha
za
rd
s
m
od
el
s
fo
r
th
e
in
di
ca
te
d
ou
tc
om
e
(p
ne
um
on
ia
,b
lo
od
st
re
am
in
fe
ct
io
n,
m
or
ta
lit
y,
di
sc
ha
rg
e
al
iv
e
fr
om
IC
U
)h
av
in
g
th
e
co
rr
es
po
nd
in
g
ri
sk
fa
ct
or
as
si
ng
le
pr
ed
ic
to
r;
C
I=
C
on
fid
en
ce
In
te
rv
al
;S
D
D
=s
el
ec
ti
ve
di
ge
st
iv
e
de
co
nt
am
in
at
io
n;
Ep
is
od
e/
Ev
er
/D
ay
s=
ty
pe
by
w
hi
ch
th
e
ri
sk
fa
ct
or
w
as
co
de
d:
Ep
is
od
e=
ex
po
su
re
ca
n
be
se
t
to
0
a
er
be
in
g
se
t
to
1,
Ev
er
=m
on
ot
on
ou
s
ex
po
su
re
(o
nc
e
ex
po
se
d,
th
e
pa
ti
en
t
re
m
ai
ns
so
un
ti
lI
C
U
di
sc
ha
rg
e)
,D
ay
s=
cu
m
ul
at
iv
e
ex
po
su
re
;*
p-
va
lu
e<
.0
5,
**
p-
va
lu
e<
.0
1,
**
*p
-v
al
ue
<
.0
01
re
pr
es
en
t
si
gn
ifi
ca
nc
e
le
ve
lf
ro
m
W
al
d-
te
st
.
101
Chapter 3. Marginal structural models to estimate aributable mortality eects
3
R
isk
Factor
Type
Patients
Patient
days
H
azard
ratio
(95%
C
I)
(%
)
(%
)
Pneum
onia
B
loodstream
infection
IC
U
m
ortality
D
ischarge
alive
from
IC
U
O
ralintubation
Episode
6914
(41%
)
37865
(34%
)
2.51
(2.18
to
2.89)***
1.64
(1.29
to
2.09)***
2.21
(2.00
to
2.45)***
0.03
(0.02
to
0.03)***
Ever
60675
(55%
)
3.63
(3.02
to
4.36)***
2.01
(1.45
to
2.79)***
2.48
(2.17
to
2.83)***
0.35
(0.34
to
0.37)***
D
ays
1.07
(1.04
to
1.09)***
1.03
(1.00
to
1.05)*
1.06
(1.05
to
1.08)***
0.78
(0.77
to
0.79)***
A
ny
intubation
Episode
7287
(43%
)
45178
(41%
)
2.66
(2.29
to
3.09)***
1.75
(1.34
to
2.29)***
1.87
(1.67
to
2.09)***
0.04
(0.03
to
0.04)***
Ever
64113
(58%
)
4.15
(3.42
to
5.05)***
2.89
(1.98
to
4.21)***
2.48
(2.15
to
2.86)***
0.33
(0.31
to
0.34)***
D
ays
1.08
(1.05
to
1.12)***
1.04
(1.01
to
1.07)**
1.05
(1.04
to
1.07)***
0.78
(0.77
to
0.79)***
Surgery
Episode
1486
(9%
)
1788
(2%
)
1.50
(0.97
to
2.33)
1.81
(0.90
to
3.66)
0.41
(0.22
to
0.77)**
0.14
(0.10
to
0.19)***
Ever
12475
(11%
)
1.79
(1.48
to
2.17)***
1.40
(1.04
to
1.89)*
0.81
(0.70
to
0.95)**
0.66
(0.61
to
0.71)***
D
ays
1.32
(1.17
to
1.49)***
1.19
(1.01
to
1.40)*
0.84
(0.75
to
0.94)**
0.71
(0.67
to
0.75)***
IC
U
-acquired
pneum
onia
Ever
966
(6%
)
10768
(10%
)
1.41
(1.05
to
1.91)*
0.68
(0.59
to
0.79)***
0.35
(0.32
to
0.38)***
D
ays
1.02
(0.99
to
1.05)
0.98
(0.96
to
0.99)**
0.93
(0.92
to
0.94)***
IC
U
-acquired
blood-
stream
infection
Ever
322
(2%
)
2797
(3%
)
0.87
(0.54
to
1.40)
1.19
(0.94
to
1.51)
0.47
(0.39
to
0.55)***
D
ays
0.99
(0.92
to
1.06)
1.01
(0.98
to
1.04)
0.96
(0.93
to
0.99)**
Table
3.12:U
nivariate
analysis
oftim
e
dependentrisk
factors
(c)forthe
onsetofIC
U
-acquired
pneum
onia,bloodstream
infection,
and
ofm
ortality
and
discharge
alive
from
IC
U
;IC
U
=Intensive
care
unit;Patient(day)s
(%
)=the
num
ber
(percentage
oftotal)
ofpatient(day)s
w
ithin
the
corresponding
risk
factor
level;H
azard
ratio=derived
from
proportionalhazards
m
odels
for
the
indicated
outcom
e
(pneum
onia,bloodstream
infection,m
ortality,discharge
alive
from
IC
U
)having
the
corresponding
risk
factor
as
single
predictor;C
I=C
onfidence
Interval;Episode/Ever/D
ays=type
by
w
hich
the
risk
factor
w
as
coded:Episode=exposure
can
be
set
to
0
a
er
being
set
to
1,Ever=m
onotonous
exposure
(once
exposed,the
patient
rem
ains
so
untilIC
U
discharge),
D
ays=cum
ulative
exposure;*p-value<
.05,**p-value<
.01,***p-value<
.001
represent
significance
levelfrom
W
ald-test.
102
33.5. Appendix
Figure 3.4: Hazard for mortality ratio of ICU-acquired pneumonia infected (a) and ICU-
acquired bloodstream infection infected (b) versus uninfected patients using a Marginal
structural proportional hazards model with varying administrative censoring times.
particular patient day. IPE and IPC were then created by inverting the conditional
probabilities of actual infection status and of remaining in the ICU up to each
day respectively. These were multiplied with each other to represent the daily
combined IPE-IPC weights. Finally, these were stabilised by division by combined
IPE-IPC weights derived from the same models for acquiring infection and being
discharged alive from the ICU but not containing time-dependent confounders as
predictors.
Because separate models were used for modelling the risk of acquiring pneumo-
nia and BSI, separate combined weights sets were obtained for these two infection
types.
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3.5.2 Sensitivity analysis
Because the MSPHM is fit on data where each patient-day is weighted for its
inverse probability of not being censored, or of staying alive in the ICU, it infers
the HAI-eect that would have been observed if the ICU population was not
discharged before the end of follow-up date. To investigate the robustness of the
model’s estimates to the follow-up period, we fied the MSPHM repeatedly under
varying end of follow-up or administrative censoring times: for example, when
implementing an administrative censoring at 15 days, the same number of patients
will be used in the analysis but their ICU follow-up will be truncated to 15 days.
Figure 3.4 shows the eect of applying various administrative censoring times on
the results of the MSPHM for the eects of pneumonia and BSI on mortality. When
decreasing the study time from 30 to 5 days, the pneumonia eect remained more
or less neutral until day 15, around which the HR shis to protective values of 0.55
at times 7-10. The graph for BSI did not show this decline at lower follow-up times.
For the two infection types, this dierent behavior of aributable mortality for
varying follow-up times was directly related to the dierent aributable mortality
early and late aer infection onset of infection (as reported in the main paper).
Pneumonia are protective for mortality early aer onset, but have more harmful
aributable mortality late aer onset, implying that the longer the follow-up time,
the more this “lag” eect of pneumonia can play a role. For BSI, no apparent
contrast was seen early and late aer onset of infection. The fairly wide confidence
intervals (despite the large sample size) are due to the wide range of IPC-weights
that were used to correct this model, which was caused by the strong associations
between time-dependent confounders and the censoring event “discharge alive”.
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Marginal structural models for partial exposure regimes
This chapter is based on the following article: Vansteelandt, S., Mertens, K., Suetens,
C. and Goetghebeur, E. (2009) ”Marginal structural models for partial exposure
regimes,” Biostatistics, 10(1): 46-59.
Summary
Intensive care unit (ICU) patients are highly susceptible to Healthcare-associated
infection (HAI) due to their poor health and many invasive therapeutic treatments.
The eect on mortality of acquiring such infections is, however, poorly understood.
Our goal is to quantify this using data from the National surveillance of infections
acquired in intensive care units (NSIH-ICU) (Belgium). This is challenging because
of the presence of time-dependent confounders, such as mechanical ventilation,
which lie on the causal path from infection to mortality. Standard statistical
analyses may be severely misleading in such seings and have shown contradictory
results. Inverse probability weighting for marginal structural models may instead
be used, but is not directly applicable because these models parametrise the eect
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of acquiring infection on a given day in ICU, versus never acquiring infection in
ICU, and this is ill-defined when ICU discharge precedes that day. Additional
complications arise from informative censoring of the survival time by hospital
discharge, and from the instability of the inverse weighting estimation procedure.
We accommodate this by introducing a new class of marginal structural models
for so-called partial exposure regimes. These describe the eect on the hazard of
death of acquiring infection on a given day s, versus not acquiring infection up to
that day, had patients stayed in the ICU for at least s days.
4.1 Introduction
ICU patients are estimated to have a 5 to 10 times higher risk of acquiring nosoco-
mial, i.e. hospital-acquired, infections than patients in other hospital units, due
to their poor health and many invasive therapeutic treatments. These infections
are believed to account for 50% of all major complications of hospitalisation and
are considered to have a substantial impact on morbidity, mortality and medical
costs (Gaynes, 1997). In 1985, the Study on the Eicacy of Nosocomial Infection
Control (Haley et al., 1985) demonstrated that surveillance of nosocomial infections
can reduce infection rates by as much as 30%, provided that suicient infection
control sta and adequate surveillance are available. Since then, surveillance of
nosocomial infections has played a fundamental role in assessing and improving
the quality of medical care.
In 1995, the Scientific Institute of Public Health (Belgium) set up a national
surveillance network in ICUs in collaboration with the Belgian Society for Intensive
Care and Emergency Medicine (Suetens et al., 1999). The aim of this network is
twofold: to assist individual ICUs to obtain local incidence statistics for the main
nosocomial infections ICU-acquired pneumonia and Bloodstream infection (BSI);
and to oer national statistics in parallel to guide the interpretation of each ICU’s
performance. Surveillance and the definition of infections that we will adopt follow
a standard protocol based on a Europe-wide consensus reached in the Hospitals in
Europe link for infection control through surveillance (HELICS) project (Suetens
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et al., 2003).
In this article, we will use data collected through the network to quantify the
eect of ICU-acquired pneumonia on mortality in ICU patients. This is a complex
problem for various reasons. First, the association between infection and mortality
is disturbed by time-dependent confounders. For instance, daily exposure to
invasive treatments such as mechanical ventilation or the presence of a central
vascular catheter increases the risk of infection, and the poor health conditions
leading to these treatments are also indicative of an increased mortality risk. These
confounders lie on the causal path from infection to mortality because infection
makes it more likely that the patient will receive invasive therapeutic treatments.
Standard adjustment approaches, such as time-dependent proportional hazards
regression, will then usually give biased results [see, for example, Andersen (1986);
Bryan et al. (2004); Kalbfleisch and Prentice (2002); Robins (1986, 1997, 2000);
Vansteelandt (2007)] Second, the censoring of the survival time upon hospital
discharge may be informative because the decision to discharge patients is closely
related to their health status, so that mortality rates may dier substantially
between those who are discharged on a given day and those who are not.
The problem of estimating the mortality rate aributable to ICU-acquired
infection has received much aention in the intensive care literature [see e.g. Carlet
(2001); Vincent (2003); Schumacher et al. (2007)], as a reliable estimate is not only
of theoretical interest but also important for determinining the potential benefits
of new drugs. Common practice is to fit logistic regression models for mortality
in ICU, adjusting for pneumonia status upon ICU discharge, for length of stay in
ICU, and possibly for time-dependent variables measured prior to infection. An
alternative approach is to base inference on proportional hazards models for time to
death, adjusting for either infection status upon ICU discharge or time-dependent
infection status, and additionally for time-dependent variables measured prior
to infection. These analyses ignore the aforementioned problems and empirical
results are therefore highly controversial, with several studies reporting relative
risk estimates for mortality ranging from neutral to severely harmful. The present
study addresses the above problems by using Marginal structural models (Herna`n
et al., 2000; van der Laan and Robins, 2003; Bryan et al., 2004).
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We review the Belgian National Surveillance Study in Section 4.2 and Marginal
structural models in Section 4.3.2. Standard inference for such models cannot be
used for estimating the eect of ICU-acquired infection on death for the following
reasons. First, these models describe the hazard of death for ICU patients had
they acquired infection in the ICU at a given number of days since admission, but
this is ill-defined when ICU discharge comes earlier. Second, infection status and
confounders were only recorded until ICU discharge, whereas survival times were
recorded until hospital discharge to alleviate the problem of informative censoring.
Similar diiculties arise in observational studies with a mortality endpoint where
exposures are incompletely measured due to loss to follow-up or end-of-study,
but survival times are assessed over a much longer time period (e.g. using death
registers).
To accommodate both problems, we propose a new class of Marginal structural
models in Section 4.3, which express the eect on the hazard of death of acquiring
infection on a given day s, versus not acquiring infection up to that day, had
patients stayed in the ICU for at least s days. We call such model in our class
a Marginal structural proportional hazards model for partial exposure regimes
(MSPHM-P), as each considered “exposure regime” specifies the “exposures” (i.e.
infections) for a given patient only up to the chosen time point s. This has the
added advantage of yielding more stable inferences since we merely aim to infer
the eect of avoiding infection during the first s days since admission, and not
during the entire ICU stay. It thus makes the new models useful even in seings
where standard Marginal structural models can be applied. We derive a class
of Consistent and asymptotically normal (CAN) estimators for the parameters
indexing our models and provide a reasonably eicient estimator in that class. In
Section 4.4, we present results obtained for the surveillance data. In Section 4.5,
we discuss the usefulness of MSPHM-Ps in more general seings.
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4.2 National ICU surveillance study
All ICUs in Belgian hospitals were invited to participate in this surveillance study
on a voluntary basis. For all patients admied to the ICU, data were recorded on
personal characteristics, reasons for ICU admission, baseline health status, and
daily indicators of received invasive treatments and acquired infections in the
ICU. ICU-acquired infections were defined as infections acquired by patients aer
the second day of ICU stay, to exclude infections that were in incubation upon
enrollment in the ICU. The third day of stay in ICU will thus be the starting point
for our analysis, excluding patients who stayed less than 3 days. We will restrict
the analysis to surveillance data collected for the year 2002 in one of the largest
hospitals which has accurate daily measurements of received invasive treatments
and acquired infections. A total of 1072 ICU patients were analysed. Of the 100
(9.3%) patients who acquired ICU-acquired pneumonia in ICU and stayed more
than 2 days, 41 (41%) died in hospital, of whom 27 in ICU, as compared to 183
(18.8%) deaths among the 972 patients who remained free of pneumonia in ICU, of
whom 99 died in ICU. Among patients who stayed more than 2 days in ICU, the
median length of stay in ICU was 4 days (Interquartile range (IQR) 3, 95th percentile
13) for those without a history of ICU and 16 days (IQR 13, 95th percentile 54.5)
for the remaining patients.
A preliminary causal analysis (Mertens and Vansteelandt, 2012) using Marginal
structural proportional hazards models (MSPHMs) revealed highly unstable results
when survival times were censored upon ICU discharge, as a result of high censoring
rates. Using patient registers, the survival status of each patient was therefore
assessed upon hospital discharge.
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4.3 Marginal structuralmodels for partial exposure
regimes
4.3.1 Notation
Throughout, we use the following notation. For each patient, let At be a counting
process that indicates 1 for ICU-acquired pneumonia at or prior to time t and
0 otherwise, where A0 = 0 by definition (see Figure 4.1). Likewise, let Dt (Ct)
be a counting process that indicates 1 if ICU (hospital) discharge happened at
or prior to time t and 0 otherwise. Define L0 to be a vector of baseline variables
collected upon admission to the ICU. In our analyses, L0 consists of age, gender,
reason for ICU admission, acute coronary care, multiple trauma, presence and
type of infections upon ICU admission, prior surgery, baseline antibiotic use and
the Simplified acute physiology score II (SAPSII) score, a severity-of-illness score
based on a set of 15 clinical parameters predicting the mortality risk of a patient
admied to the ICU (Le Gall et al., 1993). Further, for t > 0, define Lt to be a
vector of invasive therapeutic treatment indicators collected on day t, consisting
of indicators of exposure to mechanical ventilation, central vascular catheter,
parenteral feeding, presence and/or feeding through naso- or oro-intestinal tube,
tracheotomy intubation, nasal intubation, oral intubation, stoma feeding and
surgery. Discharge from the ICU defines the end of follow-up for all measured
variables, except survival time, so that At and Lt are observed for all t with Dt = 0,
but not otherwise. Survival time T is censored by discharge from the hospital. We
define K to be the end of follow-up time and, for any vector Z = (Z0, ..., ZK) and
t ≤ K , Zt = (Z0, ..., Zt). Throughout, we assume that infection and discharge on
day t can only be aected by time-dependent variables measured on previous days
(and thus not by those measured on the same day).
4.3.2 Marginal structural models
Time-dependent multi-state models for event history analysis (Andersen and Keid-
ing, 2002; Schumacher et al., 2007) may appear well-matched to the multi-state
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Figure 4.1: Multi-state model: directed arrows show the possible transitions from one
state to another.
nature (see Figure 4.1) of our problem. However, they are likely to yield biased
estimates of the eect of ICU-acquired infection on mortality, whether or not one
adjusts for the relevant past confounder history (Robins, 1997). For the unadjusted
analysis, this is so because these analyses ignore time-varying confounders like
mechanical ventilation, which increases the risk of infection and is also associ-
ated with death. For the adjusted analysis, this is so when these time-varying
confounders lie on the causal path from infection to mortality, because standard
regression adjustment for such post-infection measurements may introduce bias.
This problem of adjusting for internal (or endogenous) time-dependent covariates
has long been recognised in the survival literature (see e.g. Andersen (1986) and
the discussion in Kalbfleisch and Prentice (2002), but solutions to it have emerged
only recently. One such solution, which is becoming increasingly popular among
statisticians and epidemiologists, is to use MSPHM (Herna`n et al., 2000). We briefly
review these models in this section.
Let Ta express the counterfactual survival time (Rubin, 1978; Robins, 1986)
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which an ICU patient would, possibly contrary to fact, have had under a given
infection path a = (a1, a2, ..., aK) following which the patient is infected on day
t since ICU admission if at = 1 and uninfected if at = 0. Then a MSPHM is a
proportional hazards regression model for the counterfactual survival time Ta,
possibly conditional on baseline covariates V . It thus expresses how the hazard of
death would have been if all ICU patients had followed infection path a. A simple
example is
λa(t|V ) = λ0(t) exp (β1at + β′2V ) (4.1)
where λa(t|V ) is the hazard function that characterises the conditional survival
function of Ta, given V . It thus represents the hazard of death at time t among
patients with baseline covariates V , had they all followed infection path a. Further,
λ0(t) is an unknown baseline hazard of death at time t and β1, β2 are unknown
parameters. In model (4.1), exp(β1) expresses the causal rate ratio at time t due
to acquiring infection at time t. This represents the ratio of the mortality rate at
any time t had all patients with baseline covariates V acquired infection at time t
compared to the mortality rate at time t had these patients acquired no infection
up to time t. Further, λ0(t) expresses the hazard of death at time t for patients
with V = 0 had they followed an infection path in which they never acquired
infection in ICU. The model’s name “marginal” expresses that the model does not
involve time-dependent confounders. Adjustment for such confounders happens
by fiing the model to data from a pseudo-population in which there are no time-
varying confounders, but the target eect is the same. This pseudo-population is
constructed by reweighting subjects in the risk set at each time t by the reciprocal
of the product of the conditional probabilities of the observed infection status at
each time before time t, given the history of time-varying confounders at that time
[see expression (4.5) below] (Herna`n et al., 2000).
The considered MSPHM is not directly applicable in our study because the
exposure “ICU-acquired infection” (and, likewise, Ta) is ill-defined between ICU
discharge and death or censoring of the survival time. Since our goal is to esti-
mate the eect of “ICU-acquired” infection on mortality, it may seem natural to
define patients as uninfected when they were not infected upon ICU discharge.
However, this would make standard estimators for marginal structural models
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irregular (Robins, 2000) because there would be patients with certain prognostic
factors (namely, those who are discharged uninfected from ICU) who are pre-
cluded from becoming infected under this definition. This irregularity results
from failure of the implicit assumption of experimentation in the “assignment”
of infection (van der Laan and Robins, 2003), according to which, at each time
t = 1, ..., K , it must be true that
0 < P (At = 1|At−1, Lt−1, Dt, V ) < 1 with probability 1.
This assumption is needed to avoid inverse weighting by zero [see expression (4.5)
below].
Alternatively, one could consider the infection and ICU discharge status of
a patient as a joint exposure. Specifically, one could redefine an infection path
to be any path (d, a, as) in which a patient, while alive, will be discharged from
the ICU on day d and either acquire infection on a given earlier day s < d (if
a = 1) or stay uninfected during his/her stay in the ICU (if a = 0). The joint
causal eect of discharge and infection in the ICU on the hazard of death can be
expressed as a function of baseline covariates V through MSPHMs for multiple
interventions (Herna`n et al., 2001; Robins et al., 2003). The following is a simple
example of such a model:
λ(d,a,as)(t|V ) = λ0(t) exp[{β1 + β2(t− s)}aI(t ≥ s)
+{β3 + β4(t− d)}I(t ≥ d) + β′5V ] (4.2)
with d > s. Here, λ(d,a,as)(t|V ) is the hazard that characterises the conditional
survival function of the counterfactual survival time, given V , under infection
path (d, a, as), λ0(t) is an unknown baseline hazard of death at time t, and
β1, β2, β3, β4, β5 are unknown parameters. In particular, exp {β1 + β2(t− s)} is
the causal rate ratio at time t due to acquiring infection at time s, s ≤ t, s < d.
This represents the ratio of the mortality rate at any time t had all patients with
baseline covariates V acquired infection at time s compared to the mortality rate at
time t had these patients experienced the same discharge time, but no infection up
to time t. Note that this causal eect parameter has limited relevance from a public
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health perspective. First, it expresses the eect of acquiring pneumonia at a given
time on mortality in the hypothetical and unrealistic scenario where we would
keep the patients in the ICU until some given, later time. Second, by comparing the
same group of patients under two possible infection histories, the time of discharge
from the ICU being equal, exp {β1 + β2(t− s)} represents only the direct eect
of acquiring infection at time s on mortality at time t. As such, it does not capture
the indirect eect of infection on death that may arise when infection prolongs
the time of stay in the ICU, which may itself aect mortality risk. Furthermore,
preliminary analyses (not displayed) showed that estimates for the parameters
in the above model are highly unstable as a result of inverse weighting by small
probabilities in the estimation procedure. This is due to a lengthy follow-up for
a limited number of patients and because many time-dependent variables are
strongly predictive for ICU discharge.
4.3.3 Marginal structural models for partial infection paths
To accommodate the foregoing problems, we will infer mortality rates under infec-
tion paths (s, a) in which patients stay in the ICU for at least s days and acquire
infection (if a = 1) or not (if a = 0) on day s. Thus, under path (s, a) = (s, 0),
patients are uninfected in the ICU up to day s, their infection status being un-
specified thereaer; under path (s, a) = (s, 1), patients are uninfected in the ICU
up to day s and acquire infection on day s. By analysing mortality rates of ICU
patients under each such infection path, we will be able to answer causal questions
like “What would be the eect on the mortality rate of ICU patients of acquiring
infection at time s, versus not acquiring infection up to that time, had they stayed
in the ICU for at least s days?”. At the same time, we will be solving the problem
that the infection status is unknown or ill-defined aer ICU discharge because we
only consider infection paths which specify the infection status of patients during
their stay in the ICU. As such, these infection paths generalise the deterministic
treatment regimes of Robins (1997) which specify the treatment at each time from
start until end of study.
For a given path (s, a), let T(s,a) be the random variable representing the sub-
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ject’s time from admission in the ICU to death had they experienced infection
path (s, a) rather than their own infection history, all other things being equal. We
can then express the causal eect of infection in the ICU on the hazard of death
through MSPHM:
λ(s,a)(t|V ) = λ0(t) exp {β1 min(t, s) + β2aI(t ≥ s) + β′3V } . (4.3)
Here, λ(s,a)(t|V ) is the hazard that characterises the conditional survival function,
given V , of the counterfactual survival time under infection path (s, a), λ0(t) is an
unknown baseline hazard of death at time t, and β1, β2, β3 are unknown parameters.
Note that λ0(t) = λ(0,0)(t|0) is the hazard of death at time t among patients with
V = 0 and is hence directly identifiable from the observed data distribution. In
addition, note that exp(β2) is the causal rate ratio at time t of acquiring infection
at any time s, s ≤ t. It represents the ratio of the mortality (hazard) rate at any
time t had all patients with baseline covariates V stayed in the ICU up to at least
time s and acquired infection at that time compared to the mortality (hazard)
rate at time t had these patients also stayed in the ICU up to at least time s but
acquired no infection up to that time. By specifying only whether infection comes
before discharge, exp(β2) represents the overall eect of acquiring infection at
time s on mortality at time t under model (4.3). We call (4.3) a Marginal structural
proportional hazards model for partial exposure regimes (MSPHM-P) to express
that it determines each exposure regime (i.e. each infection path) only for a limited
time period, contrary to the more standard MSPHMs of Section 4.3.2.
4.3.4 Inference
In this section, we develop inference for the parameters indexing MSPHM-Ps
under Sequential randomisation assumption (SRA). Specifically, we assume that
at each time t ≤ s, survivors with prognostic factors L¯t−1, A¯t−1, Dt−1 = 0 and V
have the same hazard of infection and ICU discharge at time t regardless of their
counterfactual survival time T(s,a), for each infection path (s, a) that is compatible
with the observed history (A¯t−1, Dt−1 = 0). That is, for each such path (s, a) and
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each t ≤ s,
(At, Dt)q T(s,a)|L¯t−1, A¯t−1, Dt−1 = 0, T > t,
where U q V |W for random variables U, V,W indicates that U is conditionally
independent of V , given W . This assumption is reasonable when the physician’s
decision to discharge a patient from the ICU at time t is based solely on daily
patient characteristics which were recorded in L¯t−1, A¯t−1 and V and, in addition,
all time-dependent confounders for the association between infection and death
are accounted for.
Even if all patients were observed until the study end or death, analysis tools for
MSPHMs (Herna`n et al., 2000) would not be directly applicable to fit model (4.3)
under these assumptions because each infection path is specified for only a limited
period of time. Below, we give a practical algorithm for obtaining a Consistent
and asymptotically normal (CAN) estimator for the parameter β = (β1, β2, β3)′
indexing model (4.3) in the absence of unmeasured time-dependent confounders.
The motivation for this algorithm is given in the Appendix (Section 4.6), where the
resulting estimate is defined via weighted partial likelihood estimation.
First we identify, for each infection path (s, a), those patients whose observed
infection history is compatible with the path (s, a). For each time t, we thus
construct a vector of variables (St, A∗t ) which takes the value (s, a) for a given
patient at that time if that patient’s observed infection path up to time t could
have been obtained under the path (s, a). That is, for given s, (St, A∗t ) = (s, 1)
[or (St, A∗t ) = (s, 0)] for a given patient at time t if that patient was in the ICU at
time s ≤ t and acquired pneumonia at that time (or did not acquire pneumonia
up to and including that time). In contrast to inference for ordinary MSPHMs, the
data for a given patient at a given time may be compatible with multiple infection
paths and may thus carry information about more than one path. This is because
the considered paths are only partially specified. For instance, if a patient’s data
are compatible with infection path (s, 0) at time t, then they are compatible with
all infection paths (u, 0) for u < s, and may thus appear multiple times in the
database corresponding to dierent values of St.
Next, for all infection paths (s, a) jointly, we fit a proportional hazards model
116
44.3. Marginal structural models for partial exposure regimes
using only the data compatible with the given path and weighting each observation
by the reciprocal probability of following that path to account for the selective na-
ture of our subsample. Specifically, we substitute (s, a) by (St, A∗t ) in the marginal
structural model (4.3) by fiing the time-dependent proportional hazards model
λ(t|St, A∗t , V ) = λ∗0(t) exp {β∗1 min(t, St) + β∗2A∗t + β∗′3 V } , (4.4)
and weight the contribution of a patient to the risk set at time t by the stabilised
weights
swi(t, St, A¯t, D¯t, L¯t−1, V ) =
St∏
k=1
P (Ak|Ak−1 = Dk = 0, V )
P
(
Ak|Ak−1 = Dk = 0, L¯k−1, V
) (4.5)
× P (Dk = 0|Ak−1 = Dk−1 = 0, V )
P
(
Dk = 0|Ak−1 = Dk−1 = 0, L¯k−1, V
) .
These weights dier from the usual stabilised weights for Marginal structural
models (Herna`n et al., 2000, 2001) in that they consider the joint treatment process
given by infection and discharge at each time and do this only up to the artificial
time St. Note that they involve the discharge process to account for the fact that,
at each time t, those subjects who are still in the ICU (i.e. those for whom we
have information on the infection history) may form a selective subset of the study
population. The impact of weighting is to eliminate time-varying confounders by
removing their association with exposure (At, Dt) at each time t, while leaving
the causal eect of interest unchanged. The numerator probabilities in (4.5) are
included for stabilisation of the weights and are allowed to be misspecified by the
fact that model (4.3) is postulated conditional on V .
To deal with censoring of the survival status due to hospital discharge, we
proceed under the additional assumption of Ignorable censoring assumption
(ICA) (van der Laan and Robins, 2003). For our data and study seing, this as-
sumption states that among subjects with a given observed past A¯tD , D¯t, L¯tD− , V ,
where tD = min(t,D − 1) and tD− = min(t,D) − 1, the censored and un-
censored subjects at time t have the same survival time distribution; that is,
C q T |A¯tD , D¯t, L¯tD− , V, T > t, C > t for each time t. At a given time t, this
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assumption could be reasonable for short-term survival rates because we have
available a large and detailed collection of prognostic factors for survival that also
predict time of discharge from the ICU. However, for given t, it is questionable
for the longer term because we lack data monitoring the health status of patients
aer leaving the ICU. In our study, the median length of stay in hospital aer ICU
discharge was 8 days (IQR 10, 5% percentile 0, 95% percentile 50).
We can correct the above analysis for ICA by further weighting each patient’s
contribution to the risk set at time t by the stabilised weights
swc(t, A¯tD , D¯t, C¯t−1, L¯tD) =
t∏
k=1
P
(
Ck = 0|A¯kD , D¯k, Ck−1 = 0, V
)
P
(
Ck = 0|A¯kD , D¯k, Ck−1 = 0, L¯kD− , V
) (4.6)
where the numerator and denominator probabilities equal 1 when Dk = 0. Here,
we implicitly assume that hospital discharge does not causally aect survival.
Under this assumption and provided that the measured time-dependent covariates
are suicient to adjust for time-dependent confounding and censoring due to
hospital discharge, fiing model (4.4) and weighting each patient’s contribution
to the risk set at time t by the product of (4.5) and (4.6) produces a consistent
estimator for the causal rate ratio.
4.4 Data analysis
We first consider the unadjusted time-dependent proportional hazards model
λ(t|At) = λ0(t) exp (β1At)
To enhance comparability with later results, we fied this model via unweighted
pooled logistic regression with regression splines for the time eect. The estimate
of the hazard ratio of death comparing patients who acquired infection prior to
time t and those who did not, was 1.89 [95% Confidence interval (CI) 1.32, 2.71].
When adding baseline covariates (SAPSII score and reasons for admission to the
ICU), the estimated hazard ratio was no longer significant and equaled 1.37 (95%
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CI 0.93, 2.04).
To adjust for time-dependent confounding, we extended our data set to include
St and A∗t for each patient at each time t. Next, we calculated stabilised weights
by means of 6 pooled logistic regression models for the numerator and denomi-
nator weights in (4.5) and (4.6). To avoid unstable weights, we included baseline
covariates (V ) in the numerator weights and then later also in the MSPHM-P.
Specifically, we considered type of admission allowing for eect modification by
acute coronary care and by multiple trauma, presence and type of infection and of
surgery at admission, SAPSII score and age (allowing for quadratic eects on both),
gender, antibiotic use during the first 48 hours of ICU stay, and baseline values for
all previously listed invasive therapeutic treatment indicators. Time-dependent
information on exposure to invasive treatments was summarised in terms of the
presence/absence of the treatment on each of the 2 previous days and by the
total number of previous days on invasive treatments. In addition, we allowed
for quadratic eects of the number of previous days on mechanical ventilation
additionally allowing for eect modification by antibiotic use during the first 48
hours of ICU stay, and on central vascular catheter. To build parsimonious models,
we used the following conservative approach. In the first stage, all main eects
were added and then sequentially removed if non-significant at the 10% level (ig-
noring correlations between outcomes from the same patient). In the second stage,
the suggested interaction terms and quadratic eects were added if significant
following the same criterion. Splines were used to model the time eect in all
models.
Using the estimated predicted values from these models we calculated the
probability of each patient having their observed infection status up to time t,
given baseline variables and then also given time-dependent variables L¯t−1. We
calculated similar estimates for the probability of ICU discharge and hospital
discharge, the laer aer also adjusting for the infection and ICU discharge history.
To avoid unstable weights, we considered only infection paths (s, a) with 3 ≤
s ≤ 11. This implies that the estimated eect of infection on the hazard of death
pertains only to infection paths where infection is acquired during the first 11 days
starting from day 3. Note however that we included all observed person-days in
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Figure 4.2: Boxplots of the natural logarithm of the stabilised weights in function of time
t (with whiskers extending to 2.5 times the interquartile range).
the analysis.
Figure 4.2 displays the distribution of the natural logarithm of the stabilised
weights as a function of time. The stabilised weights had a median and mean
of 0.81 and 0.93, an interquartile range and standard deviation of 0.48 and 1.94
and 1% and 99% percentiles of 0.048 and 3.89 (min. 0.0039, max. 123.48). Among
weights greater than 5, the 99th, 75th and 50th percentiles are 100.59, 11.70 and
8.69. Among weights smaller than 0.2, the 1st, 25th and 50th percentiles are 0.0066,
0.069 and 0.12.
Because standard soware for Proportional hazards regression does not allow
us to reweight the risk sets at each time, we fit the discrete-time analog of (4.4) via a
weighted pooled logistic regression model using Generalised estimating equations
(GEE), treating each patient-day as an observation and using regression splines to
fit the time eect (Herna`n et al., 2000). Unbiasedness of the estimating equations
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under this logistic regression model requires use of the independence working
correlation (Vansteelandt, 2007). Note that by using GEE to fit model (4.4) we
account for the potentially strong correlation arising in the augmented dataset.
This may contain the same observations multiple times corresponding to dierent
values of St. Because the eect on the hazard of death at time t of keeping the
patient in the ICU up to time St was considered a nuisance, we modelled the eect
of St in model (4.4) using regression splines. Our causal estimate of the hazard
ratio for infection was 2.74 [95% conservative CI (1.48, 5.09)]. We conclude that
under any infection path in which patients stay in the ICU for at least a given
number of days s, the eect of acquiring infection on day s is to multiply the hazard
of death by 2.74. Confidence intervals were obtained using the robust standard
error. By not taking into account the estimation of the weights, this yields an
asymptotically conservative confidence interval for our causal parameters (Robins,
2000). Figure 4.3 shows estimated survival curves for the study population along
with 95% confidence intervals, and predicted survival curves in the hypothetical
scenario where all patients acquire infection at the third day of their stay in the ICU.
It illustrates the severe estimated impact of ICU-acquired infection on mortality.
To examine the stability of the results to extreme weights, we additionally
evaluated the eect of infection on mortality for infection paths with 3 ≤ s ≤
smax = 7, 8, 9 and 10. The weights are more stable for these analyses because
the product in (4.5) runs over a smaller number of time points. The results are
displayed in Table 4.1 and show that the eect size and significance stay the same
with increasing stability of the weights. Finally, we performed an ad-hoc procedure
whereby stabilised weights smaller than 0.2 or greater than 5 were truncated at 0.2
and 5, respectively. This yielded a hazard ratio of 2.50 [95% conservative CI (1.45,
4.31)], suggesting once more robustness to the extreme weights. Allowing for an
interaction between infection status and the number of days since acquiring the
infection revealed that, on the hazard scale, the eect of acquiring infection on a
given day s increases non-significantly by 2.8% (95% conservative CI (-1.2%, 6.7%),
P = 0.17) per day since acquiring infection. Likewise, there was no indication that
the eect of ICU-acquired infection on the hazard of death depends on the time at
which it was acquired (P = 0.29).
121
Chapter 4. Marginal structural models for partial exposure regimes
4
Figure 4.3: Marginal survival curve (upper solid line) (directly estimated from the observed
data) with 95% confidence intervals (dashed) and predicted survival curve following
immediate infection (lower solid line) (based on the Marginal structural model) with
approximate 95% confidence intervals (doed). The laer intervals acknowledge impre-
cision on the estimated causal eect, but ignore imprecision on the estimated survival
curve. Le: from 3 to 140 days aer ICU admission; Right: from 3 to 20 days aer ICU
admission.
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smax 1% perc. 99% perc. min max HR 95% CI
7 0.065 3.50 0.0071 25.94 2.75 (1.48, 5.12)
8 0.064 3.49 0.0061 35.91 2.66 (1.43, 4.94)
9 0.060 3.51 0.0053 54.14 2.70 (1.46, 5.00)
10 0.054 3.72 0.0046 81.88 2.71 (1.47, 5.01)
11 0.048 3.89 0.0039 123.48 2.74 (1.48, 5.09)
Table 4.1: Distribution of the stabilised weights (1% and 99% percentiles, minimum and
maximum), glsplhr and 95% confidence intervals in Marginal structural models for
partial infection paths with 3 ≤ s ≤ smax.
4.5 Discussion
The eect on mortality of acquiring pneumonia in ICU continues to raise contro-
versy among clinicians because standard statistical analyses have shown contradic-
tory results. Because this is partly due to inappropriate adjustment for intermediate
time-varying confounders, we have proposed to use analyses of marginal struc-
tural models. These take into account the time order in which infection, mortality
data and time-dependent confounders were collected and correct appropriately
for time-dependent confounders that lie on the causal path from pneumonia to
mortality. Inference for such models was however not directly applicable to our
data for the following two reasons: (a) the infection status of patients was ill-
defined subsequent to ICU discharge, an event which lies on the causal path from
infection to mortality; (b) the usual weights in the weighted estimating equations
for standard MSPHMs were highly unstable because there was a lengthy follow-up
for several patients and because many collected time-dependent variables were
strongly predictive of ICU discharge.
To accommodate these problems we have proposed to model mortality rates
under “partially specified” infection paths. The resulting models solve the problem
mentioned in (a) without fixing the discharge time aer the event of infection
and thus without fixing variables on the causal path from infection to mortality.
In addition, inference under these models tends to be more stable because each
infection path is specified only up to a given time s (rather than up to the study
end). As such, the weights in the inverse weighting procedure merely involve the
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first s time points and are thus less aected by lengthy follow-up with frequent
infection measurements. Alternatively, weight instability may be intercepted by
inferring only the eect of late infections, along the lines of Joe et al. (2004);
Petersen et al. (2007), or by using doubly-robust estimators which allow beer for
truncating extreme weights (Yu and van der Laan, 2006). Finally, note that our
results directly accommodate situations where exposures are not collected up to
the time where outcomes are assessed. This may happen in seings where the
mortality status of patients is assessed at the time of data analysis, i.e. later than
end-of-follow-up, through death registers, or where each patient’s treatment or
treatment compliance is closely monitored for only a limited time period. By not
fixing treatment levels observed aer this time period, the proposed models isolate
the overall eect of treatment over the given period on outcome and extrapolate
much less from the observed data than standard MSPHMs.
Alternatively, we could have chosen to assess the eect of avoiding infection
among patients who acquired infection on a given day. This eect estimand
has greater relevance since physicians are primarily interested in the eect of
preventing infection among the infected. Also, by restricting the focus to those who
acquired infection in the ICU, one avoids the diiculty that the eect of acquiring
infection on a given day in ICU is ill-defined for those who get discharged before
that day. Structural nested accelerated failure time models (SNFTMs) (Robins,
1992, 1997; Keiding et al., 1999) can be used for modelling this eect estimand.
These are models for the eect of a change in infection status on survival time
among patients with a given history of measured time-dependent confounders and
infection. Because inference for these models is more complicated, does not allow
the use of standard soware, and typically suers more from censoring of the
survival time, we have chosen to adopt marginal structural models in this article
and plan to report on structural nested models elsewhere.
Finally, it remains to be seen how sensitive conclusions are to the untestable
assumptions that there are no unmeasured time-varying confounders for the
eect of infection on mortality (SRA) and that censoring is sequentially ignorable
(ICA). The former assumption implies that among patients with prognostic factors
L¯t−1, A¯t−1, Dt−1 = 0, the causal eect of infection and ICU discharge is the same
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regardless of their infection and ICU discharge status at time t. This may not be
entirely realistic because we anticipate the causal eect of infection to be greater
among the infected and we may lack suicient prognostic factors conditional on
which this is no longer so. ICA may also be questioned because the decision to
discharge patients from hospital is intimately connected with their health status,
about which no information was recorded aer ICU discharge. In future work, we
plan to accommodate this by estimating the eect of acquiring infection in ICU on
“30-day ICU mortality”. This endpoint is uncensored and of even greater interest
to clinicians, because time to death in ICU patients can be greatly extended by
invasive therapeutic treatments.
4.6 Appendix
We will first clarify the relation between the infection paths (d, a, as) and (s, a).
Note that the infection path (d, a, as), (s < d) is defined by the infection path a =
(a1, ..., as−1, as, ..., aK) = (0, ..., 0, a, ..., a) following which a patient is infected
on a given day t since ICU admission if at = 1 and uninfected if at = 0, and
additionally by the discharge path d = (d1, ..., dd−1, dd, ..., dK) = (0, ..., 0, 1, ..., 1)
following which a patient is in the ICU on a given day t since ICU admission if
dt = 0 and has been discharged if dt = 1. The infection path (s, a) is defined
by the same infection path, but a discharge path d = (d1, ..., ds−1, ds, ..., dK) =
(0, ..., 0, Ds, ..., DK) which is only partially specified.
In the remainder of this Section, we will construct a class of unbiased estimating
functions for the parameters indexing MSPHM-Ps which contains (up to asymptotic
equivalence) all such unbiased estimating functions. For each patient in the study,
let D be the observed time from admission in the ICU to discharge from ICU. Note
that D can be recovered from the path {Dt, t = 0, ..., K} (up to the resolution
permied by discrete time). Let us first assume there is no censoring due to hospital
discharge. Then we develop inference for β indexing modelM for the observed
data
(
T,D, A¯D−1, L¯D−1
)
defined by the law of the infection and discharge process
under SRA (i.e. the assumption of no unmeasured confounding for infection and
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ICU discharge):
f(DD = 1|A¯D−1, D¯D−1 = 0, L¯D−1, V )
×
D−1∏
t=1
f(At, Dt = 0|A¯t−1, D¯t−1 = 0, L¯t−1, V ) (4.7)
where f is an unknown probability function, and by a discrete-time marginal
multiplicative intensity model (Fahrmeir and Tutz, 1994), e.g.:
λ(s,a)(t|V ) = λ0(t) exp (β′W ) (4.8)
for t = 0, 1, 2, ..., a = 0, 1, s = 1, ..., K for a given integer constant K > 0, where
W = W (a, s, t, V ) is a known function of a, s, t and V . Note that model (4.3)
in the article is a special case of (4.8) with β = (β1, β2, β3)′ and W (a, s, t, V ) =
{sI(t ≥ s), aI(t ≥ s), V }. When the hazard λ(s,a)(t|V ) is small at each time t,
this model can be approximated via the discrete-time marginal logistic regression
model:
log
{
λ(s,a)(t|V )
1− λ(s,a)(t|V )
}
= log{λ∗0(t)}+ β′W (4.9)
with regression splines to fit log{λ∗0(t)}, as used in the data analysis.
To determine an unbiased estimating functionU under modelM, letUt,(s,a){T(s,a), V ; β}
be an unbiased estimating function for β in the full data model defined by the
full data {T(s,a), V }, restriction (4.8) just for the given t and the given infection
path (s, a). Because (4.8) is a discrete-time multiplicative intensity model, such
estimating functions follow from standard results on such models. In particular, it
may be the discrete-time partial likelihood score, which for a given subject equals[
W (s, a, t, V )−
∑n
i=1W (s, a, t, Vi)I{Ti,(s,a) ≥ t} exp{β′W (s, a, t, Vi)}∑n
i=1 I{Ti,(s,a) ≥ t} exp{β′W (s, a, t, Vi)}
]
dN(t)
(4.10)
where Ti,(s,a) is the realisation of T(s,a) for the ith subject and where dN(t) indicates
1 if the counterfactual survival time T(s,a) ∈]t − 1, t] for the considered subject.
In the data analysis, Ut,(s,a){T(s,a), V ; β} is the score function for β in the logistic
regression model (4.9).
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Define
U =
K∑
t=1
t−1∑
s=1
1∑
a=0
I(As = a,As−1 = 0, Ds = 0)sws,a(Ls−1)Ut,(s,a){T(s,a), V ; β}
(4.11)
with
sws,a(Ls−1) =
P (As = a,Ds = 0|As−1 = Ds−1 = 0, V )
P (As = a,Ds = 0|As−1 = Ds−1 = 0, L¯s−1, V )
×
s−1∏
k=1
P (Ak = Dk = 0|Ak−1 = Dk−1 = 0, V )
P (Ak = Dk = 0|Ak−1 = Dk−1 = 0, L¯k−1, V ) (4.12)
Then U is an unbiased estimating function in modelM. Indeed, first note that U
is a function of the observed data because replacing T(s,a) by T yields the same full
data function under the Consistency assumption that we observe T(s,a) = T for
subjects with As = a,As−1 = 0, Ds = 0. Furthermore, for s < t− 1 and provided
that SRA holds,
E
[
I(As = a,As−1 = 0, Ds = 0)sws,a(Ls−1)Ut,(s,a){T(s,a), V ; β}
]
= E
[
E{I(As = a,Ds = 0)sws,a(Ls−1)|As−1 = Ds−1 = 0, L¯s−1, T(s,a)}
×I(As−1 = Ds−1 = 0)Ut,(s,a){T(s,a), V ; β}
]
= E
[
E{I(As = a,Ds = 0)sws,a(Ls−1)|As−1 = Ds−1 = 0, L¯s−1}
×I(As−1 = Ds−1 = 0)Ut,(s,a){T(s,a), V ; β}
]
= E [P (As = a,Ds = 0|As−1 = Ds−1 = 0, V )
×I(As−1 = Ds−1 = 0)sws−1,0(Ls−2)Ut,(s,a){T(s,a), V ; β}
]
= ...
= E
[
Ut,(s,a){T(s,a), V ; β}P (As = a,Ds = 0|As−1 = Ds−1 = 0, V )
×
s−1∏
k=1
P (Ak = Dk = 0|Ak−1 = Dk−1 = 0, V )
]
= 0 (4.13)
where the last equality is true because the estimating functionsUt,(s,a){T(s,a), V ; β}
are conditionally unbiased given V . We conclude that U is an unbiased estimating
function.
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Note that the estimating functions used in the article were obtained this way.
For instance, solving an estimating equation with estimating function U and
Ut,(s,a)
(
T(s,a), V ; β
)
as given in (4.10) is mathematically equivalent to fiing the
time-dependent, discrete-time multiplicative intensity model
λ(t|V ) = λ0(t) exp {β′W (A∗t , St, t, V )} , (4.14)
where λ0(t) is an unknown baseline hazard, where A∗t , St, t > 0 are defined as
in Section 3.4, and where the risk set at each time is weighted by the weights
(4.12). Note that (4.14) and (4.12) are obtained by substituting (s, a) by (St, A∗t ) in
the multiplicative intensity model (4.8) and the weights sws,a(Ls−1), respectively.
Similarly, as in the data analysis, the discrete-time marginal logistic regression
model (4.9) can be fied upon substituting (s, a) by (St, A∗t ) and weighting the
corresponding subject’s contribution at time t by swSt,A∗t (LSt−1).
Starting from the single unbiased estimating function for β in modelM that
we have now identified, we will construct a class of unbiased estimating functions
for β in modelM which contains (up to asymptotic equivalence) all such unbiased
estimating functions. Upon noting that SRA is equivalent to ICA, even when
the length D of the infection period is random, this construction follows from
standard results on the construction of CAN estimators for parameters indexing
a conditional mean model under ICA (Robins et al., 1999). Indeed, application
of Theorem 1.3 in van der Laan and Robins (2003) shows that, up to asymptotic
equivalence, all CAN estimators of β under modelM can be obtained by solving an
estimating equation based on estimating functions in the set {U}+ TSRA, where
U is an arbitrary unbiased estimating function for β under this model (as already
constructed) and where TSRA is the tangent space (Bickel et al., 1993) for the
infinite-dimensional parameters indexing the infection and discharge process (4.7),
which is assumed to satisfy SRA. A similar argument as in Theorem 1.2 (van der
Laan and Robins, 2003) shows that TSRA = TSRA,1 + TSRA,2 where
TSRA,1 =
[
D−1∑
s=1
Zs
(
A¯s, D¯s, L¯s−1, V
)
−E{Zs
(
A¯s, D¯s, L¯s−1, V
) |A¯s−1, D¯s−1, L¯s−1, V } : Zs arbitrary]
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TSRA,2 =
[
Z(A¯D−1, D¯D, L¯D−1, V )
−E{Z(A¯D−1, D¯D, L¯D−1, V )|A¯D−1, D¯D−1, L¯D−1, V } : Z arbitrary
]
(4.15)
It further follows from Theorem 1.2 in van der Laan and Robins (2003) that for given
estimating function U , the choices Zs
(
A¯s, D¯s, L¯s−1, V
)
= E
(
U |A¯s, D¯s, L¯s−1, V
)
and Z
(
A¯D, D¯D+1, L¯D, V
)
= E
(
U |A¯D, D¯D+1, L¯D, V
)
are optimal in the sense
that they yield an eicient estimator of β under modelM in the class of estimators
obtained by solving estimating equations in the class {U}+ TSRA for given U .
Finally, the above methods are easily adapted to handle ICA following the
lines of van der Laan and Robins (2003) and to account for estimation of the
parameters indexing the infection and discharge process (4.7). It also follows from
Theorem 2.4 in van der Laan and Robins (2003) that we obtain an asymptotically
conservative confidence interval for our causal parameters by not taking into
account estimation of the weights, provided that the unknown parameters in the
models for the weights are eiciently estimated.
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CHAPTER 5
Augmented and doubly-robust G-estimation under
Structural nested accelerated failure time models
This chapter is based on an article currently being prepared for submission, and
which is wrien in collaboration with S. Vansteelandt.
Summary
Structural nested failure time models (SNFTMs) are models for the eect of a time-
dependent exposure on a survival outcome. They have been introduced along with
so-called G-estimation methods to provide valid adjustment for time-dependent
confounding induced by time-varying variables. Adjustment for informative cen-
soring in SNFTms is possible via inverse probability of censoring weighting (IPCW).
In the presence of considerable dropout, this can imply substantial information loss
and consequently imprecise eect estimates. In this article, we aim to increase the
eiciency of IPCW G-estimators under a SNFTM by deriving an augmented esti-
mator that uses both censored and uncensored observations, and oers robustness
against misspecification of the model for the censoring process, provided that a
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model for a specific functional of the survival time and time-dependent covariates
is correctly specified. The empirical properties of the proposed estimators are
studied in a simulation experiment, and the estimators are used in the analysis of
surveillance data from the field of hospital epidemiology.
5.1 Introduction
Structural nested accelerated failure time models (SNFTMs) (Robins, 1992, 1998))
are models for the eect of a time-dependent exposure variable on a survival out-
come. G-estimation under such models can successfully adjust for time-dependent
confounding by time-varying variables satisfying the following three conditions:
being predictive for (i) outcome, (ii) exposure, and (iii) aected by previous expo-
sure (Robins, 1986). In particular, under the usual assumptions of correct model
specification and of no unmeasured confounding, G-estimation for SNFTMs yields
estimates for the causal eect of the considered time-dependent exposure variables
on the survival outcome on a relative risk scale. This is in contrast to standard
methods, for example Cox proportional hazards regression with time-dependent
predictors, which will typically yield biased estimates of the joint exposure eect on
the hazard of survival whether or not one adjusts for aforementioned time-varying
variables (Robins, 1992).
In the presence of censored survival times, G-estimation procedures can be
adjusted to prevent selection bias due to censoring or dropout being possibly
correlated with survival. This is possible using Inverse probability of censoring
(IPC) weights under the Ignorable censoring assumption (ICA) (Robins, 1998).
Using this procedure, the estimating equations that define the G-estimator for
each subject are weighted by the reciprocal of the cumulative probability of not
being censored throughout follow-up, and this using IPC weights that are derived
from subjects with observed and censored survival times. However, because the
G-estimation procedure relies only on subjects who have an observed survival
time, this analysis gives ineicient estimates especially in datasets with high
rates of censoring. Moreover, when particular covariates are strongly associated
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with censoring (which leads to highly variable IPC weights), using the Inverse
probability of censoring weighted (IPCW) G-estimator will necessitate to make
a tradeo between the bias due to incorporating subjects with extreme weights,
and the possibility of bias due to truncating these extreme weights towards less
influential values. Furthering ideas by Robins (2000), van der Laan and Robins (2003)
and Tsiatis (2006), we address these issues by proposing an Augmented Inverse
probability of censoring weighted (A-IPCW) G-estimator that is more eicient and
also doubly-robust in the sense that it protects against misspecification of either
the model for the censoring event or a model for a functional of the survival time
and time-dependent covariates, but not necessarily both.
The above introduced methods will be used for the estimation of the aributable
eect on mortality of Healthcare-associated infection (HAI). We will use a SNFTM
to verify what would happen with the distribution of survival times of hospitalised
patients under a hypothetical intervention that would eliminate these infections.
This article is structured as follows. Aer a brief description of notation in
section 5.2, section 5.3 summarises concepts on SNFTMs, G-estimation of their
causal parameters, and correction for (non-)administrative censoring. Section
5.4 introduces the augmented estimator that oers doubly-robustness against
misspecification of the models for the drop-out process or the outcome. Sections
5.5 and 5.6 show a simulation experiment and an application, and are followed
by a discussion. The Appendix gives technical details on the derivation of the
augmented estimator and its robustness properties, explains the implementation
of estimation routines into statistical soware, and gives further details on the
simulation and application.
5.2 Notation, definitions and identifying assump-
tions
Data is assumed to have derived from a cohort with longitudinal follow-up at
discrete time points t = (0, 1, .., Tm), with Tm the fixed maximum follow-up
time. The time point t is used to index the following time-varying variables. In this
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Chapter, we let variableCt indicate whether a subject was under follow-up (Ct = 1)
or was lost from follow-up (Ct = 0) at or before time t. Let variable At indicate
if a subject was exposed (At = 1) or not (At = 0) at t. Lt is a multidimensional
vector of confounders and eect modifiers. Variable Yt indicates whether a subject
acquired the studied outcome (Yt = 1) or not (Yt = 0) by t, and will only be
observed at time points were Ct = 1. Variables (At, Ct, Yt) are assumed to have
absorbing state at (1, 0, 1). At t = 0, we define A0 = D0 = 0, C0 = 1, and L0 as
a vector of baseline variables. Let Vt = (Ct−1At, Ct−1Lt) be the set of observed
prognostic variables at time t. For any time-dependent variable (or combination
thereof) Zt, let Zt = (Z0, Z1, ..., Zt). We assume the following order of events at
each time point: Lt → At → (Ct, Yt).
Let the survival time T be the discrete time from study start at t = 0 until
the event of interest Yt = 1. T is only observed for subjects with Yt = 1 during
study follow-up. Survival time will be administratively censored at Tm for subjects
with YTm = 0. Let Tt,0 be the subject’s time until the event of interest that would
have occurred had he or she experienced the observed exposure history At−1 until
t− 1, but zero exposure from time t onwards (Rubin, 1974; Robins, 1998). This is a
counterfactual survival time because it is unobserved for subjects who were exposed.
We define the following assumptions under which the distribution of Tt,0 can be
identified. The Consistency assumption (Cole and Frangakis, 2009; Vanderweele,
2009) states that the counterfactual survival time Tt,0 at any t ≤ T equals the
observed survival time T for subjects who were unexposed through follow-up (ie.
with AT = 0). The Sequential randomisation assumption (SRA) (Rosenbaum and
Rubin, 1983; Robins et al., 1992) Tt,0 q At|At−1, Lt, T ≥ t states that at each time
t the counterfactual exposure-free survival time Tt,0 is independent of exposure
At, given the history At−1, Lt−1 of exposure and of measured confounders, among
subjects who are alive just prior to time t. For observational data, SRA is also
referred to as the ”assumption of no unmeasured confounding”. It states that
adjustment for the observed history (At−1, Lt) suices to identify the causal eect
of exposure At on survival. The Ignorable censoring assumption (ICA) (Robins, 1992;
Robins et al., 1994; Rubin, 1976) Tt,0 q Ct|At, Lt, Ct−1 = 1, Tt,0 ≥ t for each t >
0 states that the observed history (At, Lt) is suicient to predict censoring at
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time t in the sense that censoring carries no residual information about survival,
conditional on the covariate history up to time t. Finally, we make the Positivity
assumption (Rosenbaum and Rubin, 1983) that P (Ct = 1|Ct−1 = 1, At, Lt, T ≥
t) > 0 for each t > 0 with probability 1.
5.3 Estimation of causal parameters under SNFTMs
5.3.1 Mapping of counterfactual survival times
A Structural accelerated failure time model (SFTM) (Cox and Oakes, 1984) postu-
lates that
T1,0
d
=
T∑
t=1
exp{γ(t, At, Lt;ψ0)} (5.1)
with γ() a known function of time, (At, Lt) and an unknown parameter vector
ψ0 of dimension p, satisfying γ() = 0 if ψ0 = 0 or AT = 0. The ”
d
= ” stands for
equality in distribution. The parameter ψ0 encodes the causal eect of exposure
on survival time because it enables mapping the observed survival time T into
the counterfactual survival time T1,0 under the absence of exposure. For example,
taking γ(At, Lt;ψ0) = ψ0At, then ψ0 < 0, ψ0 > 0 and ψ0 = 0 will indicate a
beneficial, harmful and neutral eect of exposure respectively; the SFTM’s ψ0
coeicient then parametrises the causal survival ratio (T/T0) on the log scale. The
causal null hypothesis H0 : T
d
=T1,0 can be studied by testing ψ0 = 0.
In what follows, we will use the more restrictive SNFTM (Robins, 1992), which
models, at each time t, the counterfactual survival time Tt,0 corresponding to
observed exposure history At−1 until t− 1, but zero exposure from time t onwards.
In particular, it postulates that for subjects who are alive at time t and have
covariate history (At, Lt),
Tt,0
d
= t− 1 +
T∑
u=t
exp{γ(Au, Lu;ψ0)} (5.2)
Estimating ψ0 in the the above SNFTM will enable us to answer the question ”For
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each remaining day under exposure, what would be the change in the remaining
time to outcome when removing this exposure?”.
5.3.2 The G-estimation procedure
Let Tt,0(ψ) be the counterfactual exposure-free survival time generated by SNFTM
(5.2), for a given candidate parameter ψ for the true but unknown ψ0. We as-
sume no censoring of survival time for the moment. The G-estimation procedure
introduced by Robins (1992) then proceeds by validating the chosen value ψ by
using Tt,0(ψ) as a substitute for Tt,0 and evaluating if it obeys SRA. Under this
assumption, counterfactuals are independent of actual exposure status at each
time conditionally on the exposure and covariate history. To assess this conditional
independence we will construct a model for exposure at each time t. With binary,
time-dependent and monotonous exposure, we will model the discrete-time hazard
of exposure using a pooled logistic regression model of the form
E(At|At−1 = Yt−1 = 0, Lt) = expit(αtLt) (5.3)
for t = 1, ..., Tm, with E(At|At−1 = Yt−1 = 0, Lt) the discrete-time hazard of
exposure at time t and expit(u) = expu/(1 + expu). The causal G-estimate ψˆ of
ψ0 is then found as the value of ψ that gives an estimate of η equalling 0 in the
following pooled logistic regression model
E(At|At−1 = Y t−1 = 0t−1, Lt) = expit[α′Lt + η′gt{Tt,0(ψ), Lt}] (5.4)
for t = 1, ..., Tm, with gt() a known vector function of dimension p. G-estimation
may proceed via a grid-search, ie. defining a starting range of ψ values and
increment, and then scanning this range until acceptable values are found.
Estimates for ψ0 can alternatively be obtained by solving an estimating equation
U(ψ) =
∑
i
∑T
t=1 Uit(ψ) = 0 for ψ, with
Uit(ψ) = gt{Ti,(t,0)(ψ), Lit}{Ait − E(Ait|Ait−1 = Yit−1 = 0, Lit; αˆ)}
×(1− Ait−1)(1− Yit−1) (5.5)
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which is the Score function for the coeicient η in model (5.3). Because under
SRA, the hypothesis ψ = ψ0 corresponds to η = 0 in (5.4), we use predictions
of E(At|Ait−1 = Yit−1 = 0, Lt; αˆ) under model (5.3), thus not depending on
Tt−1,0(ψ), in function (5.5). The function U(ψ) = 0 can be viewed as an unstan-
dardised score statistic for the null hypothesis η = 0 in model (5.4). Because
n−1/2U(ψ) is asymptotically normally distributed with mean zero and variance
given by Σ{Ui(ψ)}, the variance-covariance matrix of Ui(ψ) =
∑T
t=1 Uit(ψ), find-
ing the root of U(ψ) is usually done by minimising the test statistic S(ψ) =
n−1U(ψ)′Σ{Ui(ψ)}−1U(ψ) (Robins, 1992), with the point estimate ψˆ of ψ0 being
the value of ψ that gives S(ψ) = 0.
5.3.3 Censoring of survival time
The above SNFTM and G-estimation procedure is only valid when the survival
times T of all individuals have been observed. In case of administrative censoring
however, which happens whenever T surpasses the end-of follow-up time Tm,
only X = min(T, Tm) will be observed. Aention must be given not to use the
truncated survival time X to calculate Tt,0(ψ0) from SNFTM (5.2). Indeed, because
Tm is independent of exposure (through the definition of administrative censoring),
using the observed exposure history until Tm may result in values Tt,0(ψ0) that
depend on exposure history, thereby violating SRA with Tt,0(ψ0) in lieu of Tt,0. To
accommodate this, under the one-parameter SNFTM γ(At, Lt;ψ0) = ψ0At, the
following derivation is commonly considered when calculating the counterfactual
exposure-free administrative censoring time Tm(t,0)(ψ) for candidate ψ parameters
(Robins, 1992; Joe et al., 2012):
Tm(t,0)(ψ) = t− 1 + (Tm − t+ 1) exp{ψI(ψ < 0)} (5.6)
and
∆t,0(ψ) = I{Tt,0(ψ) < Tm(t,0)(ψ)} (5.7)
Xt,0(ψ) = min{Tt,0(ψ), Tm(t,0)(ψ)} (5.8)
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with ∆t,0(ψ)Xt,0(ψ) andXt,0(ψ) the re-censored counterfactual outcome indicator
and survival time respectively. At each t, Tm(t,0)(ψ) is the sum of the passed time t
and the remaining counterfactual exposure survival time (Tm−t) exp{ψI(ψ < 0)}
under the ”most harmful exposure” history, which is defined as the combination
of exposures that provides the biggest contraction of the remaining Tm − t days
until end-of-follow-up time Tm. In what follows, we replace gt{Tt,0(ψ), Lt} with
gt{Xt,0(ψ),∆t,0(ψ), Lt}.
Additionally, when subjects drop out before arriving at the end of follow-up
time Tm, their corresponding survival times T are unobserved as well, this time
due to non-administrative censoring. Incorporating data from subjects with non-
administrative censoring is particularly worrysome when the reason for drop-out
or censoring is linked to the unobserved survival time. Restricting the analysis to
cases who did not drop out, ie. had an observed survival time T ≤ Tm or who were
still under follow-up at Tm, may then induce selection bias in the estimates of ψ0.
Also, because exposure is only defined under follow-up, we append Ct−1 = 1 to
the conditioning events of the SRA and of the models for exposure (5.3) and (5.4).
Selection bias can be eliminated under ICA by solving the weighted complete-case
estimating equation
U(ψ) =
∑
i
CiTUi(ψ) =
∑
i
X∑
t=1
CiTUit(ψ)
W stabit
= 0. (5.9)
for ψ, with Uit(ψ) now being
Uit(ψ) = gt{Xt,0(ψ),∆t,0(ψ), Lt}
×{Ait − E(Ait|Ait−1 = Yit−1 = 0, Cit−1 = 1, Lit; αˆ)}
×(1− Ait−1)(1− Yit−1) (5.10)
and
W stabit =
Xi∏
s=t
pis(V is;φ)
pis(Vi0;φ∗)
(5.11)
with
pis(V is;φ) = P (Cs = 1|Ys−1 = 0, Cs−1 = 1, V is) (5.12)
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in which P (Ct = 1|Yt−1 = 0, Ct−1 = 1, V t) is the conditional probability of
being censored at t conditional on being uncensored until then, modelled by
known functional pit(V t;φ) and unknown parameter vector φ. These probabilities
can be obtained by discrete-time logistic regression, for example pit(V t;φ) =
expit{φ′(1, Vt)}. We will call the solution to (5.9) the IPCW G-estimator. It only
takes into account the complete cases described above (having CiTm = 1), who
are inversely weighted by the cumulative conditional probability of remaining
uncensored from time t onwards, defined by the product of pis(V is;φ) in (5.12).
See Appendix 5.8.1 for a proof of the unbiasedness of estimating function (5.9).
The probabilities pis(Vi0;φ∗) are included in the denominator of W stabit to make IPC
weights more stable, ie. less variable. They are obtained from a similar model as
(5.12).
5.3.4 Choices for gt()
Partial robustness against misspecification of the exposure model can be achieved
by defining
gt{Xt,0(ψ),∆t,0(ψ), Lt} = ∆t,0(ψ)− exp(β′Lt)
∫ Xt,0(ψ)
t
λ0,t(s)ds (5.13)
in estimating equation (5.9), with λ0,t(.) the unknown baseline hazard function and
β the unknown parameter vector obtained under the landmark Cox Regression
model
λt(s) = λ0,t(s) exp(β
′Lt), s ≥ t (5.14)
for the hazard of Xt,0(ψ) amongst subjects with Xt,0(ψ) ≥ t. Because Xt,0(ψ)
and ∆t,0(ψ) can only be derived for subjects with observed or administratively
censored survival time, Cox model (5.14) is fied using subject-times inversely
weighted for earlier derived cumulative censoring probabilities (5.11).
The martingale residual (5.13) (Therneau et al., 1990) contrasts the counterfac-
tual outcome indicator under SNFTM (5.2) with its conditional expectation obtained
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under model (5.14). Using such parametrisation for gt{Xt,0(ψ),∆t,0(ψ), Lt} has
the advantage of providing partial robustness against misspecifying the exposure
model, because an estimating function with mean zero at the true exposure eect
ψ0 is obtained when either the model for onset of exposure E(At|At−1 = Yt−1 =
0, Ct−1 = 1, Lt; αˆ) or the model for the counterfactual hazard of Xt,0(ψ) condi-
tional on (Xt,0(ψ) ≥ t, At−1, Lt) is correctly specified, but not necessarily both.
Estimators that use (5.13) will be therefore called a Exposure risk doubly-robust
(EXPDR) G-estimators. Furthermore, because parametrisation (5.13) delivers a
conditional mean-zero choice for gt{Xt,0(ψ),∆t,0(ψ), Lt}, it can be shown that
it will improve eiciency of the estimator based on estimating function (5.5), see
Vock et al. (2013, appendix B.5) for a proof of this in similar seings.
5.4 Augmented G-Estimation of ψ0
Estimates obtained by estimating function (5.9) are ineicient as they ignore
observations from subjects who were non-administratively censored during the
study. Robins et al. (1994) and Scharfstein et al. (1999) introduced Augmented
Inverse probability of censoring weighted (A-IPCW) estimators specifically to
improve the eiciency of IPCW estimators. We apply such augmentation to the
IPCW G-estimator that solves (5.9), resulting in the A-IPCW estimating function
of the form:
CTU(ψ) +
Tm∑
t=1
mt(V t; ξ)
pit(V t;φ)
{pit(V t;φ)− Ct}Ct−1 (5.15)
with CTU(ψ) defined as in (5.9) and
mt(V t; ξ) = E
{
CTmU(ψ)|V t, Ct−1 = 1
}
(5.16)
a model for the full data estimating function U(ψ), represented by known func-
tion mt() and unknown parameter vector ξ, for instance a linear model such as
mt(V t; ξ) = ξ
′(1, V t).
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Equation (5.15) is derived from IPCW estimating function (5.9) with the objective
of obtaining an eicient estimator for ψ0 within the class of estimators obtained
by augmenting the corresponding IPCW G-estimator with unbiased estimating
functions under the models for the censoring mechanism pit(V t;φ) (5.12), and
provided that the full data model (5.16) is correctly specified. For this derivation,
we relied on semiparametric theory concepts described elsewhere (van der Laan
and Robins, 2003; Tsiatis, 2006), see Appendix 5.8.2 for details and for a proof
of the unbiasedness of estimating equation (5.15). The corresponding A-IPCW
G-estimator moreover has the desirable property of being doubly-robust in the
sense that it is consistent and asymptotically normal if either one of the models
pit(V t;φ) ormt(V t; ξ) is correctly specified at each time t, but not necessarily both;
see Appendix 5.8.3 for a proof of this property.
As compared to the IPCW G-estimator, the A-IPCW G-estimator of (5.15) has
an augmentation term that also uses the partial information available from those
subjects who are non-administratively censored. At end of follow-up time Tm, the
mt(V t; ξ) term can be wrien as
E{CTmU(ψ)|V Tm , CTm−1 = 1}
= E{CTmU(ψ)|V Tm , CTm = 1}piTm(V Tm ;φ)
+E{CTmU(ψ)|V Tm , CTm = 0}{1− piTm(V Tm ;φ)}
= E{U(ψ)|V Tm , CTm = 1}piTm(V Tm ;φ)
= E{piTm(V Tm ;φ)U(ψ)|V Tm , CTm = 1} (5.17)
which can be estimated under a model for piTm(V Tm ;φ)U(ψ) based on subjects
remaining uncensored at Tm, and subsequently used to make predictions for
subjects with CTm = 0 at time point Tm under ICA. This assumption is key to the
demonstration of doubly-robustness: piTm(V Tm ;φ) absorbs the inverse probability
weight at time Tm within the summation of U(ψ) in (5.9), thereby reconstructing
the full-data estimating function UTm(ψ) which is independent of CTm given the
past (V Tm , CTm). For ease of notation, let
E{piTm(V Tm ;φ)U(ψ)|V Tm , CTm = 1} ≡ UwTm(ψ) (5.18)
141
Chapter 5. Augmented and doubly-robust G-estimation
5
E{pit(V t;φ)Uwt+1(ψ)|V t, Ct = 1} ≡ Uwt (ψ) (5.19)
with UwTm(ψ) and U
w
t being functions of V Tm and V t respectively. By using the
reasoning behind (5.17) at arbitrary t = Tm, ..., 1, we have that the mt(V t; ξ) term
can be wrien as
E{CTmU(ψ)|V t, Ct−1 = 1} = E
[
E{CTmU(ψ)|V t+1, Ct, Ct−1 = 1}|V t, Ct−1 = 1
]
= E{pit(V t;φ)Uwt+1(ψ)|V t, Ct = 1}
≡ Uwt (ψ) (5.20)
Note that functions Uwit (ψ), t = 1, ..., Tm, and thus the functions mt(V t; ξ), can be
calculated recursively using the conditional distribution of V t+1, given (V t, Ct−1 =
1). Just as with the construction of UwTm(ψ), at each t, the augmentation term in
(5.15) has the eect that all available information V t of subjects under follow-up
at that time (Ct = 1) is used, to model either E(Uwt+1|..) if they survived t, or Uit
if not. The general eect of the term E{CTmU(ψ)|V t, Ct−1 = 1} is therefore that
the full data Ui =
∑
t Uit estimating equation is reconstructed for subjects with
non-administrative drop-out.
5.5 Simulation study
A simulation experiment was conducted to verify the empirical properties of the
aforementioned estimators. Samples were created using a previously proposed data
generating mechanism for a longitudinal study with dropout (Young et al., 2009).
For each subject, we generated T0 = −ln(1 − U)/λ with U ∼ U(0, 1) and λ =
exp(−4). For t = 1, .., 10, we generated (Lt, At, Ct) according toLt ∼ N [l0+l1(1−
U)+l2At−1, σ2t ],E(At|At−1, Lt) = expit(a0+a1t+a2Lt) andE(Ct|Ct−1, At, Lt) =
expit(c0 + c1t + c2Lt + c3At), with (l0, l1, l2, σt) = (0, 95, 5, 10), (a0, a1, a2) =
(−6, 0, .05), (c0, c1, c2) = (−1.5, 0,−.01,−.5). The observed survival time T is
next created by SNFTM (5.2) and the following algorithm at each t: (1) if T0 >∫ t
0
exp(ψ0At)dt then Yt = 0, (2) else if T0 ≤
∫ t
0
exp(ψAt)dt then Yt = 1, (3) if
Yt = 0, then create a new subject-time and repeat above procedure; if Yt = 1
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then T = t+ {T0−
∫ t
0
exp(ψAsds} exp(−ψAt), with ψ = (0,−.25, .25). A typical
scenario with null exposure eect will yield a sample with 65% of survival times
being unobserved due to non-administrative censoring, 65% of survival times of
complete cases being unobserved due to administrative censoring, and 44% and 20%
cumulative exposure rate in the complete cases and the total group respectively.
Simulated data are analysed under a SNFTM and using the IPCW, A-IPCW,
EXPDR-IPCW and EXPDR-A-IPCW G-estimators. Parameters of working models
were estimated using discrete-time pooled Logistic regression (D’Agostino et al.,
1990) for the models for exposure (5.3) and censoring (5.12), using Cox proportional
hazards regression for counterfactual hazard model (5.14), and using linear regres-
sion for full data model (5.16). The model for exposure was correctly specified and
used all subjects. The model for censoring was either correctly specified following
the aforementioned simulation scenario, or misspecified by only including Lt. The
model for the counterfactual hazard only included Lt, and only used subjects with
observed or administratively censored survival time, with each subject day IPC
weighted according to the weights as in (5.11). Full data model (5.16) was fied
on each t and included At and Lt and their interactions as main eects. 95%
confidence bounds for ψˆ are obtained via inversion of the score statistic, or the
values ψ around ψˆ that give S(ψ) = χ20.95(p), the Chi-square statistic correspond-
ing with cumulative probability of 0.95 and p degrees of freedom. We accounted
for estimation of nuisance parameters of working models (if used) (5.3), (5.12)
and (5.14) but not of augmentation model (5.16). This was done by calculating
[Σ{Ui(ψ)}]−1 in the Score statistic based on estimating function (5.5) in which
gt{T0(ψ)} is replaced by a column vector of all scores of aforementioned models as
well as gt{T0(ψ)}, and then by calculating the score statistic for those columns of
(5.5) that correspond with parameter η in model (5.4), see Robins (1992) for details.
For A-IPCW G-estimators, this will give a conservative confidence interval under a
correctly specified model for censoring and a misspecified full data model (Tsiatis,
2006). Each simulation experiment involves 500 repetitions having 5000 subjects
each. Estimation algorithms were implemented in STATA and MATA, details of
which are given in Appendix 5.8.4.
Table 5.1 summarises the results. All estimators with correctly specified working
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models (first four lines of the table) yield median bias well within acceptable range
of empirical standard deviation. The IPCW estimator has a higher empirical
standard deviation than the A-IPCW estimator, with a reduction of up to 40%
when applying augmented estimation. Interestingly, augmented estimation leads
to a reduction in empirical variance for the IPCW estimator, but not so much for
the EXPDR estimator. As seen in lines 5 and 6 of the table’s results, the A-IPCW
estimator based on a misspecified working model for censoring yields empirical
eect sizes that remain unbiased, unlike the IPCW estimator. This demonstrates the
augmented estimator’s doubly-robustness property. Such misspecification did not
lead to an inflation of variance, with the empirical standard deviation remaining
largely unchanged as compared to the augmented estimator with correct IPC
weights.
In the last 4 lines of the table, results are shown from scenarios where IPC
weights are set to 1, thereby using the augmented estimators’ property of being
robust against misspecification of these weights. Under this scenario, unbiased-
ness of augmented estimators was only achieved under very specific forms of
the regression model for the full data, see Appendix 5.8.7 for details including
diagnostics that we used to evaluate model fit. Interestingly, the A-IPCW estimator
with weights set to 1 further improves in terms of empirical variance as compared
to the estimator with correctly specified weights. Also, the non-augmented EXPDR
estimator already partly adjusts for the bias due to seing censoring weights to 1.
Estimated confidence intervals of estimators with correctly specified working
models for censoring roughly achieve nominal coverage. Under IPC weights set
to 1, the A-IPCW estimator’s variance is estimated conservatively, this is due to
not taking into account estimation of full data model parameters for estimation of
the asymptotic variance. The EXPDR-A-IPCW estimator under IPC weights set
to 1 gives optimistically estimated variance, this is due to either aforementioned
reason or its small empirical bias.
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5.6 Application
Proposed estimators are used in the analysis of the aributable eect on mortality
of Healthcare-associated infection (HAI) (see Appendix 5.8.5 for background). We
use data from the Belgian National surveillance of infections acquired in intensive
care units (NSIH-ICU), a study that started in 1997 and is still ongoing. For this
article, data collected during period 2007-2012 is analysed, consisting of observa-
tions on 14 898 patients admied to Intensive care unit (ICU). Using a maximum
follow-up time in ICU of Tm = 30 days, the data contains 107 570 person-days,
and is arranged so that there is one observation per person per day that he or she
remained in ICU. Keeping with the notation of this article, t will denote the day
since admission within ICU, At is exposure to Ventilator-associated pneumonia
(VAP) at or before day t, Lt is a rich set of variables collected at ICU admission and
at each t (listed in Appendix 5.8.5), Ct will denote ”remaining in the ICU through
day t”, and T indicates the survival time.
Working models for exposure, censoring and counterfactual hazard of out-
come were fied as explained in the previous section. We only carried out a
model building procedure (using a stepwise selection algorithm) for the models
for exposure and censoring, based on available prognostic variables for mortality
and HAI. The baseline daily probability function in these models was approxi-
mated using a 2nd order polynomial. Full data model (5.16) at each t included
as main eects aggregated components of Vt, details of which are given in Ap-
pendix 5.8.7. For each estimator, two parametrisations of SNFTM (5.2) for the
eect of VAP on mortality are constructed: γ(At, Lt;ψ) = ψAt where exposure
is strictly monotonous and one parameter for the overall eect at all times is
estimated, and γ(At, Lt;ψ) = ψaI{cum(At) > d} + ψbI{cum(At) ≤ d}, (with
cum(At) =
∑t
s=1As) which encodes a separate exposure eect for the 1st d = 4 in-
fection days (parameterψb) versus later on (parameterψa). With a two-dimensional
causal parameter, gt(x) in estimating equation (5.5) becomes a two-dimensional
vector function, which we chose to be gt(x) = (x, x2). Calculation of the counter-
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factual administrative censoring time Tm(ψ) following (5.6) then goes as follows:
Tm(t,0)(ψ) = t− 1 + (Tm − t+ 1) exp{ψaI(ψa < 0)}I{cum(At) > d}
+(Tm − t+ 1) exp{ψbI(ψb < 0)}I{cum(At) ≤ d} (5.21)
Of 605 (4.1%) patients with one or more episodes of VAP, 151 (25%) died, com-
pared to 1 273 deaths (8.9%) that occurred in 14 293 (95.9%) VAP-free patients.
The group of complete cases, meaning those patients with either observed death
up to day 30 in the ICU or still alive and remaining in the ICU at that time, con-
tained 1 844 patients (12.4% of all patients) and corresponding 27 319 patient days
within the ICU. For these patients, 1 424 deaths and 306 episodes of VAP were
observed. Estimated daily conditional probabilities of remaining under follow-up
had a range of [0.22, 0.99] across all time points. Once stabilised by probabilities
pit(A0, L0;φ
∗), this range became [0.27, 1.7]. The cumulative stabilised conditional
censoring probabilities up to day 30 as defined by the inverse of (5.12) still suf-
fered from a minority of patient days with extremely low cumulative probabilities,
having a total min-max range of [1.41 × 10−6, 1786]. Due to this, we were not
able to reach converging optimisations for any of the studied estimators, and were
forced towards a sensitivity analysis in which IPC weights were truncated to either
[0.2 − 5], [0.1 − 10] and [1p − 99p] ranges (with the laer the 1 to 99 percentile
range of weights, corresponding to value range [0.047−21.4]), as well as a scenario
with weights set to 1. IPC weight truncation followed the procedure described in
Appendix 5.8.6.
Results are summarised in Table 5.2, see also Appendix 5.8.8 for preliminary
gridsearches of one- and two-parameter G-estimators. Estimators with weights
not set to 1 and/or augmented estimators yield lightly protective or neutral one-
parameter estimates, for example the EXPDRA-IPCW estimator with weights set
to 1 that gives a log survival time ratio (lSR) of VAP-exposed versus -unexposed
patient days of −0.14 (95% CI −0.56, 0.16). When separated in eects until or
aer day 4 aer onset of infection, most estimators yield eect estimates early
aer infection that are more protective than those late aer onset, for example
the aforementioned estimator giving a lSR of −2 (95% CI −12,−0.15) early versus
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0.11 (95% CI −0.32, 0.63) later on. This is except for the A-IPCW estimator with
IPC weights set to 1, the results of which show that early infection eects are more
harmful than late aer infection. However, results for this estimator and weight
seing should be taken with caution, because convergence was only obtained
by seing a lag eect on the variables encoding exposure in the full data model,
with lag size also influencing the one- and two-parameter estimates and their
precision (the table gives results using a lag of 4 days). In terms of eiciency, we
see that full data augmentation brought by the A-IPCW estimator only improves
in the scenario where IPC weights are set to 1. Our results demonstrate this across
estimators, for example for the A-IPCW estimator with weights set to 1 having a
standard error of 0.08 as compared to the IPCW estimator with a standard error of
0.45, as well as within an estimator across truncation ranges, for example EXPDRA-
IPCW estimator with one-parameter standard error 0.1 under IPC weights set to 1
compared to 0.18 under weights truncated towards a [1p-99p] range. Of course, by
seing weights to 1, the doubly-robustness property of the augmented estimator
will be lost.
5.7 Discussion
The augmented G-estimators for the causal parameters of a SNFTM will be useful
when parameter estimates from a standard G-estimator are too variable due to
insuicient observations with complete survival time (for example due to censor-
ing of the survival time). Furthermore, because standard G-estimators only use
data from subjects with observed survival time or that survived long enough to
be administratively censored, it can yield biased results in data with high rates
of non-administrative censoring. In such circumstances, the robustness against
misspecification of the model for IPC weights is certainly useful, and can provide
estimates dierent from those of the standard G-estimator. Added advantage is
that the doubly-robustness oers protection for a ’deliberate’ misspecification of
the model for censoring weights such as truncation or seing these to 1.
Causal models such as the SNFTM have the property of enabling valid adjust-
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ment for time-dependent confounding in contrast to stratification-based methods
such as Logistic or Cox proportional hazards regression. Under the usual assump-
tions, both SNFTMs (used here) and Marginal structural proportional hazards
models (MSPHMs) (Robins, 2000; Herna`n et al., 2001) yield relative risk estimates
with causal interpretation. MSPHMs, while also applying IPC weighted estimation
to correct for dependent censoring, adjust for (time dependent) confounding of
the exposure-outcome association by separately calculated Inverse probability of
exposure (IPE) weights. The use of the SNFTM has the following advantages over
the MSPHM: (1) The MSPHM infers on exposure histories such as ”contrary to
what is observed, assign exposure regime a to all subjects” which may be unrealistic
when studying an exposure such as HAI. In contrast, the SNFTM restricts aention
to the subgroup of exposed subjects to calculate the exposure-free survival time.
By doing so, the SNFTM’s findings translate directly in an easy to use message
such as ”by preventing a patient from geing infected, his or her survival time
will be increased or reduced by a factor X”. (2) By directly exploiting SRA in the
G-estimation procedure, the SNFTM avoids the need for IPE weights. These can
introduce bias in the MSPHM’s results when the models for exposure are wrongly
specified or when the fied models yield extreme weights for particular subjects.
In spite of this, a disadvantage of SNFTMs relative to MSPHMs is that no standard
soware exists for routine use of the G-estimation procedure. When survival times
are subject to administrative censoring, back-calculation of counterfactuals in the
presence of re-censoring can also lead to non-smooth estimating functions (Joe
et al., 2012; Vock et al., 2013). On top of this, implementation of the augmenta-
tion term calls for the use of an estimating equation approach and corresponding
optimisation routines, which might be even more tedious to implement.
The protective to neutral relative risks that we found for the eect of infection
on mortality are unexpected from a clinical point of view. This can be explained by
insuicient adjustment for prognostic factors of the mortality-censoring relation:
assuming that exposure is protective for censoring and harmful for mortality, and
assuming an unmeasured common prognostic factor U that aects censoring and
outcome in the same way as exposure (thereby violating ICA), then restricting the
analysis to subjects under follow-up will create a negative non-causal association
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between C and Y , and as a consequence a protective non-causal eect of A
on Y . Therefore, collecting extra prognostic factors for the mortality-censoring
relationship might be a valid future strategy. An alternative is to try to avoid IPC
weighting, and choose a competing risk approach, for example as done by Bekaert
et al. (2009) in a similar seing as this study but working under a MSPHM.
5.8 Appendix
5.8.1 Unbiasedness of the Complete-case IPCW estimator
We first demonstrate unbiasedness of (5.9) when using unstabilised weights, de-
fined as:
W unstabit =
Xi∏
s=t
pis(V is;φ) (5.22)
by which we have:
E
{
CiT∏Xi
s=t pis(V is;φ)
Uit(ψ)
}
= E
{ Xi∏
s=t
I(Cis = 1)
pis(V is;φ)
Uit(ψ)
}
= E
[
E
{ Xi∏
s=t
I(Cis = 1)
pis(V is;φ)
Uit(ψ)
∣∣∣∣V iXi , CiX−1 = 1}
]
= E
[
E(CiX = 1|V iXi , CiX−1 = 1)
piXi(V is;φ)
E
(∏Xi−1
s=t I(Cis = 1)∏Xi−1
s=t pis(V is;φ)
Uit(ψ)
∣∣∣∣V iXi , CiX−1 = 1)
]
= E
{Xi−1∏
s=t
I(Cis = 1)
pis(V is;φ)
Uit(ψ)
}
= ..
= E
{
I(Cit−1 = 1)Uit(ψ)
}
= 0 (5.23)
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with ICA being used in the third equality, and the last equality due toUit(ψ) defined
in (5.10) having mean zero given (V t, Ct−1 = 1), and showing unbiasedness of this
estimating function when applying unstabilised weights W unstabit .
When using stabilised weights W stabit instead, the above derivation becomes
E
{
CiTm
Xi∏
s=t
pis(Vi0)
pis(V is)
Uit(ψ)
}
= E
{
I(Cit−1 = 1)
Xi∏
s=t
pis(Vi0)Uit(ψ)
}
= 0 (5.24)
again because Uit(ψ) has mean zero given (V t, Ct−1 = 1), of which V0 is part.
Using derivation (5.24), it can be shown that stabilisation probabilities pis(V0) can
be extended to pit(V t), therefore including all available information up to time t.
However, such approach might be cumbersome, because it necessitates building of
separate models at each time point.
5.8.2 Derivation of the AIPCW estimator
We follow Tsiatis (2006) (Section 10.3, Theorem 10.4) for this derivation. A minimal
requirement for having an eicient estimator is that (locally, under some model) its
influence function is orthogonal to the tangent space for the parameters indexing
the censoring model pit(V t;φ). This tangent space consists of all functions of the
form
ΛC =
[∑
t
dt(V t)
{
Ct − pit(V t;φ)
}
Ct−1
]
(5.25)
We thus seek to find functions d0t satisfying
0 = E
([
CTU(ψ) +
∑
t
d0t(V t){Ct − pit(V t;φ)}Ct−1
]
×
∑
t
dt(V t){Ct − pit(V t;φ)}Ct−1
)
for all dt (5.26)
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the right hand side part of which can be wrien as
E
[
CTU(ψ)
∑
t
dt(V t){Ct − pit(V t;φ)}Ct−1
]
(5.27)
+ E
[∑
t
d0t(V t){Ct − pit(V t;φ)}Ct−1
∑
s
ds(V s){Cs − pit(V t;φ)}Cs−1
]
(5.28)
By looking at arbitrary ds(V s){Cs−pis(V s;φ)}Cs−1 within
∑
t dt(V t){Ct−pit(V t;φ)}Ct−1
and conditioning on (V s, Cs−1), (5.28) gives:
E
(
Cs−1E
[∑
t
d0t(V t){Ct − pit(V t;φ)}Ct−1ds(V s)(Cs − pis(V s;φ))
∣∣V s, Cs−1])
(5.29)
First, note that
E
(
Cs−1E
[ s−1∑
t=1
d0t(V t){Ct − pit(V t;φ)}Ct−1ds(V s){Cs − pis(V s;φ)}
∣∣∣V s, Cs−1])
= E
(
Cs−1
s−1∑
t=1
d0t(V t){1− pit(V t;φ)}Ct−1ds(V s)E
[{Cs − pis(V s;φ)}∣∣V s, Cs−1])
(5.30)
which equals 0, due to E[{Cs − pis(V s;φ)}|V s, Cs−1 = 1] = 0.
Further,
E
(
Ct−1E
[ T∑
t=s+1
d0t(V t){Ct − pit(V t;φ)}ds(V s){Cs − pis(V s;φ)}Cs−1
∣∣∣V t, Ct−1])
= E
(
Ct−1
T∑
t=s+1
ds(V s){1− pis(V s;φ)}Cs−1d0t(V t)E
[{Ct − pit(V t;φ)}∣∣V t, Ct−1])
(5.31)
which equals 0, due to E[{Ct − pit(V t;φ)}|V t, Ct−1 = 1] = 0.
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Finally, the term in (5.29) corresponding to t = s is
E
(
Cs−1E
[
d0s(V s)ds(V s){Cs − pis(V s;φ)}2
∣∣V s, Cs−1])
= E
(
Cs−1d0s(V s)ds(V s)E[{Cs − pis(V s;φ)}2|V s, Cs−1]
)
= E
[
d0s(V s)ds(V s)Cs−1var{Cs|V s, Cs−1}
]
= E
[
d0s(V s)ds(V s)Cs−1pis(V s;φ){1− pis(V s;φ)}
]
(5.32)
Similarly, (5.27) gives
E
(
Ct−1E
[
CTU(ψ)
∑
t
dt(V t){Ct − pit(V t;φ)}
∣∣V t, Ct−1])
= E
[
Ct−1
∑
t
dt(V t){1− pit(V t;φ)}E{CTU(ψ)|V t, Ct−1}
]
(5.33)
Combined, we obtain that (5.26) equals
E
[∑
t
dt(V t){1− pit(V t;φ)}Ct−1E{CTU(ψ)|V t, Ct−1 = 1}
+
∑
t
d0t(V t)dt(V t)Ct−1pit(V t;φ){1− pit(V t;φ)}
]
= E
(∑
t
dt(V t){1− pit(V t;φ)}Ct−1
×[E{CTU(ψ)|V t, Ct−1 = 1}+ d0t(V t)pit(V t;φ)]) (5.34)
This equals 0 whenever
E{CTU(ψ)|V t, Ct−1 = 1} = −d0t(V t)pit(V t;φ) (5.35)
or when
d0t(V t) = −E{CTU(ψ)|V t, Ct−1 = 1}
pit(V t;φ)
(5.36)
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yielding estimating function:
CTU(ψ) +
∑
t
E{CTU(ψ)|V t, Ct−1 = 1}
pit(V t;φ)
{pit(V t;φ)− Ct}Ct−1 (5.37)
5.8.3 Proof of doubly-robustness of the AIPCW estimator
Under the true censoring model pit(V t;φ), the estimating function for ψ is unbiased
due to E{CTU(ψ)} = 0 (see Appendix 5.8.1) and
E
{
pit(V t;φ)− Ct
∣∣V t, Ct−1 = 1} = 0, (5.38)
which also holds when pit(V t;φ) is stabilised by pit(V 0) as in (5.11). We now show
that they are also unbiased if the censoring model is misspecified, provided that
the model for the conditional distribution of Vt+1 given (V t, Ct−1 = 1) holds at
each time t. First, using
Uw∗iTm(ψ) = E
{
pi∗Tm(V iTm ;φ
∗)Ui(ψ)
∣∣V iTm , CiTm = 1} (5.39)
Uw∗it (ψ) = E
{
pi∗t (V it;φ
∗)Uw∗i,t+1(ψ)
∣∣V it, Cit = 1} (5.40)
with pi∗t (V it;φ
∗) the misspecified censoring probabilities, and Uw∗i,Tm(ψ) and U
w∗
i,t (ψ)
the models using both the misspecified probabilities as well as the estimating
function U(ψ) that is weighted for the misspecified pi∗t (V it;φ
∗).
The A-IPCW estimating function can be rewrien as
E
[
CTmU(ψ) +
Tm−1∑
t=1
Uw∗t (ψ)Ct−1
{
1− Ct
pi∗t (V t;φ∗)
}
+CTm−1U
w∗
Tm(ψ)− CTm−1CTm
Uw∗Tm(ψ)
pi∗Tm(V Tm ;φ
∗)
]
(5.41)
= E
(
E
[
CTmU(ψ) + CTm−1U
w∗
Tm(ψ)− CTm−1CTm
Uw∗Tm(ψ)
pi∗Tm(V Tm ;φ
∗)
+
Tm−1∑
t=1
Uw∗t (ψ)Ct−1
{
1− Ct
pi∗t (V t;φ∗)
}∣∣∣∣V Tm , CTm−1]
)
(5.42)
155
Chapter 5. Augmented and doubly-robust G-estimation
5
= E
(
E
[
CTmU(ψ)− CTm
E{pi∗Tm(V Tm ;φ∗)U(ψ)|V Tm , CTm = 1}
pi∗Tm(V Tm ;φ
∗)
∣∣∣∣V Tm , CTm−1]
+CTm−1U
w∗
Tm(ψ) +
Tm−1∑
t=1
Uw∗t (ψ)Ct−1
{
1− Ct
pi∗t (V t;φ∗)
})
(5.43)
= E
(
E
[
CTmU(ψ)− E{CTmU(ψ)|V Tm , CTm = 1}
∣∣∣∣V Tm , CTm−1]
+CTm−1U
w∗
Tm(ψ) +
Tm−1∑
t=1
Uw∗t (ψ)Ct−1
{
1− Ct
pi∗t (V t;φ∗)
})
(5.44)
= E
[
CTm−1U
w∗
Tm(ψ) +
Tm−1∑
t=1
Uw∗t (ψ)Ct−1
{
1− Ct
pi∗t (V t;φ∗)
}]
(5.45)
= E
[
CTm−1U
w∗
Tm(ψ) + CTm−2U
w∗
Tm−1(ψ)− CTm−2CTm−1
Uw∗Tm−1(ψ)
pi∗Tm−1(V Tm−1;φ
∗)
+
Tm−2∑
t=1
Uw∗t (ψ)Ct−1
{
1− Ct
pi∗t (V t;φ∗)
}]
(5.46)
= E
[
E
{
CTm−1U
w∗
Tm(ψ)− CTm−1
Uw∗Tm−1(ψ)
pi∗Tm−1(V Tm−1;φ
∗)
∣∣∣∣V Tm−1, CTm−2}
+CTm−2U
w∗
Tm−1(ψ) +
Tm−2∑
t=1
Uw∗t (ψ)Ct−1
{
1− Ct
pi∗t (V t;φ∗)
}]
(5.47)
= E
(
E
[
CTm−1U
w∗
Tm(ψ)− E{CTm−1Uw∗Tm(ψ)|V Tm−1, CTm−1}
∣∣∣∣V Tm−1, CTm−2
]
+CTm−2U
w∗
Tm−1(ψ) +
Tm−2∑
t=1
Uw∗t (ψ)Ct−1
{
1− Ct
pi∗t (V t;φ∗)
})
(5.48)
= E
[
CTm−2U
w∗
Tm−1(ψ) +
Tm−2∑
t=1
Uw∗t (ψ)Ct−1
{
1− Ct
pi∗t (V t;φ∗)
}]
(5.49)
= ..
= E
{
C0U
w∗
1 (ψ)
}
(5.50)
At time Tm, we use the fact that, under a correct model for the conditional distri-
bution ofV[Tm+1] given (V Tm , CTm−1 = 1), the termsCTmU(ψ) andCTmU
w∗
T (ψ)/pi
∗
Tm
(V Tm ;φ
∗)
are equal and can be dropped (see line 5.45). At times t = 0, ..., Tm − 1, under a
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correct model for the conditional distribution of V[t+1] given (V t, Ct−1 = 1), the
terms CtUw∗t+1(ψ) and CtU
w∗
t (ψ)/pi
∗
t (V t;φ
∗) are equal and can be dropped (see
line 5.49 for t = Tm − 1). From times t = Tm − 1 until 1, we use ICA by leing
Uw∗t+1(ψ) within CtU
w∗
t+1(ψ) be extrapolated to all contributions with Ct = 1, as in
the first line of (5.48) for t = Tm − 1. The remaining term E{C0Uw∗1 (ψ)} in (5.50)
is the average complete-case estimating function Ui(ψ) for which the misspecified
censoring weights are absorbed recursively at each t through multiplication with
pi∗t (V t;φ
∗). This estimating equation uses all subjects (due to C0 = 1), which
makes it formally a full data estimating function that has mean zero.
5.8.4 Algorithm to construct the AIPCW estimator and im-
plementation of estimators in STATA/MATA
In practice, the augmented term of the estimator that solves (5.15) will be con-
structed as follows.
1. Fit model (5.12) for the censoring mechanism and calculate the censoring
probabilities pit(V t;φ). Note that these are also calculated to determine the
cumulative probabilities of remaining uncensored in the IPCW G-estimator
that solves (5.9).
2. Fit models for Uwt defined by (5.18) and (5.19), recursively for times t =
Tm, .., 1, and starting with the U(ψ) contributions derived for survival times
T ≥ Tm. This can be done by linear regression models as shown in the main
paper. Under ICA at each time t, for both subgroups (Ct = 1, Ct−1 = 1) and
(Ct = 0, Ct−1 = 1), this model is then used to calculate predicted values
of Uwt (ψ), which are subsequently used in a model for the prediction of
Uwt−1(ψ).
3. Finally, solve the A-IPCW estimator for ψ using estimating equation (5.15).
To allow automatic and direct optimisation (as opposed to a manual and iterative
grid-search) of the G-estimate for ψ, we implemented above steps (2) and (3) into
STATA version 10’s matrix programming language MATA (StataCorp LP, College
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Station, TX, USA), resulting in the algorithm given below. Using known censoring
weights pit and exposure residuals A− P (At = 1|At−1, .) (estimated using regular
STATA), the algorithm is called upon in MATA for:
1. Construction of re-censored counterfactual survival times Xt,0(ψ) and sur-
vival indicator δ0(ψ) [using function gestXdtgp()],
2. Construction of IPCW (5.9), EXPDR-IPCW ( with gt{Xt,0(ψ)} based on 5.13),
A-IPCW and EXPDR-A-IPCW (5.15) estimating equations (using functions
gestUtgp1(),gestXtgpccdr1(),gestdda12d() andgestdda12-
ccdr1() respectively),
3. Nelder-Mead optimisation of the Score test statistic (see main paper section
5.3.2) towards a minimum, and
4. Estimation of 95% confidence limits and standard errors by gridsearch of
Score test statistic.
For EXPDR estimators, hazard functions are estimated by going back to STATA
within the MATA algorithm seing a particular ψ.
MATA functions rely on the following matrices (with n the number of subjects,
N the number of subjectdays): Y (n× Tm, outcome Y ), A (n× Tm, exposure A),
R [n × Tm, exposure residual from estimating equation (5.5)], CCUM [n × Tm,
IPC weights (5.11)], I (n× 1, complete-case indicator CTm), CT (n× Tm, CTmCt),
Xcensp (N × 1, scores for estimating the parameters of the censoring model),
Xexpp (N × 1, scores for estimating the parameters of the exposure model), CP
(n× Tm, 1− Ct with Ct = 1 recoded to missing, for use by augmentation model),
CPP (n× Tm, 1− Ct), L (nTm × ql, time-dependent confounders), L0 (nTm × ql0 ,
time-independent confounders), C (n × Tm, stabilised probability of remaining
under follow-up at day t).
∗ IPCW E s t i m a t i n g Equat ion and S c o r e S t a t i s t i c
c a p t u r e mata : mata drop g e s t X d t g p ( )
mata
r e a l m a t r i x g e s t X d t g p ( r e a l s ca la r q )
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{
i f (q<−13.3) q=−13.3
q11=q
e x t e r n a l Y , A , CT
r = . 0 0 0 1
c o l = c o l s ( Y )
row=rows ( Y )
m= J ( co l , co l , 1 )
for ( i = 1 ; i<=c o l ; i ++) {
for ( j = 1 ; j<=c o l ; j ++) {
i f ( i>j ) m[ i , j ]=0
}
}
n= J ( co l , co l , 1 )
for ( i = 1 ; i<=c o l ; i ++) {
for ( j = 1 ; j<=c o l ; j ++) {
i f ( i>=j ) n [ i , j ]=0
}
}
Aq=q11 ∗A
Ap=exp ( Aq )
At=Ap
Yp = Y : ∗ At
Ytgp = round ( e d i t v a l u e ( Yp , . , 0 ) ∗m’ , r )
q31=q11
i f ( q31>=0) q31 =0
Ctgp= J ( 1 , co l , 0 )
f o r ( j = 1 ; j<=c o l ; j ++) {
C t g p s i 1 = ( co l−j + 1 ) ∗ exp ( q31 )
i f ( Ctgps i1>=co l−j + 1 ) C t g p s i 1 = co l−j +1
Ctgp [ . , j ]= round ( Ctgps i1 , r )
}
P = Ytgp :<Ctgp
P0 = 1:−P
Xtgp = P0 : ∗ Ctgp + P : ∗ Ytgp
dtgp = P : ∗ CT
r e t u r n ( Xtgp , dtgp )
}
end
c a p t u r e mata : mata drop g e s t U t g p 1 a ( )
mata
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r e a l m a t r i x g e s t U t g p 1 a ( r e a l s c a l a r q )
{
e x t e r n a l R
D = 1
X = g e s t X d t g p ( q ) [ , ( 1 : : 3 0 ) ]
U = D : ∗ X
Uts = U : ∗ R
r e t u r n ( Uts )
}
end
c a p t u r e mata : mata drop g e s t U t g p 1 ( )
mata
r e a l m a t r i x g e s t U t g p 1 ( r e a l s c a l a r q )
{
e x t e r n a l CCUM
D = 1
Xa = g e s t U t g p 1 a ( q )
U = D : ∗ Xa
Uts = CCUM: ∗U
r e t u r n ( Uts )
}
end
c a p t u r e mata : mata drop g e s t s s p ( )
mata
r e a l m a t r i x g e s t s s p ( r e a l s c a l a r q )
{
e x t e r n a l I
Uts1 = g e s t U t g p 1 ( q )
Uts1 = e d i t v a l u e ( Uts1 , . , 0 )
Uts1 =rowsum ( Uts1 )
Uts1 = e d i t v a l u e ( I : ∗ Uts1 , . , 0 )
r e t u r n ( Uts1 )
}
end
c a p t u r e mata : mata drop g e s t s p 5 ( )
mata
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r e a l s c a l a r g e s t s p 5 ( r e a l s c a l a r q )
{
e x t e r n a l Xcensp , Xexpp , Cx
i f ( Cx ==1) Up=Xcensp , Xexpp , g e s t s s p ( q )
i f ( Cx ==0) Up=Xexpp , g e s t s s p ( q )
X c o l s = c o l s ( Up )
n=rows ( Up )
Ups= colsum ( Up [ , X c o l s ] )
sigma =n ∗ v a r i a n c e ( Up )
i s i g m a = invsym ( sigma )
t =Ups ∗ i s i g m a [ Xco l s , X c o l s ] ∗ Ups ’
return ( t )
}
end
∗EXPDR−IPCW E s t i m a t i n g Equat ion and S c o r e S t a t i s t i c
c a p t u r e mata : mata drop g e s t X t g p c c d r 1 ( )
mata
r e a l m a t r i x g e s t X t g p c c d r 1 ( r e a l s ca la r q )
{
e x t e r n a l Y
s t a t a ( ” qu i : cap drop Xt ” )
s t a t a ( ” qu i : cap drop dt ” )
Xdt= g e s t X d t g p (q )
nvs =vec ( Xdt [ , ( 1 : : 3 0 ) ] ’ ) , vec ( Xdt [ , ( 3 1 : : 6 0 ) ] ’ )
Y t t =vec ( Y ’ )
nvss = s e l e c t ( nvs , Y t t [ , 1 ] : ˜ = 0 )
i d x = s t a d d v a r ( ( ” doub le ” , ” i n t ” ) , ( ” Xt ” , ” dt ” ) )
s t s t o r e ( . , idx , nvss )
s t a t a ( ” qu i : cap drop phcb ” )
s t a t a ( ” qu i : cap drop pxb ” )
s t a t a ( ” qu i : cap drop phc ” )
s t a t a ( ” qu i : cap drop c r e s ∗ ” )
s t a t a ( ” qu i : cap drop U t i ” )
s t a t a ( ” qu i : compress ” )
s t a t a ( ” qu i : s t s e t Xt i f cT==1&am==0 [pw= cw0cumit2 ] , f a i l u r e ( dt ==1) ” )
s t a t a ( ” qu i : s t c o x l 1 ∗ l 0 ∗ , b a s e c h a z a r d ( phcb ) e s r ( c r e s ∗ ) nohr ” )
s t a t a ( ” qu i : p r e d i c t pxb , xb ” )
s t a t a ( ” qu i : gen phc=phcb ∗ exp ( pxb ) ” )
s t a t a ( ” qu i : gen U t i = ( dt−phc ) ∗ cw0cumit2 ∗ r e s e ∗ cT ∗(1−am) ” )
s t a t a ( ” p r e s e r v e ” )
s t a t a ( ” s o r t c a s e day ” )
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s t a t a ( ” keep c a s e U t i c r e s ∗ ” )
s t a t a ( ” c o l l a p s e ( sum ) U t i c r e s ∗ , by ( c a s e ) ” )
s t a t a ( ” drop c a s e ” )
s t a t a ( ” o r d e r c r e s ∗ U t i ” )
s t a t a ( ” mata : Xcox= s t d a t a ( . , . ) ” )
s t a t a ( ” r e s t o r e ” )
s t d r o p v a r ( ( ” Xt ” , ” dt ” , ” phcb ” , ” pxb ” , ” phc ” ) )
e x t e r n a l Xcox
r e t u r n ( Xcox )
}
end
c a p t u r e mata : mata drop g e s t s p 5 c c d r 1 ( )
mata
r e a l s c a l a r g e s t s p 5 c c d r 1 ( r e a l s c a l a r q )
{
e x t e r n a l Xcensp , Xexpp
Up=Xcensp , Xexpp , g e s t X t g p c c d r 1 ( q )
X c o l = c o l s ( Up )
n=rows ( Up )
Ups= colsum ( Up )
sigma =n ∗ v a r i a n c e ( Up )
i s i g m a = invsym ( sigma )
t =Ups [ , X c o l ] ∗ i s i g m a [ Xcol , X c o l ] ∗ Ups [ , X c o l ] ’
return ( t )
}
end
∗AIPCW E s t i m a t i n g Equat ion and S c o r e S t a t i s t i c
mata : l =4
c a p t u r e mata : mata drop ges tdda12d ( )
mata
r e a l m a t r i x ges tdda12d ( r e a l r o w v e c t o r q )
{
e x t e r n a l CPP , CP , L , L0 , X , C , Y , Y2 , A , I , l
L f =L
c o l = c o l s ( Y )
row=rows ( Y )
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Cdr=CPP : / C
Cdr=1:−Cdr
R1=CPP : ˜ = .
R1= e d i t v a l u e ( R1 , 0 , . )
R2=CP
R2= e d i t v a l u e ( R2 , 0 , . )
Uts = e d i t v a l u e ( g e s t U t g p 1 (q ) , . , 0 )
Ut s r = Uts
for ( i = 1 ; i<=c o l ; i = i + 1 ) {
Uts r [ . , i ]= rowsum ( Uts [ . , ( 1 : : i ) ] )
}
Ars =A
for ( i = 1 ; i<=c o l ; i = i + 1 ) {
Ars [ . , i ]= rowsum ( A [ . , ( 1 : : i ) ] )
}
EUt= J ( row , co l , . )
EUt [ . , c o l ]= Uts r [ . , c o l ]
for ( i = c o l ; i >=3; i = i −1) {
U t i =EUt [ . , i ] : ∗ R2 [ . , i ] : ∗ C [ . , i ]
U t i i = s e l e c t ( Ut i , U t i [ , 1 ] : ˜ = . )
At=A [ . , i ]
A r s t = Ars [ . , i ]
L 0 i = s e l e c t ( L0 [ , ( 1 : : 2 ) ] , X [ . , 2 ] : = = i )
AL0i =At : ∗ L 0 i
L f i = s e l e c t ( Lf , X [ . , 2 ] : = = i )
Yt =Y2 [ . , i ]
i f ( i>l ) {
A l t =A [ . , i−l ]
A r s l t = Ars [ . , i−l ]
}
L 0 i a = L 0 i : ∗ R2 [ . , i ]
Y i = Yt : ∗ R2 [ . , i ]
A l i = A l t : ∗ R2 [ . , i ]
A r s l i = A r s l t : ∗ R2 [ . , i ]
L f i a = L f i : ∗ R2 [ . , i ]
L 0 i i = s e l e c t ( L0 ia , L 0 i a [ , 1 ] : ˜ = . )
Y i i = s e l e c t ( Yi , Y i [ , 1 ] : ˜ = . )
L f i i = s e l e c t ( L f i a , L f i a [ , 1 ] : ˜ = . )
A l i i = s e l e c t ( A l i , A l i [ , 1 ] : ˜ = . )
A r s l i i = s e l e c t ( A r s l i , A r s l i [ , 1 ] : ˜ = . )
i f ( i>l ) {
X i i = A l i i , A r s l i i , L 0 i i , L f i i , J ( rows ( U t i i ) , 1 , 1 )
X i = ( A l t , A r s l t , L0 i , L f i ) : ∗ R1 [ . , i ] , J ( rows ( U t i ) , 1 , 1 )
}
e l se {
X i i = L 0 i i , L f i i , J ( rows ( U t i i ) , 1 , 1 )
X i = ( L0 i , L f i ) : ∗ R1 [ . , i ] , J ( rows ( U t i ) , 1 , 1 )
}
b= invsym ( X i i ’ ∗ X i i ) ∗ X i i ’ ∗ U t i i
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EUt [ . , i ]= X i ∗ b
i f ( i >3) {
EUtim=Y2 [ , i −1 ] : ∗ e d i t v a l u e ( Uts r [ , i − 1 ] , . , 0 ) + (1 :−Y2 [ , i −1]) : ∗ e d i t v a l u e ( EUt [ , i
] , . , 0 )
EUt [ , i −1]=EUtim
}
}
Utdr = e d i t v a l u e ( EUt : ∗ Cdr , . , 0 )
Uts = I : ∗ Uts
Uts = e d i t v a l u e ( Uts , . , 0 )
U= Uts : + Utdr
Up=rowsum (U)
return ( Up )
}
end
c a p t u r e mata : mata drop ges tdp5 ( )
mata
r e a l s ca la r ges tdp5 ( r e a l s ca la r q )
{
e x t e r n a l R , Xcensp , Xexpp , Cx
i f ( Cx ==1) Ud p=Xcensp , Xexpp , ges tdda12d (q )
i f ( Cx ==0) Ud p=Xexpp , ges tdda12d (q )
X c o l s = c o l s ( Ud p )
n1=rows ( Ud p )
U= colsum ( Ud p )
sigma =n1 ∗ v a r i a n c e ( Ud p )
i s i g m a = invsym ( sigma )
t =U[ , X c o l s ] ∗ i s i g m a [ Xco l s , X c o l s ] ∗U[ , X c o l s ] ’
r e t u r n ( t )
}
end
∗EXPDR−AIPCw E s t i m a t i n g Equat ion and S c o r e S t a t i s t i c
c a p t u r e mata : mata drop g e s t d d a 1 2 c c d r 1 ( )
mata
r e a l m a t r i x g e s t d d a 1 2 c c d r 1 ( r e a l r o w v e c t o r q )
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{
e x t e r n a l CPP , CP , L , L0 , X , C , Y , Y2 , A , I
L f = s q r t ( L )
c o l = c o l s ( Y )
row=rows ( Y )
Cdr=CPP : / C
Cdr=1:−Cdr
R1=CPP : ˜ = .
R1= e d i t v a l u e ( R1 , 0 , . )
R2=CP
R2= e d i t v a l u e ( R2 , 0 , . )
Uts0 = g e s t X t g p c c d r 1 ( q )
Uts0c = c o l s ( Uts0 )
Uts = e d i t v a l u e ( Uts0 [ , Uts0c ] , . , 0 )
Ut s r = Uts
Ars =A
f o r ( i = 1 ; i<=c o l ; i = i + 1 ) {
Ars [ . , i ]= rowsum ( A [ . , ( 1 : : i ) ] )
}
EUt= J ( row , co l , . )
EUtR=EUt
EUt [ . , c o l ]= Uts r
f o r ( i = c o l ; i >=3; i = i −1) {
U t i =EUt [ . , i ] : ∗ R2 [ . , i ] : ∗ C [ . , i ]
U t i i = s e l e c t ( Uti , U t i [ , 1 ] : ˜ = . )
At=A [ . , i ]
L i = s e l e c t ( L , X [ . , 2 ] : = = i )
L f i = s e l e c t ( Lf , X [ . , 2 ] : = = i )
A L f i =At : ∗ L f i
A L L f i =At : ∗ L f i : ∗ L f i
ALLLf i =At : ∗ L f i : ∗ L f i : ∗ L f i
L 0 i = s e l e c t ( L0 , X [ . , 2 ] : = = i )
AL0i =At : ∗ L 0 i
Ai =At : ∗ R2 [ . , i ]
L 0 i a = L 0 i : ∗ R2 [ . , i ]
AL0ia = AL0i : ∗ R2 [ . , i ]
A L f i a = A L f i : ∗ R2 [ . , i ]
A L L f i a = A L L f i : ∗ R2 [ . , i ]
ALLLf ia = ALLLf i : ∗ R2 [ . , i ]
A i i = s e l e c t ( Ai , Ai [ , 1 ] : ˜ = . )
L 0 i i = s e l e c t ( L0 ia , L 0 i a [ , 1 ] : ˜ = . )
A L 0 i i = s e l e c t ( AL0ia , AL0ia [ , 1 ] : ˜ = . )
A L f i i = s e l e c t ( ALf ia , A L f i a [ , 1 ] : ˜ = . )
A L L f i i = s e l e c t ( ALLf ia , A L L f i a [ , 1 ] : ˜ = . )
A L L L f i i = s e l e c t ( ALLLf ia , ALLLf ia [ , 1 ] : ˜ = . )
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X i i = A i i , A L f i i , A L L f i i , AL0 i i , J ( rows ( A i i ) , 1 , 1 )
X i = ( At , ALf i , ALLf i , AL0i ) : ∗ R1 [ . , i ]
X i = Xi , J ( rows ( U t i ) , 1 , 1 )
b= invsym ( X i i ’ ∗ X i i ) ∗ X i i ’ ∗ U t i i
EUt [ . , i ]= X i ∗ b
i f ( i >3) {
EUtim=Y2 [ , i −1 ] : ∗ Uts r + (1 :−Y2 [ , i −1]) : ∗ e d i t v a l u e ( EUt [ , i ] , . , 0 )
EUt [ , i −1]=EUtim
}
}
Utdr = e d i t v a l u e ( EUt : ∗ Cdr , . , 0 )
Uts = I : ∗ Uts
Uts = e d i t v a l u e ( Uts , . , 0 )
U= Uts : + Utdr
Up=rowsum (U)
r e t u r n ( Uts0 [ , ( 1 : : Uts0c−1) ] , Up )
}
end
c a p t u r e mata : mata drop g e s t d p 5 c c d r 1 ( )
mata
r e a l s c a l a r g e s t d p 5 c c d r 1 ( r e a l s c a l a r q )
{
e x t e r n a l Xcensp , Xexpp , Cx
i f ( Cx ==1) Ud p=Xcensp , Xexpp , g e s t d d a 1 2 c c d r 1 ( q )
i f ( Cx ==0) Ud p=Xexpp , g e s t d d a 1 2 c c d r 1 ( q )
X c o l s = c o l s ( Ud p )
Ud p=Ud p [ , X c o l s ]
X c o l s = c o l s ( Ud p )
n1=rows ( Ud p )
U= colsum ( Ud p )
sigma =n1 ∗ v a r i a n c e ( Ud p )
i s i g m a = invsym ( sigma )
t =U[ , X c o l s ] ∗ i s i g m a [ Xco l s , X c o l s ] ∗U[ , X c o l s ] ’
return ( t )
}
end
∗ o p t i m i s a t i o n o f s c o r e s t a t i s t i c
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∗− s c o r e s t a t i s t i c f u n c t i o n g e s t s e s t ( )
∗− Nelder Mead s t a r t i n g v a l u e r s 1 s and s t e p s i z e r s 1 d
cap mata : mata drop s i ( )
mata
v o i d s i ( todo , x , y , g , H)
{
y= g e s t s e s t ( x )
}
end
c a p t u r e mata : mata drop opt nm ( )
mata
r e a l m a t r i x opt nm ( r e a l r o w v e c t o r q )
{
S= o p t i m i z e i n i t ( )
o p t i m i z e i n i t w h i c h ( S , ” min ” )
o p t i m i z e i n i t e v a l u a t o r ( S , & s i ( ) )
o p t i m i z e i n i t e v a l u a t o r t y p e ( S , ” d0 ” )
o p t i m i z e i n i t t e c h n i q u e ( S , ”nm” )
o p t i m i z e i n i t p a r a m s ( S , q [ 1 ] )
o p t i m i z e i n i t n m s i m p l e x d e l t a s ( S , q [ 2 ] )
o p t i m i z e i n i t t r a c e l e v e l ( S , ” t o l e r a n c e ” )
o p t i m i z e i n i t c o n v p t o l ( S , . 0 0 0 1 )
o p t i m i z e i n i t c o n v m a x i t e r ( S , 5 0 )
r s = o p t i m i z e ( S )
return ( r s )
}
end
no i : mata
r s = r s 1 s
rd = r s 1 d
r s d = r s 1 s + r s 1 d
f 0 = g e s t s e s t ( r s )
f0m= g e s t s e s t ( r s d )
i f ( f0 <100) {
while ( m r e l d i f ( f0m , f 0 ) > . 001) {
rs , f0 , f0m , m r e l d i f ( f0m , f 0 ) , rd
f0m= f 0
rsm= r s
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r s = round ( opt nm ( ( rs , rd ) ) , . 0 0 1 )
f 0 = g e s t s e s t ( r s )
rd = round ( abs ( ( rsm:− r s ) / 2 ) , . 0 0 1 )
i f ( rd < . 0 02 ) rd = 0 . 0 0 2
i f ( rd>r s 1 d ) rd = r s 1 d
/ / i f ( f0 <1) nm d = ( . 5 , . 0 1 )
}
rs , f 0
}
e l se {
r s = .
}
end
∗ v a r i a n c e c a l c u l a t i o n
∗− g e n e r i c s c o r e s t a t i s t i c f u n c t i o n g e s t s e s t ( )
mata
r s 1 5 = .
r s 1 9 5 = .
r s 1 e = .
r s 2 5 =−1
r s 2 9 5 =−1
r s 2 e =−1
s = . 0 0 0 0 1
i f ( r s 1 ˜ = . ) {
f 0 = round ( g e s t s e s t ( r s 1 ) , s )
f 0 1 = round ( g e s t s e s t ( r s 1 + 0 . 5 ) , s )
i n c b = round ( ( f01−f 0 ) / . 5 , s )
i n c b
}
p t o l =10 e−4
p=1
c h i s q = round ( i n v c h i 2 ( p , . 9 5 ) , . 0 1 )
c h i s q
i f ( f0<=c h i s q ) {
c i r o w s =800
i n c b = round ( ( ( ch i sq−f 0 ) / i n c b ) / 4 , s )
i n c b
mu= J ( c i rows , 5 , . )
su= round ( r s1 , s )
f = f 0
nc =0
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i n c = i n c b
i f ( abs ( su )<=i n c ) i n c = 1 . 1 ∗ abs ( su )
j =1
mu[ j , 1 ] = round ( su , s )
mu[ j , 2 ] = round ( f , s )
mu[ j , 3 ] = m r e l d i f ( f , c h i s q )
mu[ j , 5 ] = round ( inc , s )
mu[ j , 4 ] = round ( i n c ∗ m r e l d i f ( f , c h i s q ) , s )
while (mu[ j ,2]<= c h i s q & mu[ j ,3]> p t o l & j<c i r o w s & nc ==0) {
j = j +1
mu[ j , 1 ] = round (mu[ j −1 ,1]+mu[ j −1 ,4 ] , s )
mu[ j , 2 ] = round ( g e s t s e s t (mu[ j , 1 ] ) , s )
mu[ j , 3 ] = m r e l d i f (mu[ j , 2 ] , c h i s q )
i f ( j >=5) {
i f (mu[ j , 3 ] / mu[ j −4 ,3]>=.9) i n c = 1 . 1 ∗ i n c
i f (mu[ j , 3 ] / mu[ j −4 ,3]<=.1) i n c = . 9 ∗ i n c
}
mu[ j , 5 ] = round ( inc , s )
mu[ j , 4 ] = round ( i n c ∗mu[ j , 3 ] , s )
ru =mu[ j , 1 ]
i f ( j >=50) {
i f (mu[ j , 2 ] = =mu[ j −49 , 2 ] ) nc =1
}
mu[ j , ]
}
mu [ ( 1 : : j ) , . ]
i f ( j<c i r o w s&nc ==0) r s 1 9 5 = ru
ml= J ( c i rows , 5 , . )
s l = round ( r s1 , s )
f = f 0
nc =0
i n c = round ( incb , s )
i f ( abs ( su )<=i n c ) i n c = 1 . 1 ∗ abs ( su )
j =1
ml [ j , 1 ] = round ( s l , s )
ml [ j , 2 ] = round ( f , s )
ml [ j , 3 ] = m r e l d i f ( f , c h i s q )
ml [ j , 5 ] = round ( inc , s )
ml [ j , 4 ] = i n c ∗ m r e l d i f ( f , c h i s q )
while ( ml [ j ,2]<= c h i s q & ml [ j ,3]> p t o l & j<c i r o w s & nc ==0) {
j = j +1
ml [ j , 1 ] = round ( ml [ j −1,1]−ml [ j −1 ,4 ] , s )
ml [ j , 2 ] = round ( g e s t s e s t ( ml [ j , 1 ] ) , s )
ml [ j , 3 ] = m r e l d i f ( ml [ j , 2 ] , c h i s q )
i f ( j >=5) {
i f ( ml [ j , 3 ] / ml [ j −4 ,3]>=.9) i n c = 1 . 1 ∗ i n c
i f ( ml [ j , 3 ] / ml [ j −4 ,3]<=.1) i n c = . 9 ∗ i n c
}
ml [ j , 5 ] = round ( inc , s )
ml [ j , 4 ] = round ( i n c ∗ ml [ j , 3 ] , s )
r l =ml [ j , 1 ]
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i f ( j >=50) {
i f ( ml [ j , 2 ] = = ml [ j −49 , 2 ] ) nc =1
}
ml [ j , ]
}
ml [ ( 1 : : j ) , . ]
i f ( j<c i r o w s&nc ==0) r s 1 5 = r l
r s 1 e = ( r s 1 9 5 − r s 1 5 ) / ( 2 ∗ 1 . 9 6 )
}
end
5.8.5 Aributable eect of Healthcare-associated infection
on mortality
Although the estimation of this eect has been looked at in many studies and
research articles, the results remain controversial with for example relative risk
estimates for the mortality eect of pneumonia acquired in the ICU - a common
type of HAI - ranging from being harmful to neutral. This has raised the long-
standing research question whether patients in the ICU tend to die ”from” or
”with” infection (Carlet, 2001), the former statement implying that infection indeed
causally aects survival, the laer that it is merely an eect of other events that
eventually lead to death. Research for a precise and well-defined aributable eect
of infection on mortality and into a correct method for its estimation is needed
because it provides healthcare professionals with the exact information on the
costs (both in terms of mortality as morbidity) that arise when a patient acquires a
HAI, and because it provides input (in terms of results to be expected) for hospitals
wanting to implement infection control strategies for the prevention of HAI (Frank,
2007).
Exposure to infection being non-randomised and time-dependent implies that
the analysis for the aributable eect must adjust for time-dependent confounders
of the exposure-mortality relationship. This is challenging, both in terms of finding
a methodology that gives interpretable eect estimates and in obtaining data
containing information to enable suicient adjustment. As mentioned above,
standard stratification-based methods, such as the adjusted Cox proportional
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hazards model, are known to give biased eects when these are stratified for
time-dependent confounders that act as cause and eect of exposure at dierent
time points. Such models are therefore particularly problematic when aiming to
estimate lagged eects of exposure to infection on mortality, such as the eect on
mortality at time t of onset of infection up to (at least) d days previously, and this
with the aim to get insight in the burden of infection immediately or late aer its
onset.
In terms of finding valid data to estimate the aributable eect of infection,
ongoing interest in the prevention of ICU-acquired infection has lead to many
patient-based surveillance studies in which besides baseline information collected
at the patient’s admission to the ICU also daily information on clinical exposures
and outcomes has become available. Because these daily measured variables can be
considered as proxy information for the patient’s daily changing health status, they
are candidates for adjusting the crude eect of infection on mortality. However,
when relying on ICU surveillance studies for studying a patient’s survival, a further
challenge is that only data on a patient’s follow-up within the ICU are available.
This implies that survival times of patients that recovered and were at some point
discharged from the ICU will be unobserved or censored. This type of censoring
is typically non-administrative because for each ICU patient it may happen at a
dierent time-point, and dependent on his or her health status at that time-point.
The consequence is also that only a minority of patients that died in the ICU will
have an actually observed survival time. Typical ICU follow-up data of survival will
also include administrative censoring at a time-point Tm, aer which the remaining
subjects of the original cohort are too low-numbered and specific to justify further
follow-up.
The “NSIH-ICU” follows the “Hospitals in Europe link for infection control
through surveillance (HELICS)” protocol which is the common standard for Euro-
pean networks wanting to conduct surveillance of ICU-acquired infections (Suetens
et al., 2007; Mertens et al., 2013). ICUs participating in national surveillance need to
collect data on the occurrence of ICU-acquired infections for all patients admied
to the ICU during 3 consecutive months. Besides this, specific follow-up data on
each patient’s daily exposure to a set of clinical exposure variables needs to be
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Baseline Daily-varying
gender mechanical ventilation
multiple trauma central vascular catheter
acute coronary care presence of naso or oro-intestinal tube
age feeding through a naso or oro-intestinal tube
SAPS II score parenteral feeding
prior surgery stoma feeding
type of admission nasal/oral intubation
AB use in 48h before or aer admission tracheotomy intubation
Table 5.3: Lt variables available for adjusting the aributable
eect of ICU-acquired infection on mortality; Age categories
< 40, 40 − 59, 60 − 69, 70 − 74,≥ 80; SAPS=Simplified acute
physiology, categories < 20, 20 − 39, 40 − 59,≥ 60; Type of
admission categories Medical/ Scheduled surgery/ Unscheduled
surgery; AB use=Antibiotic, categories None/ Prophylactic/ Ther-
apeutic/ Combination; Surgery categories None/ Elective/ Urgent.
collected; see Table 5.3 for a description of all collected variables.
5.8.6 Procedure for weight truncation
To prevent extreme weights, IPC weights were truncated in the following way.
Going backwards from the last day to the first, we will truncate these probabilities
to fit within the range [1/wtrunc, wtrunc], that is, whenever
∏t
T pis(V s)/pis(V 0) ex-
ceeds wtrunc or is lower than 1/wtrunc, we will put pit(V t) = pit(V 0) at days 1, .., t,
which will stabilise the calculation of (5.11) at these time points. If necessary,
this procedure will truncate for each subject his or her pit(V t) and corresponding
pit(V t) = pit(V 0) values during the first few days of follow-up. The truncated
probabilities will aect the A-IPCW estimator both through IPC weights Wt in
the term for complete cases as well as through the censoring probabilities pit(V t)
in the augmentation term for all subjects. The set of weight truncation ranges
[1/wtrunc, wtrunc]. wtrunc was chosen to be (5, 10, 21.4), the first two values arbitrarily,
while the last value corresponded to a truncation of inverse cumulative stabilised
conditional censoring probabilities outside the 99 percentiles range (discussed in
main paper).
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5.8.7 Full data modelling
To facilitate the full data modelling process of the Simulation study, we constructed
residual plots for each of the Tm = 10 time-points at which a full data model
(5.16) was estimated. Construction of these plots proved to be useful specifically
under the simulation scenarios with IPC weights set to 1, with unbiasedness
of augmented estimators A-IPCW and EXPDR-A-IPCW thus completely relying
on correct specification of the full data model. Plots were constructed for the
converging value of ψ, and showed for a particular full data model the residual
versus the fied value. Observations where ploed according to exposure status
at t (the time at which the model was constructed) and/or at T (the time of the
subject’s outcome or administrative censoring). Figures 5.1-5.4 show these plots for
A-IPCW and EXPDR-A-IPCW estimators, each figure starting with full data model
at Tm = 10. For both A-IPCW and EXPDR-A-IPCW estimators under the scenario
where IPC weights were set to 1, we compare the residual plots generated under a
“general” full data model with main eects (A,L,AL) that yielded an empirically
biased estimator with those generated under a “specific” full data model giving
unbiased (or least-biased) empirical estimators. Plots are those of the first run of a
simulation, with a true exposure eect ψ0 = −0.25.
For both estimators A-IPCW and EXPDR-A-IPCW, the plots were useful in
detecting non-linearities in the residuals generated by a “general” full data model
at time t = 10 with main eects (A,L,AL), see plots at “day 10” of Figures
5.1 and 5.3. This was resolved by constructing a full data model based on poly-
nomial main eects of the confounder L, therefore resulting in main eects
(L,LL,LLL,A, LA,LLA) and (A,LA,LLA,LLLA) for A-IPCW and EXPDR-
A-IPCW estimators, respectively (see plots at “day 10” of Figures 5.2 and 5.4).
Allowing for nonlinearities in the full data model also has the eect of making
the range of residuals more compact, as seen when going from a min-max range
[−2.1, 0.7] in the first plot of Figure 5.1 to range [−0.5, 0.2] in the first plot of
Figure 5.2. Such compacter range of residuals might explain why A-IPCW and
EXPDR-A-IPCW estimators under IPC weights set to 1, besides being unbiased,
also have lowest empirical variance.
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Even under a full data model that gives unbiased empirical results for the
estimator, we see regions with outlying observations in the residual plots, indicating
that lack of fit of a full data model does not necessarily aect the unbiasedness
of an estimator. This can be seen in the plots at day 1 of Figures 5.2 and 5.4,
in which we see outlying regions of observations for both A = 0 and A = 1,
with a clearly defined region for observations having (At = 0, AT = 1), marking
those observations that are unexposed at t but gaining exposure later on. Using
information beyond time t in a full data regression model at time t would violate
ICA, the question therefore remains whether it is possible at all to find full data
models that can handle such outlying residuals, and if so, how this would aect
the estimator’s empirical properties (bias as well as variance).
The EXPDR-A-IPCW estimator only gave unbiased results under a full data
model with prognostic variable L strictly entering the model through interactions
with A. A hypothesis for this is that the EXPDR-A-IPCW estimator is based on
functional g{T0(ψ)} that uses a proportional hazards regression model having L
as main eect, and therefore can be considered as already partly adjusting for L,
but this needs to be investigated.
Figures 5.5 and 5.6 show similar residual plots for full data models used for the
Application’s A-IPCW and EXPDR-A-IPCW estimators, respectively. Also here,
we give results for the full data models constructed when IPC weights were set
to 1, and this from day 30 to day 3 (augmentation stops at day 3 because no
loss to follow-up occurs during the first 2 days), and using 3−day intervals. For
the A-IPCW estimator, despite absence of nonlinearities in the residual plot at
day 30, outlying residuals for observations under exposure are visible at all days
until day 6. These are due to the lag-eect (4 days) being set on the variables
encoding exposure status in the full data models, and which were omied from the
models for days 6− 3. The last residual plot (at day 3) for this estimator shows a
small group of observations under absence of exposure where residuals are linearly
related to predictions, which indicating lack of fit for these observations. Such
problems were not seen for the EXPDR-A-IPCW estimator, despite the diiculty of
this estimator’s full data model to adequately model observations under absence
of exposure.
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Figure 5.1: Simulation: plot of residual versus predictions for the full data regression
model as used by the AIPCW estimator with censoring weights set to 1, example of
one simulation repetition, full data model main eects (L,A,LA).
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Figure 5.2: Simulation: plot of residual versus predictions for the full data regression
model as used by the AIPCW estimator with censoring weights set to 1, example of
one simulation repetition, full data model main eects (L,LL,LLL,A,LA,LLA).
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Figure 5.3: Simulation: plot of residual versus predictions for the full data regression
model as used by the EXPDR-AIPCW estimator with censoring weights set to 1, example
of one simulation repetition, full data model main eects (L,A,LA).
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Figure 5.4: Simulation: plot of residual versus predictions for the full data regression
model as used by the EXPDR-AIPCW estimator with censoring weights set to 1, example
of one simulation repetition, full data model main eects (A,LA,LLA,LLLA).
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Figure 5.5: Application: plot of residual versus predictions for the full data regression
model as used by the AIPCw estimator with censoring weights set to 1 and with full
data model main eects (A,A,L, L0).
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Figure 5.6: Application: plot of residual versus predictions for the full data regression
model as used by the EXPDR-AIPCW estimator with censoring weights set to 1 and
with full data model main eects (A,LA,LLA,L0A).
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5.8.8 Application: preliminary gridsearches for one- and two-
parameter estimators
Figures 5.7-5.14 show results of preliminary gridsearches that were obtained during
optimisation of the Application’s one- and two-parameter IPCW, EXPDR-IPCW,
A-IPCW, and EXPDR-A-IPCW estimators, and this for all studied truncation sce-
narios. Roots of these gridsearches were subsequently used as starting values in a
Nelder-Mead optimisation for each estimator, using half the gridsearch stepsize as
optimisation stepsize.
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Figure 5.7: plot of Score statistic S versus candidate ψ values for the overall eect of
Ventilator-associated pneumonia on mortality, IPC weight truncation [1]; IPC=Inverse
probability of censoring.
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Figure 5.8: plot of Score statistic S versus candidate ψ values for the overall ef-
fect of Ventilator-associated pneumonia on mortality, IPC weight truncation [.2-5];
IPC=Inverse probability of censoring.
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Figure 5.9: plot of Score statistic S versus candidate ψ values for the overall ef-
fect of Ventilator-associated pneumonia on mortality, IPC weight truncation [.1-10];
IPC=Inverse probability of censoring.
184
55.8. Appendix
Figure 5.10: plot of Score statistic S versus candidate ψ values for the overall eect
of Ventilator-associated pneumonia on mortality, IPC weight truncation [1p-99p];
IPC=Inverse probability of censoring.
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Figure 5.11: Contour plot of Score statistic S versus candidate ψ1 and ψ2 values for
the joint eect of Ventilator-associated pneumonia (days 1-4 versus aer 4th day of
infection), IPC weight truncation [1]; IPC=Inverse probability of censoring.
186
55.8. Appendix
Figure 5.12: Contour plot of Score statistic S versus candidate ψ1 and ψ2 values for
the joint eect of Ventilator-associated pneumonia (days 1-4 versus aer 4th day of
infection), IPC weight truncation [.2-5]; IPC=Inverse probability of censoring.
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Figure 5.13: Contour plot of Score statistic S versus candidate ψ1 and ψ2 values for
the joint eect of Ventilator-associated pneumonia (days 1-4 versus aer 4th day of
infection), IPC weight truncation [.1-10]; IPC=Inverse probability of censoring.
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Figure 5.14: Contour plot of Score statistic S versus candidate ψ1 and ψ2 values for
the joint eect of Ventilator-associated pneumonia (days 1-4 versus aer 4th day of
infection), IPC weight truncation 1-99 percentiles; IPC=Inverse probability of censoring.
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Concluding remarks
6.1 Summary of results
We used data from the National surveillance of infections acquired in intensive
care units (NSIH-ICU) (see Chapter 2) to estimate the aributable mortality of
Healthcare-associated infection (HAI). Particularly in the intensive care literature,
the analysis of this eect gives controversial results. This controversy was con-
firmed when using standard stratification-based methods for confounder adjust-
ment (such as cross-sectional logistic regression or time-dependent proportional
hazards regression) to estimate this eect, with estimated aributable mortality
eects that ranged from being protective to risk increasing depending on the
statistical method that was applied on the same data.
A major problem with standard methods is their diiculty on how to adjust
properly for confounding of the relation between the time-dependent variable
“exposure to HAI” and the outcome variable “mortality”. This is particularly chal-
lenging in the presence of time-dependent prognostic variables that act as cause
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and eect of exposure at dierent time points. In the Introduction (Chapter 1),
we give an overview of the key facts that show why standard stratification-based
methods may give a biased estimate of the joint or aggregate causal aributable
mortality eect whether or not regression adjustment is made for such variables,
and this due to time-dependent confounding of the exposure-outcome relationship.
Another problem is the diiculty of how to account for subjects that drop out of
the study before the end of follow-up time. In our study, this comes in the form of
Intensive care unit (ICU) patients that are being discharged alive from the unit,
and therefore have a survival time outcome that is unobserved or censored. When
the reason for such drop-out is linked to prognostic factors that also aect survival
time, this will lead to selection bias. We then showed how estimators from causal
inference, such as Inverse probability weighting under Marginal structural models
and G-estimation under Structural nested models, can avoid the aforementioned
issues and deliver estimates with causal interpretation.
In a first stage, we opted for the use of Inverse probability of exposure and
censoring weighted (IPECW) estimation under a Marginal structural proportional
hazards model (MSPHM) (Chapter 3). However, the strong association of certain
prognostic factors with censoring coupled with the multitude of time-points lead
to very low estimates of the cumulative probability of remaining under follow-
up, resulting in extremely high Inverse probability of censoring (IPC) weights for
certain patients. Truncation of these weights was thus needed, with the resulting
causal eect estimate being possibly biased.
To resolve this, we developed two estimators of joint causal eects that allow
for less dependence on (extreme) IPC weights. In the first, IPECW estimation
under a Marginal structural proportional hazards model for partial exposure regimes
(MSPHM-P) (Chapter 4), we analysed aributable mortality at discharge from the
hospital, which is a less sensitive study outcome compared to mortality at discharge
from the unit. We also used a regime defined by “being exposed to infection while
remaining in the unit” that involves multiplication of inverse probability weights
over less subject days, and therefore poses a smaller risk of these weights becoming
too influential.
The second estimator that we proposed, Augmented Inverse probability of cen-
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soring weighted (A-IPCW) G-estimation under Structural nested accelerated failure
time model (SNFTM) (Chapter 5) avoids the use of inverse probability of exposure
weights, and also yields estimates of the aributable eect that remain unbiased
under misspecification of either the model for the censoring mechanism or either
a model for the full data. This last property of doubly-robustness then allows to
ignore IPC weighting completely, for example by seing IPC weights to 1 for all
patients. Of equal importance is that the A-IPCW G-estimator provides improved
eiciency compared to the standard Inverse probability of censoring weighted
(IPCW) G-estimator, and this because it is able to use data from all patients instead
of only those with observed or administratively censored survival time.
The proposed estimators are used in the analysis of the aributable eect on
mortality of three types of ICU-acquired infections: ICU-acquired pneumonia,
Ventilator-associated pneumonia (VAP), and Bloodstream infection (BSI), using
historical multicentric data from the NSIH-ICU program (Chapters 3,4,5).
The proposed estimators are certainly worthwhile in their features of providing
eect estimates with causal interpretation (IPECW, IPCW and A-IPCW estimators)
and with the property of being doubly-robust and/or having improved eiciency
(A-IPCW G-estimator under a SNFTM); however their application to the case study
at hand did not entirely resolve the issues surrounding extreme IPC weights. For
estimation under a MSPHM-P, the combined inverse probabilities for exposure and
for remaining uncensored still lead to influential values to such extent that only
regimes up to a certain time-point could be studied. For the A-IPCW G-estimator,
full data modelling became increasingly diicult when IPC weights were set to 1.
In the next Section, we explain how censored data can lead to both extreme IPC
weights as well as diiculties in full data modelling. Therefore, the research for
this problem does not stop here, and in what follows we give an overview of topics
that we think warrant further investigation.
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6.2 Further research
6.2.1 Inverse weighting versus augmentation to adjust for
non-ignorable censoring
As previously mentioned, for IPCW estimators under both the MSPHM and the
SNFTM, the estimated IPC weights had to be truncated in order for these estima-
tors to converge. The group of subjects with extreme weights was more restricted
when estimating under a SNFTM as compared to a MSPHM, because the standard
G-estimator only uses observations from subjects with observed survival time or
complete follow-up, which is a very selective group of subjects within the complete
group. This has lead us to propose an A-IPCW G-estimator for the parameters
of a SNFTM, which guarantees unbiased estimation of these parameters that is
doubly-robust against misspecification of either a model for censoring or a model
for the full data. We hereby followed Tan (2007)’s reasoning that the logical way
in which Inverse probability weighted (IPW) estimators are further improved is
by reducing the bias and/or variance of the estimates of their parameters. While
our study is novel in that we connected G-estimation with augmented estimation,
recent literature on doubly-robust estimation has shown that further improve-
ments in eiciency are still possible. Indeed, while doubly-robust IPW estimators
may behave well under correct specification of both working models, they lose
this property when at least one of these models is misspecified (Kang and Schafer,
2007). Vansteelandt (2012) showed that the standard IPW estimator can be very
sensitive towards misspecification of the propensity scores model in regions of
prognostic factors L with very low overlap of the variable for which confounding
with the outcome is to be resolved (in our case censoring), meaning those subjects
or their time-point contributions with propensity score close to 0 or 1, and that
such bias will be hardly resolved in a doubly-robust IPW estimator with minor mis-
specification of the outcome regression model. Vansteelandt and Joe (2014) also
demonstrated that such “extreme” propensity scores will lead to inflated variance
of both the standard and the doubly-robust IPW estimator, and therefore to impre-
cise estimates. With these issues in mind, recent years have seen new versions of
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doubly-robust IPW estimators with the specific objective of minimising bias and/or
variance when one or both working models have been misspecified (Bang and
Robins, 2005; Robins et al., 2007; Tan, 2007, 2008; Cao et al., 2009; Tsiatis et al., 2011;
van der Laan and Rose, 2011; Rotnitzky et al., 2012; Vermeulen and Vansteelandt,
2014). The simulation experiments of these studies specifically demonstrate good
behavior in the presence of extreme and influential inverse probability weights. As
many estimators proposed in this study rely on IPW, with those of Chapters 3 and
5 specifically relying on truncated IPC weights, which can be seen as deliberate
misspecification of the propensity score model, these estimators are therefore
victim to the issues mentioned above. A future strategy is therefore to verify
what recent techniques for doubly-robust IPW estimators could oer to data with
extreme IPC weights under many time-points (such as ours).
Next to the development of the A-IPCW G-estimator, we elaborated on other
strategies to cope with extreme IPC weights in Chapter 5 on SNFTMs. One strategy
builds on the observation that the A-IPCW G-estimator yields its best results in
terms of precision when IPC weights were set to 1, and this both in the simulation
study as the application. Furthermore, the simulation study showed that this low
precision could be accompanied with unbiasedness of the causal eect through
careful construction of the full data model. In the context of our case study where
we were forced to truncate (and deliberately misspecify) IPC weights in order for
the G-estimation to converge, a valid approach might therefore be to abandon
IPC weighting and direct all aention to full data modelling. Because the IPECW
estimator under a MSPHM used in Chapter 3 also relied on (truncated) IPC weights
and equally suered from inflated variance, it would be worthwhile to develop an
A-IPCW estimator under a MSPHM that would allow seing IPC weights to 1 in
the same way as for the A-IPCW G-estimator. The augmentation algorithm under a
MSPHM will likely dier from the one used under the SNFTM, unless the MSPHM’s
estimating equation is restricted to subjects with observed or administratively
censored survival time.
Continuing with the scenario where IPC weights were set to 1, we experienced
in our case study many problems in achieving convergence of particular versions
of the A-IPCW G-estimator. This was due to strong correlation of the exposure
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event with the outcome in the group of subjects with observed outcome. Let us
hypothesise that, at a particular study time-point t, very limited overlap exists in the
joint distribution of (Lt,At) between censored and uncensored subjects. In an IPCW
estimator, this can lead to Ct = 1 (censoring) being set almost deterministically
for particular strata formed by (Lt,At). This will result in very low probabilities
for non-censoring and in extreme weights, to an extent that these need to be
truncated in order to achieve convergence of the estimator. Therefore, for the
IPCW estimator, the issue will be non-positivity of the conditional probability of
remaining uncensored. In a full data augmentation procedure, due to particular
strata containing lile info on censoring at t, it might be diicult to correctly
postulate a model for the mean full data outcome for non-censored subject days,
which results in lack of fit and high residuals for these subject-days. The inverse is
possible as well, with a good fiing full data model for non-censored subject days
that however gives bad predictions for censored subject days. Such problems can
then be exacerbated during augmentation over censored subjects and recursively
over all time-points. The result of this is an estimating function with high variance
of individual contributions and/or diiculties to reach a meaningful minimum for its
average. Therefore, for the augmented estimator, the issue will be extrapolation, or
the full data model needing to extrapolate its predictions over particular covariate
regions made up by the distribution of (Lt,At) with very low overlap between
Ct = 0 and Ct = 1. In this light, the problems with the A-IPCW G-estimator
under IPC weights set to 1 might seem expected, especially because we performed
augmentation on the same data that lead to extreme IPC weights in the first place.
A future research strategy would be to investigate the possible common reasons
for non-positivity and extrapolation, as well as remedies for these issues. In the
seing of inverse probability of exposure weighting, Kurth et al. (2005); Crump et al.
(2009) suggest to remove from the analysis those subjects with low propensity of
exposure, the rationale being that these represent a particular subgroup of patients
for which it is unrealistic (based on subject maer) to formulate a counterfactual
or population outcome. However, applying such reasoning to subgroups with
high propensity for being censored will be problematic if the factors that lead to
such high propensity are not clearly defined. Furthermore, when A and L are
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time-dependent, it will be equally problematic to base exclusions of observations
on strata formed by (At, Lt). To illustrate this, consider again causal Directed
acyclic graph (DAG) 1.7 of Chapter 1 that represents the data aer applying IPECW.
Now consider the situation where we remove from the data particular strata of
L2 and A2 due to these giving extreme IPC weights. Stratification on L2 will then
generate time-dependent confounding and bias of the causal eect of A1 on Y2,
while stratification on A2 might lead to impossible estimation of the eect of A2
on Y2. For these reasons, removing particular strata can only proceed if it strictly
relies on baseline variables. One practical solution to resolve non-positivity would
be to lower the study follow-up period Tm, as we did in Chapter 3 where we applied
MSPHMs.
It is important to note that the censoring event in our study marks the time-
point when a patient is discharged alive from the ICU. The link with a subject’s
underlying health status is therefore clearly established, to the extent that Ct = 1
marks the time-point where the patient is no longer in need of intensive care. This
way, it is not diicult to think of possible reasons for violation of positivity and
the corresponding need for extrapolation, for example by imagining that healthy
patients would be discharged while unhealthy patients need to remain in the ICU.
The IPCW and A-IPCW estimators work under the Ignorable censoring assumption
(ICA), meaning that (Lt,At), the measured covariate history up to t, is suicient to
predict censoring at t, without residual association with future survival. The eect
of a violation of this assumption due to omiing a particular prognostic factor can
be studied as follows (Vanderweele et al., 2008). Let exposure A have a protective
eect on censoring C (A = 1 leads to C = 0) and a harmful eect on outcome Y
(A = 1 leads to Y = 1). Let ICA be violated by an unknown common prognostic
factor U that causes censoring and outcome in the same way as exposure (U = 1
leads to C = 0 and to Y = 1). Restricting the analysis to subjects under follow-up
(C = 0) will then create a non-causal association between A and U because in
this subgroup A = 0 (U = 0) will be associated with U = 1 (A = 1), therefore
creating a negative relationship between A and U and as consequence a protective
eect of A on Y . The common cause U of C and Y can be seen as C being
negatively associated with Y , collider-stratification on C therefore creates the
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path A → U → Y , with negative eect on the first and a positive eect on the
second arrow. Applying this reasoning to our case study, the protective causal
eects of HAI on mortality we have found can be seen in light of such violation
of ICA. It is therefore a valid strategy to obtain supplementary measurements on
time-dependent prognostic factors to bring more predictive power in censoring
risk. If these factors have overlapping distributions over censored and uncensored
subjects, this might resolve the issues with respect to non-positivity as well.
6.2.2 Avoiding the ignorable censoring assumption
Given the comments of the previous Section, a valid strategy would be to investigate
methods for causal eect estimation that avoid ICA. The use of models for the
subdistribution hazard (Fine and Gray, 1999; Beyersmann and Schumacher, 2008)
falls in such strategy. In this so-called “competing risk” approach, the survival time
T now signifies the time-point t at which a subject experiences either the outcome
event (Yt = 1) or the censoring event (Ct = 1), these two now being called
competing events because they compete for first occurrence within each subject.
Using this approach and keeping with a discrete-time setup, the cause-specific
hazard of the outcome event Y is defined as:
λcsY (t) = P (Yt = 1|Yt−1 = 0 and Ct−1 = 0) (6.1)
while the subdistribution hazard of the outcome event Y is of the form:
λsdY (t) = P (Yt = 1|Yt−1 = 0 or Ct−1 = 1) (6.2)
Because the subdistribution hazard λsdY (t) conditions on (Yt−1 = 0 or Ct−1 = 1),
it will keep subjects in the risk set aer censoring, without any possibility of ex-
periencing the outcome event, and unlike the cause-specific hazard λcsY (t) that
uses as risk set those subjects under actual follow-up (Yt−1 = 0 and Ct−1 = 0).
Competing risk methods avoid the need for ICA: censored subjects remain in the
risk set, they do not experience the outcome event, so no assumptions are stated
with respect to the risk for outcome relative to subjects that were not censored.
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As a consequence, there will be no need to make use of IPC weighting or full data
augmentation to adjust for non-ignorable censoring. A competing risk analysis
is therefore less ambitious in the results that it delivers, by strictly focusing on
the outcome event at a patient’s end of follow-up, which might be due to censor-
ing. This is in relative contrast to an IPCW or A-IPCW estimator, which tries to
reconstruct or create an ICU population not being discharged alive. Models for the
subdistribution hazard have seen frequent use in studies of aributable mortality
of HAI (Wolkewitz et al., 2009). They suer from the same problems as standard
stratification-based regression methods however, by not taking into account time-
dependent confounding by prognostic variables aected by exposure, and as such
their parameters have no causal interpretation. Bekaert et al. (2009) developed and
applied a subdistribution hazard model for counterfactual outcomes, while Naimi
and Tchetgen Tchetgen (2015) proposed the use of subdistribution hazard models
within the parametric G-formula, both with the objective of obtaining estimators
with causal interpretation.
A strategy that avoids any adjustment for non-ignorable censoring would consist
in following all subjects until their length of follow-up reaches the administrative
censoring time. In the context of our study, this would mean that data has to be
collected on subjects aer these were discharged alive from the ICU. However,
many issues will arise when doing so; first, while the actual surveillance study is
straightforward in its practical organisation by only demanding eorts from ICU
sta, this will most certainly involve other partners when patients are followed
aer discharge from the unit. Second, the fact that censoring will be limited
to a fixed end of follow-up date will not avoid the need for adjustment of the
crude mortality eect of infection for time-dependent prognostic factors. These
factors will likely dier when a patient is followed inside versus outside the ICU, the
method therefore will need to take into account these dierent environments during
which adjustment needs to take place. A possibility is to ignore any adjustment
post ICU-discharge, similar to what we did in Chapter 4 were we analysed hospital
aributable mortality eects.
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6.2.3 G-Estimationunder a structural nested failure timemodel
Because a SNFTM directly models the survival time, the administrative censoring
time will need to be recalculated for each candidate value of the causal parameter
in the G-estimation procedure, leading to possible administrative re-censoring of
the counterfactual survival time. This can lead to information loss for the dierent
candidate parameters, due to mapping observed survival times into administra-
tively re-censored counterfactual survival times. As a consequence, irreguralities
will be created in the estimating function for ψ, a phenomenon which is actually
cited as one of the main issues preventing the adaptation of SNFTMs on a larger
scale (Joe et al., 2012). Structural nested cumulative hazard models (Young et al.,
2009; Martinussen et al., 2011; Piccioo et al., 2012) oer a solution for this prob-
lem, in that they avoid re-censoring by modelling the failure indicator at each
time-point. However, these are not without problems either, such as the risk of the
counterfactual outcome exceeding the logical boundaries of the binary outcome.
In Chapter 5, we proposed an Exposure risk doubly-robust (EXPDR)-IPCW G-
estimator, that oers robustness against misspecification of the model for expo-
sure, but that also yielded beer eiciency as compared to the standard IPCW
G-estimator. In future research, one could focus fully on the properties of this
particular estimator, and its added value relative to the standard (non robust)
G-estimator that uses gt{Xt,0(ψ),∆t,0(ψ), Lt} = ∆t,0(ψ) (the counterfactual ad-
ministrative re-censoring indicator). This last estimator is unstudied as well, as
our standard G-estimator was based on Xt,0(ψ), the counterfactual administrative
re-censored survival time. For the EXPDR G-estimator, it would also be interesting
to study the feasibility of obtaining a correctly specified proportional hazards
model for ∆t,0(ψ), particularly in scenarios where the model for the onset of expo-
sure is misspecified. Additionally, we can study a direct analogue of our proposed
EXPDR G-estimator for the standard G-estimator based on Xt,0(ψ), for example
by leing gt{Xt,0(ψ),∆t,0(ψ), Lt} = Xt,0(ψ) − E[Xt,0(ψ)|Lt, Yt−1 = CT = 0],
with E[Xt,0(ψ)|Lt, Yt−1 = CT = 0] postulating a linear regression model for the
re-censored counterfactual survival time. We expect this last estimator to bring
improvements in speed, which is particularly a problem of the actual EXPDR G-
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estimator as it includes the estimation of a hazard model within the G-estimation
procedure.
Speed is particularly an issue with our proposed A-IPCW and/or EXPDR G-
estimators, because these incorporate the estimation of the parameters of at least
one working model within the G-estimation procedure. It would be interesting
to verify the properties of these estimators under naive versions of estimated
working models, for example for a fixed value of the candidate causal parameter ψ.
While this approach would lose the property of doubly-robustness, it may keep
the improvements in eiciency as compared to the standard IPCW G-estimator.
6.2.4 Avoiding the sequential randomisation assumption
The imbalances of exposed and unexposed patient groups with respect to prog-
nostic variables and the need to rely on the Sequential randomisation assumption
(SRA) can be avoided when choosing randomised experiments as (alternative)
study type. Such experiments study groups of patients that are randomised for
particular intervention strategies for the prevention of HAI. Their primary outcome
is mostly onset of infection, but other outcomes such as mortality are considered
as well. A randomised experiment will oer more realistic estimates of the eect
of prevention strategies on the reduction of infection incidence and its eect on
mortality and morbidity, as compared to observational surveillance studies where
mortality eects are estimated by comparing groups of patients with and with-
out infection, therefore (unrealistically) hypothesising about all infections being
prevented (Klompas, 2010; Umscheid et al., 2011). However, the drawback of such
experiments is that, while designed properly for (already low) anticipated incidence
rates for particular types of infection, designing these studies for detecting dier-
ences in (the even lower) aributable mortality will lead to infeasibly high numbers
of patients to randomise. This renders the estimation of the aributable mortality
eect of preventive measures of HAI by means of randomised experiments only
practical when done by meta-analysis (Melsen et al., 2013). Also, the calculated
aributable mortality needs to be interpreted in light of the actual intervention(s)
that were studied, making it diicult to extrapolate findings of such studies for
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policy measures.
Data from randomised experiments can be used for the estimation of the at-
tributable mortality of infection, however such analysis will equally suer from
imbalances with respect to prognostic variables. In this case this is due to infection
status being collected post-randomisation and therefore associated with outcome
through common unmeasured prognostic variables. In such study design, and
under the assumption that the intervention will only aect the outcome through
infection, a technique such as Instrumental variable analysis (Greenland, 2000) is
needed. However, such analysis estimates the eect of exposure by verifying how
the risk of outcome changes when exposure would be avoided, therefore suering
from the similar drawback of using a counterfactual mortality outcome where all
infections are prevented.
6.2.5 Variance estimation
This work mainly focused on unbiased estimators for the joint causal eect of
time-dependent exposures, and by doing so neglected somewhat the issues on how
to estimate the variance or confidence interval of the proposed estimators. This is
however important, because even an estimator with the promise of being unbiased
will be of limited use when the estimate of its confidence interval is too high. The
estimators that we used rely on the estimation of nuisance parameters indexing
working models for inverse probability of censoring and/or exposure weights (for
IPECW and IPCW estimators), and a working model for the full data (A-IPCW G-
estimator). Estimation of the variance of the causal parameter of these estimators
will need to account for the uncertainty of nuisance parameters, failure to do so will
lead to a conservative estimate of the asymptotic variance (van der Laan and Robins,
2003; Tsiatis, 2006). Furthermore, in the case of an IPCW estimator for causal
parameter ψ that is doubly-robust under either a working model for IPC weights
indexed by φ or a full data model indexed by ξ (such as the A-IPCW G-estimator),
correct estimation of ξ (φ) will yield an estimator of the asymptotic variance of ψˆ
that does not depend on the estimation of φ (ξ) being accounted for (Tsiatis, 2006;
Vermeulen and Vansteelandt, 2014). In Chapter 5 on SNFTMs, we accounted for
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estimation of all nuisance parameters except for those of the full data model. In a
next step, it would be interesting to implement this, together with verifying whether
the aforementioned property of the estimated asymptotic variance being insensitive
towards accounting for estimation of nuisance parameters is also feasible for the
EXPDR G-estimator that we proposed.
In Chapter 5, we accounted for estimation of nuisance parameters by sup-
plementing the estimating function for the causal parameter with those of the
nuisance parameters, and then obtaining a 95% Confidence interval (CI) by inver-
sion of the score test. An alternative is an estimator of the asymptotic variance
based on the sandwich method [see equation (1.83) in Chapter 1], but this has
the additional diiculty that the matrix of partial derivatives of the estimating
function with respect to the estimated parameters needs to be obtained, either
analytically or numerically. The bootstrap procedure (Wasserman, 2004) is also
an alternative, but can be tedious if it needs to include estimation of all working
models.
6.2.6 Dierences in eect estimates
Our study presents estimates for the causal eect of HAI on mortality using esti-
mators under three models: a MSPHM, a MSPHM-P, and a SNFTM. These three
models all give dierent results for this eect, we discuss briefly the possible rea-
sons for this. First, MSPHMs and SNFTMs produce parameter contrasts between
dierent types of counterfactual outcomes, and therefore lead to dierent interpre-
tations. The SNFTM maps at each time-point the observed into the exposure-free
survival time within subgroups formed by exposure At and prognostic factors
Lt, therefore producing conditional contrasts. The MSPHM on the other hand,
produces parameter estimates of population contrasts that are unconditional or
strictly conditional on baseline variables, meaning that it calculates the hazard
for the entire population being exposed, even when this would be unrealistic in
practice. Due to the dierent eect types and to the non-collapsibility of condi-
tional eects in nonlinear models (Herna`n et al., 2011), it is problematic to directly
compare estimates from SNFTM and MSPHM modelling approaches on the same
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data. The following approaches might enhance comparability. One can compare
the predicted counterfactuals of both models that do have realistic interpretation,
in our case this would be the survival times under absence of exposure. Related to
this, is Chevrier et al. (2012)’s approach to fit a proportional hazard model on the
counterfactuals produced by the SNFTM, to obtain causal parameter estimates
in the form of hazard ratios. In the context of a point treatment study, Sato and
Matsuyama (2003) explain a modification of the inverse probability weights under
a marginal structural model that leads to conditional (instead of population) esti-
mates. Herna`n et al. (2005) describe a way to convert the causal survival time ratio
as estimated by a SNFTM into a causal hazard ratio. Also, Robins et al. (1994) de-
scribe an approach to derive population contrasts from SNFTMs using a technique
called “blipping up”, which was recently adopted by Piccioo et al. (2012) under a
Structural nested cumulative failure time model.
Next to this, we list other reasons that help explain the found dierences in
eect estimates. The studies on MSPHMs and MSPHM-Ps looked at the eect of
ICU-acquired pneumonia, while the study using SNFTMs looked at the eect of
Ventilator-associated pneumonia, which is a subgroup of the former group. We
studied ICU mortality as outcome in the studies on MSPHMs and SNFTMs, while
this was hospital mortality in the study on MSPHM-P. Also, dierent datasets
were used, with national multicentric data used for the MSPHMs and SNFTMs
(however from dierent time-periods), while data from one center was used for the
MSPHM-P. Estimation under all three models suered from extreme IPC weights,
but we handled this issue in dierent ways in the three studies. For the study on
the MSPHM, we truncated weights starting at the subject day that these exceeded
a certain value, a strategy which was also followed in the study using a SNFTMs
but repeated for a number of truncation ranges. This study also presented an
analysis that allowed IPC weights being set to 1. On the other hand, the study on
the MSPHM-P avoided extreme IPC weights by limiting the number of days within
its exposure regimes. Our hypothesis is that this last analysis feature might have
the most impact on the dierences between the results of the three studies, more
specifically on the reason why the study using the MSPHM-P presents a harmful
eect while the other two present slightly protective towards neutral eects. The
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studies using the MSPHMs and the SNFTMs also demonstrate a harmful eect of
infection on mortality late aer infection onset, which is in agreement with the
harmful eect found by the MSPHM-Ps if we would assume that this estimate is
driven by mortality occurring late aer infection onset.
6.2.7 Interpreting and using eect estimates
Given the protective and neutral aributable mortality eects that we found for
ICU-acquired pneumonia and/or VAP, it would be problematic to conclude that
prevention for these types of HAI is not needed any more. Next to investigating the
eects of infection on morbidity outcomes (see the next section), these results also
call for verifying whether the case definition of the studied infection type is sui-
ciently specific. It is worth noting for example that the majority of ICU-acquired
pneumonia (and therefore also of VAP that are declared in the NSIH-ICU program
are diagnosed using so-called “semi-or non-quantitative” techniques, which are
know to be much less specific than quantitative techniques for pneumonia detec-
tion (Fagon et al., 1993; Chastre et al., 2003). A future strategy might therefore exist
in defining subgroups of infection (based on diagnostic strategy for example) that
give higher risks for mortality, and investigate the aributable mortality for these
specific subgroups. Such knowledge can then form a basis for possible fine-tuning
of case definitions used for standardised surveillance.
6.2.8 Analysing morbidity
While this study focused on estimators for the aributable eect of HAI on mor-
tality, it would also be of interest to look at eects on morbidity parameters, such
as Length of stay (LOS) within the unit or hospital, or use of medical treatment.
Consider the estimation of the aributable eect of HAI on morbidity outcome
“discharge alive from the ICU”. Such analysis will aim to estimate the extra LOS that
HAI-patients need to recover from HAI, as compared to uninfected patients. To esti-
mate this eect, we will need to adjust carefully for all available time-independent
and -dependent confounders for the HAI-LOS association, and secondly we need
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Figure 6.1: Causal directed acyclic graph depicting non-causal association between expo-
sure (A) and the morbidity outcome (Y ) through the mortality event (D).
to separate the eect on mortality from the one on discharge alive from the ICU.
Analysing time to discharge from the ICU, and using LOS of both survivors as
well as non-survivors to do so, will be problematic. This is because LOS can be
the result of dierent pathways that patients can follow in response to HAI, for
example with infection leading to death (discharge alive) being due to absence
(presence) of appropriate treatment. This means that the analysis will be chal-
lenged by mortality acting as a competing event for the morbidity outcome, in the
remaining paragraphs we demonstrate this further and outline eventual estimation
strategies.
As an example, we consider a study with a single time point Tm = 1. We
assume the causal DAG of Figure 6.1, with variables U0, A, L as explained before,
and variables D and Y now representing the mortality and morbidity (for example
“discharge alive from the unit”) events respectively. Causal DAG (6.1) shows a
“survivors-only” analysis in which D is surrounded by a box, indicating that the
analysis selects on observations with D = 0. In such analysis, non-causal paths
A→ D ← L→ Y andA→ D ← L← U → Y will be opened through collider-
stratification on D. Stratification on variable L to block these paths then leads to a
stratified model for the risk of morbidity Y , for example P (Y = 1|a, L,D = 0; βm)
indexed by unknown parameter βm. Now consider the counterfactual outcomes
Ya and Da, or the outcomes that would be observed if exposure level A = a would
be assigned instead of the observed exposure level. Note that we do not consider
the counterfactual Y(a,d=0), or the morbidity outcome when assigning exposure
level A = a and when keeping the subject alive (d = 0), because we consider the
event D to be non-intervenable. By this, for the two outcomes Y and D combined,
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define the set of counterfactual outcomes (Ya, Y1−a, Da, D1−a).
Using the aforementioned stratified model for the risk of morbidity outcome
Y , we aempt to formulate a causal contrast that compares the risk of morbidity
across exposed and unexposed subjects as follows:
P (Y = 1|A = 1, L,D = 0; βm)
P (Y = 1|A = 0, L,D = 0; βm) =
P (Y1 = 1|A = 1, L,D1 = 0; βm)
P (Y0 = 1|A = 0, L,D0 = 0; βm)
=
P (Y1 = 1|L,D1 = 0; βm)
P (Y0 = 1|L,D0 = 0; βm) (6.3)
in which the first equality is due to the consistency assumption, and the second
due to SRA (modified to include conditioning on Da = 0). Contrast (6.3) cannot be
considered as a causal contrast. This is because the numerator and denominator
of (6.3) are defined within dierent subgroups, being based on D1 = 0 and D0 = 0
respectively. To resolve this, we might be tempted to rely on ICA and remove
the conditioning statement D = 0 from the expectations in contrast (6.3), as we
did previously in the context of censoring due to discharge alive from the ICU.
However, a typical censoring event leads to an unobserved outcome, while under a
“dropout due to death” scheme, the outcome event is simply undefined. Use of ICA
will be therefore invalid.
The morbidity event being undefined in a subject that drops out due to death is
also the reason why contrast (6.3) is non-causal. To see this, in the numerator of this
contrast, the subgroup D1 = 0 will be a mixture of subjects having (D0 = 0, D1 =
0) and subjects having (D0 = 1, D1 = 0), or those subjects that will survive no
maer what exposure level [hence called “always survivors (as)”] and those that
will only survive when being unexposed (or where exposure protects against death)
respectively. The denominator of (6.3) uses subgroup D0 = 0, which is a mixture of
subjects having (D0 = 0, D0 = 0) and subjects having (D0 = 0, D1 = 1), or the
same “as” group as used for the numerator but now complemented with subjects
that only survive when being exposed (or where exposure leads to death). We see
now that the expectations in the numerator and denominator of contrast (6.3) both
condition on subgroup “as”, but that they dier in terms of their complementing
subgroups. It is clear that a comparison of the risk of morbidity between groups
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(D0 = 1, D1 = 0) and (D0 = 0, D1 = 1) is non-causal, because a subject of the
former group can never be part of the laer group. Also, within each one of these
subgroups, it will be impossible to validly compare the risk of morbidity, because
it will be undefined due to death in one of the contrast’s studied exposure levels.
Subgroups defined by counterfactual mortality outcomes under possible levels of
exposure are called Principal strata. Following the above arguments, we will aempt
to restrict the estimation of the causal contrast towards subgroup “as”, which is
called Principal stratification (Robins, 1986, Section 12.2; Frangakis and Rubin, 2002).
Because we cannot identify from the observed data which subjects belong to this
principal stratum, identifying assumptions will need to be formulated that allow
calculating the causal contrast within this subgroup. Following this, and using a
longitudinal study design, (Tchetgen Tchetgen, 2014) recently introduced Survivor
Marginal structural models, which are described to estimate causal contrasts in
individuals that would survive any exposure regime.
6.3 Final conclusion
When searching methods for the statistical estimation of the aributable eect
of HAI on mortality, one needs to avoid (1) the time-dependent confounding by
prognostic factors for mortality that can act as cause and eect of infection, and
(2) the selection bias due to non-ignorable censoring and caused by only analysing
data from subjects under follow-up within the ICU or hospital. Estimators from
causal inference are able to correct for these issues. However, these are known
to struggle with strong associations between the censoring event and particular
time-dependent factors, including exposure to HAI. We proposed novel estimators
of joint causal eects that (1) allow to use exposure regimes and study endpoints
that are less sensitive towards non-ignorable censoring, and (2) provide robustness
of the causal estimand towards misspecification of the model for censoring.
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